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The aorta is not simply a tube or conduit, but a highly complex part of the vascular tree, 
originating from the left ventricular (LV) outflow tract and aortic valve and extending to its 
major thoracic and abdominal branches. Passing blood from the heart to the limbs and major 
organs is one functional aspect of the aorta; of equal importance is its capacity to distend and 
recoil in response to pulsatile flow, thereby reducing afterload for the LV and facilitating diastolic 
perfusion of the coronary arteries. 
 Intrinsic aortic wall abnormalities have been described in inherited connective tissue disorders 
like Marfan syndrome and bicuspid aortic valve disease, in which loss of fibrillin-1 microfibrils 
will lead to dissociation of smooth muscle cells from the medial matrix components, resulting in 
accelerated cell death and matrix disruption (1-3). Recent reports in literature indicate similar aortic 
involvement in patients with classical congenital heart disease entities such as tetralogy of Fallot, 
transposition of the great arteries, coarctation of the aorta and patients after the Ross procedure, 
suggesting a similar degenerative process that results in structural weakness of the aortic wall 
(1). Whether these aortic wall changes result from an intrinsic medial abnormality like in Marfan 
Syndrome or are secondary to hemodynamic states before and after surgical repair (or both) is 
unknown (1). Whatever the etiology of aortic wall pathology given this heterogeneity, aortic 
dilatation and reduced aortic elasticity will evolve when loss of structural support of the aortic wall 
progresses (1,3). 
 Interestingly, increased aortic dimensions and reduced aortic elasticity may be the initial steps 
in a negative cascade affecting aortic valve competence and LV function. Aortic elasticity is an 
important determinant of LV afterload, as a compliant aorta permits phasic distension and recoil 
in response to pulsatile flow, thereby reducing afterload for the LV (4,5). Reduced elasticity will 
therefore lead to increased systolic blood pressure and pulse pressure, which in turn will increase 
myocardial oxygen demand by increasing LV afterload (6). Furthermore, aortic stiffness proved 
to be an important determinant of the myocardial ischemic threshold in coronary artery disease 
during exercise, underlining the relation between aortic stiffness and myocardial performance (7). 
 Both reduced elasticity and dilatation of the aorta have a detrimental effect on aortic valve 
function, especially if the aortic valve is already structurally malformed by being bicuspid or 
quadricuspid (8). Increased dimensions of the aortic annulus lead to loss of coaptation of the 
aortic valve leaflets, resulting in varying degrees of central aortic regurgitation (3). In addition, 
aortic valve dynamics are closely related to distensibility of the aortic root. During systole, as the 
aortic valve opens, the aortic root should expand simultaneously (8,9). Any disturbance in this 
synchronized process results in increased stress on the aortic valve leaflets, which will ultimately 
result in degeneration of the aortic valve leaflets and consequent aortic regurgitation (8,10,11). 
Aortic regurgitation will then lead to a volume overload of the LV, hence increasing LV dimensions 
that consequently will result in decreased LV ejection fraction (12).
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 As life expectancy of congenital heart disease patients has significantly improved over 
the past decades, pediatric and adult cardiologists will be increasingly confronted with the 
challenge of patients with concomitant aortic sequelae. Therefore, non-invasive monitoring of 
aortic dimensions and elasticity, in conjunction with aortic valve competence and LV function, is 
clinically highly desirable in patients with potential aortic wall abnormalities. Echocardiography 
is widely used for routine assessment of the aortic root, aortic valve and ventricular function, but 
does not permit evaluation of the entire aorta (13). Magnetic resonance imaging (MRI) provides 
advantages such as unlimited field-of-view within the entire thorax for accurate and reproducible 
assessment of aortic and cardiac anatomy and function (13-15). Recently, MRI has also been 
established as an accurate non-invasive tool for assessment of aortic stiffness by measuring aortic 
distensibility and pulse wave velocity, as MRI allows for correction of through-plane motion for 
distensibility measurements and for direct measurement of the path length of pulse waves in the 
proximal and distal aorta, even in the presence of a tortuous aortic vessel (16). 
 The main objective of the current thesis is to assess aortic wall elasticity and aortic 
dimensions and their impact on aortic valve competence and LV function in patients with a 
bicuspid aortic valve, transposition of the great arteries, tetralogy of Fallot and patients after 
the Ross procedure, with the use of MRI. In addition, MRI was also used to test whether a similar 
interaction is present between pulmonary artery dynamics and the right ventricle in the above 
mentioned entities. 
 Chapter 2 reviews the 5 most common entities of inherited connective tissue disorders 
and classical congenital heart disease with intrinsic aortic wall abnormalities, with description 
of the potential role of MRI in their evaluation and management. Chapter 3 describes in 
vivo validation, as well as testing of reproducibility of aortic pulse wave velocity as assessed 
with MRI, as indicator of aortic elasticity.  Chapter 4 studies aortic elasticity, aortic valve 
competence and LV function in non-stenotic bicuspid aortic valve patients. Chapter 5 and 
6 describe aortic elasticity, aortic valve competence and LV function, and the results of 
pulmonary flow dynamics in relationship with right ventricular function in patients after the 
arterial switch operation, respectively. Chapter 7 addresses aortic dimensions and elasticity 
in conjunction with aortic valve and LV function in patients with repaired tetralogy of Fallot 
after pulmonary valve replacement. Chapter 8 describes the outcome of patients who have 
previously undergone the Ross procedure in our institution for a dysfunctioning aortic valve. 
Chapter 9 studies aortic elasticity, aortic valve competence and LV function in patients after 
the Ross procedure. Finally, Chapter 10 describes the results of pulmonary flow dynamics in 
relationship with right ventricular function in patients after the Ross procedure.
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MR Imaging of Structure and Function of the Aorta in 
Inherited and Congenital Aortic Disease




In this chapter the 5 most common entities of inherited connective tissue disorders and classical 
CHD with intrinsic aortic wall abnormalities will be discussed, including Marfan syndrome, 
bicuspid aortic valve disease, coarctation of the aorta, tetralogy of Fallot and transposition of the 
great arteries, with description of the potential role of MRI in their evaluation and management.
2. Disease: five entities with aortic wall abnormalities
2.1. Marfan syndrome
Prevalence and epidemiology
Marfan syndrome is a heritable connective tissue disorder resulting in a highly variable 
degree of premature aortic medial degeneration with a high risk of progressive aortic 
dilatation and subsequent aortic dissection or rupture (1,2). Marfan syndrome is caused by 
a mutation of the FBN1 gene on chromosome 15 that codes for fibrillin-1, in the absence of 
which elastin is more readily degraded by matrix metalloproteinases and smooth muscle 
cells will dissociate from the medial matrix components (3,4). 
Pathophysiology and follow-up
Aortic dilatation is the most common cause of morbidity and mortality in patients with 
Marfan syndrome, as dilatation of the sinus of Valsalva is found in 60 - 80% of adult patients 
(Figure 1) (5). The relative abundance of elastic fibers in the ascending aorta as compared 
to other regions of the arterial tree, coupled with the repetitive stress of LV ejection, 
probably account for aortic dilatation that usually occurs primarily in the aortic root (5). 
Therefore, the majority of patients with Marfan syndrome present with enlargement of the 
ascending aorta or a type A dissection and only in very rare cases with a type B dissection 
involving the descending aorta (1). Aortic dissection is associated with increasing aortic 
diameter, but may also occur in non-dilated aortas (1,2). Replacement of the aortic root 
with a composite-graft conduit has been recommended before the diameter exceeds 5.0 
- 5.5 cm (1,2). Independent predictors of progressive aortic dilatation that will prompt the 
recommendation for surgery when the aorta is smaller than 5.0 cm include rapid growth 
of the aortic diameter (> 1 cm / year), a family history of premature aortic dissection (< 5 
cm), the presence of greater-than-mild aortic regurgitation (AR), and in patients who are 
pregnant or contemplating pregnancy (1,2). AR may result from distortion of the aortic 
valve cusps’ coaptation by the enlarged aortic root and occurs in 15 - 44% of patients (1). 
Especially in young children, progression of findings is more important as a criterion for 
surgery than absolute size of the aorta (1). 
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Figure 1.
Figure 1 a-b.  Black-blood turbo spin-echo MR coronal (a) and axial (b) images in a 46-year old female suspected for 
Marfan syndrome. Pear-shaped aortic root (a) with dilatation up to 5.1 cm, supporting the diagnosis 
of Marfan syndrome.
 Recent MRI reports indicate that reduced aortic distensibility is an independent predictor 
of progressive aortic dilatation, in addition to aortic diameters (2). As elastin fragmentation 
in the aortic media is scattered in an irregular pattern along the aorta, regional distensibility 
may be sensitive in the detection of regional variations in aortic stiffness (2). For optimal 
risk stratification, aortic stiffness may be taken into account in combination with aortic 
dimensions and the previously mentioned predictors of progressive aortic dilatation (4,2,5). 
MRI has been recommended for routine assessment of aortic diameters and stiffness in 
patients with Marfan syndrome, as well as for the follow-up of aortic complications such as 
intramural hematoma and aortic aneurysms (4,1,2). Evaluation of aortic dilatation should 
be performed every 6 months to determine the rate of progression, which can be extended 
to annual evaluation when the aortic size is stable over time (1). MRI can also be used to 
adequately monitor the beneficial effect of beta-blocker administration on the progression 
rate of aortic dilatation and reduction of aortic complications (1).
2.2 Bicuspid aortic valve disease
Prevalence and epidemiology 
The bicuspid aortic valve (BAV) is the most common congenital cardiac malformation, occurring 
in 1 - 2% of the population (6,7). BAV is the result of abnormal aortic cusp formation due to 
inadequate production of fibrillin-1 during valvulogenesis (4,8) (Figure 2). Adjacent cusps fuse 
to form a single aberrant cusp, larger than its counterpart yet smaller than 2 normal cusps 
combined (8). BAV is likely the result of a complex developmental pathology rather than simply 




Figure 2 a-b.  The elastic laminae of the aortic media provide structural support and elasticity to the aorta. In 
normal tricuspid valve patients (a), fibrillin-1 microfibrils tether smooth muscle cells to adjacent 
elastin and collagen matrix components. In patients with BAV (b), deficient microfibrillar elements 
result in smooth muscle cell detachment, MMP release, matrix disruption, cell death and a loss of 
structural support and elasticity. 
Previously published in: ‘Clinical and Pathophysiological Implications of a Bicuspid Aortic Valve’, Fedak et al. Circulation 2002. Published with 
permission of Elsevier. 
Pathophysiology and follow-up
AR is the most frequent (80%) complication in patients with BAV and usually occurs from cusp 
prolapse, fibrotic retraction or dilation of the sinotubular junction, in many cases requiring aortic 
valve replacement (4,8). BAV is also present in the majority of elderly patients with significant aortic 
stenosis, reflecting the propensity for premature fibrosis, stiffening and calcium deposition in these 
abnormally functioning valves (3,6). The vascular complications of BAV are less well understood and 
are associated with significant morbidity and mortality (7,8). The histology of the ascending aortic 
wall in patients with BAV shows strong similarities with the fibrillin-1-deficient aortas of patients 
with Marfan syndrome, with accelerated degeneration of the aortic media due to loss of fibrillin-1 
microfibrils as well as focal abnormalities within the aortic media such as matrix disruption and 
smooth muscle cell loss (Figure 2) (3,6). Interestingly, BAV is present in more than 70% of patients 
with coarctation, and both conditions are by themselves and certainly in combination known to be 
associated with similar aortic wall abnormalities and concomitant aortic dilatation (3,6).
 As a consequence of abnormal aortic wall composition in BAV, serious complications like 
progressive aortic root dilatation (50 - 60% of all patients with BAV) (Figure 3) and/or aneurysm 
formation may finally result in aortic dissection (5% of all patients with BAV) (7,9). Despite this lower 
incidence of aortic dissection than in Marfan syndrome (40%), BAV is the more common etiology 
in aortic dissection as Marfan syndrome is a much rarer entity (0.01% vs 1 - 2% of patients with 
BAV) (8). Two different phenotypes of aortic dilatation have been described. Dilatation of the mid-
ascending aorta is most commonly present (70%) and is associated with aortic valve stenosis, 
suggesting a post-stenotic causative mechanism (7). Aortic root dilatation is much rarer (13%), 
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being determined by male gender and degree of AR (7). Aortic root replacement is generally more 
aggressively recommended for patients with BAV (i.e., 4 - 5 cm) than for those of patients with a 
tricuspid aortic valve (i.e., 5 - 6 cm) (8). Subdivision into the 2 existing phenotypes may further refine 
the surgical approach by suggesting aortic root sparing when only dilatation of the mid-ascending 
aorta is present (7).
Figure 3.
Figure 3 a-d.  Phase contrast modulus (a) and phase (b) images of a bicuspid aortic valve, gradient-echo image of the 
aortic root (c), and gadolinium-chelate enhanced MR angiographic image of the thoracic aorta (d) in 
a 54-year old female. Note the combination of the slit-like bicuspid aortic valve with slit flow (a,b) and 
post-stenotic dilatation that measured 4.6 cm (c), together with other aortic pathology; aortic kinking 
(*, d) and pseudo coarctation (arrow, d). This patient had Turner syndrome. 
 A recent MRI study reported frequent aortic root dilatation and reduced elasticity in the 
entire aorta, suggesting that not only the proximal part of the aorta is affected in BAV, but 
that aortic wall lesions extend into the entire aorta (10). Evaluation of the elastic properties 
of the ascending aorta might be useful to identify patients who are at risk of progressive 
aortic dilatation, analogous to patients with Marfan syndrome (2,10). Increased aortic stiffness 
was also associated with LV hypertrophy, as a result of increased LV afterload (10). Sustained 
LV hypertrophy is associated with reduced diastolic filling and therefore - as diastolic LV 
dysfunction is a major contributor to congestive heart failure - the presence of LV hypertrophy 
might pose a future risk for LV function in patients with BAV (10). As many patients with BAV 
will require cardiac surgery during their lifetime, close monitoring of aortic dimensions, aortic 




2.3 Coarctation of the aorta
Prevalence and epidemiology
Coarctation of the aorta accounts for 5% of all CHD and is defined as a congenital 
narrowing of the aorta, most commonly located in a juxtaductal position just distally to 
the origin of the left subclavian artery (11). A wide spectrum of narrowing of the aorta 
can be observed, from a discrete narrowing to a hypoplastic aortic arch, whether or not 
associated with intra-cardiac defects like a VSD or aortic valve pathology (10). Classic 
symptoms are heart failure and an increased blood pressure proximal to the narrowing, 
as well as a low perfusion status of the body distally to the coarctation (10). Coarctation of 
the aorta is associated with a significantly increased cardiovascular morbidity and reduced 
life expectancy even after successful surgical correction at a young age (11-16). Structural 
aortic wall abnormalities with reduced aortic elastic properties proximal and distal to the 
site of coarctation imply that coarctation of the aorta is a systemic vascular disease (4,13). 
Neonates with coarctation were found to have reduced elastic properties of the aorta before 
and after successful operation, suggesting a primary defect (15). Concomitant presence of 
BAV in 20 - 85% of patients with coarctation and the strong histological similarity of aortic 
wall abnormalities between both entities is also suggestive for an inherited origin of aortic 
wall pathology (3,6,9).
Pathophysiology and follow-up
After initially successful surgical repair, complications may occur such as persistence of 
hypertension, recoarctation, aortic dilatation and aneurysm formation (Figure 4) (13). 
Persisting resting and exercise-induced hypertension have been reported in 10 - 46% and 
30 - 60%, respectively, being the most important postoperative cardiovascular events 
(2,12). Hypertension in coarctation is accompanied by an increase in aortic medial collagen 
and a decrease in smooth muscle (increased stiffness) that may persist after successful 
repair and coincides with aortic abnormalities of a coexisting BAV (3,4). In addition, late 
hypertension may be caused by functional recoarctation at the site of surgical repair due 
to decreased distensibility (16). Impaired LV function, increased LV mass and concomitant 
adverse LV remodeling even in postoperative patients with normal blood pressure can be 
attributed to the reduced aortic elastic properties which result in increased LV afterload (17). 
Furthermore, arterial hypertension and a resting pressure gradient are major contributing 
factors to early atherosclerotic development and should therefore be primary targets for 
therapy (13).
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Figure 4.
Figure 4 a-b.  Gadolinium-chelate enhanced MR angiographic images in a 34-year old male. Follow-up study 
after coarctation repair. Shaded surface full volume rendering display image (a) and selected vo-
lume rendering display image (b). Flow speed was significantly increased at the level of stenosis 
due to residual / re-coarctation (arrow, a, b). MR phase contrast flow volume was 7.2 l/min as 
measured immediately distal from the level of the stenosis, and 6.0 l/min measured at the level of 
the diaphragm. This indicates flow decrease from the proximal to the distal descending thoracic 
aorta, excluding hemodynamically significant collateral flow. Note the relative normal size of the 
intercostal arteries; no major collaterals were observed at MR angiography. 
 Adults after surgical repair of coarctation, especially when associated with BAV, should be closely 
monitored for detection of recoarctation as well as progressive aortic dilatation (13). Risk factors for 
these long-term aortic complications are the presence of BAV, advanced age and hypertension (4). 
Systematic MRI screening performed at 2 to 5 year intervals has been found to be the most ‘cost-
effective’ approach for the follow-up of patients after coarctation repair, with early detection of aortic 
complications like recoarctation (4,18). Spin-echo MRI is essential to detect abnormalities of the 
aortic wall and associated intracardiac abnormalities, while contrast-enhanced 3-D MR angiography 
provides a highly accurate view of the entire reconstructed aorta and this may obviate the need for 
invasive x-ray angiography by catheterization for planning of treatment (Figure 4) (14). A combination 
of anatomic and flow data obtained by MRI is able to predict a catheterization peak-to-peak gradient 
≥ 20 mm Hg, considered to be the reference standard for hemodynamic severity of (re-) coarctation 
(14). The combination of narrowest aortic cross-sectional area and heart rate-corrected mean flow 
deceleration in the descending aorta distinguishes between those who have transcatheter pressure-
gradients above and below 20 mm Hg, which can be used to determine the need for intervention 
(14). Velocity-encoded MRI is also useful to determine presence and hemodynamics of collateral 
vessels, which maintain distal aortic perfusion depending on the severity of the aortic obstruction 
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(19). Finally, promising utilities are MRI-guided balloon angioplasty and MRI-guided deployment of 
stents to repair aortic coarctation, as recent studies indicate that the combined use of MRI and X-ray 
imaging is effective for relieve of stenosis with a significant reduction of radiation exposure (20). 
2.4 Tetralogy of Fallot
Prevalence and epidemiology
Tetralogy of Fallot (TOF) is the most commonly encountered cyanotic CHD entity with a frequency 
of nearly 10% of all CHD patients (21). Anterior displacement of the outflow septum is the 
primary defect, resulting in a VSD, overriding of the aorta, RVOT obstruction and right ventricular 
hypertrophy (21). Patients after TOF repair frequently encounter longstanding pulmonary 
regurgitation and associated impaired right ventricular function after primary repair (21). 
Pathophysiology and follow-up 
Progressive dilatation of the aortic root during long-term follow-up has also frequently been 
described after TOF repair, ranging in incidence between 15 - 88% depending on definition of 
aortic root dilatation (Figure 5) (21-24). Two hypotheses have been postulated to explain this 
observation. Increased blood flow from both ventricles to the overriding aorta before surgical 
repair is thought to be an underlying pathogenic mechanism, posing increased stress on the 
aortic wall (3,21,23,24). This premise is supported by risk factors such as longer shunt-to-repair 
interval and a higher prevalence of pulmonary atresia (PA) among patients with TOF and aortic 
root dilatation (23). Secondly, histological changes of the aortic media such as non-inflammatory 
loss of smooth muscle cells and fragmentation of the elastic fibers have been reported, resembling 
those observed in patients with Marfan syndrome and BAV (3,21).
 The potential for complications of aortic root dilatation that may necessitate surgical 
intervention is increasingly recognized in patients after TOF repair (22). A recent study reported 
the progressive nature of aortic dilatation in patients with TOF, as aortic dilatation increased at 
a rate of 1.7 mm/year, in contrast to 0.03 mm/year in healthy controls (24). Also, more marked 
histological changes were observed with increasing age, suggesting that aging coupled with 
volume overloading on top of intrinsic aortic wall abnormalities have an additional adverse 
effect on the aortic histology and thus aortic dilatation (21). Additionally, AR associated with 
progressive dilation of the aortic root is frequently present and 15 - 18% of patients after TOF 
repair show mild degrees of AR (Figure 5) (24). Recent case reports of aortic dissection late after 
TOF repair in adults whose aortic roots exceeded 6 cm in diameter indicate that close monitoring 
of aortic dimensions is mandatory, especially when a dilated ascending aorta is present (25). 
Aortic root surgery may be considered for patients after TOF repair in case of progressive AR and 
aortic root dilatation exceeding 5.5 cm, particularly when the primary indication for surgery is 
pulmonary valve replacement and both procedures may be combined (26). At present, there is 
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no consensus on beta-blocker administration for prevention of progressive aortic root dilatation, 
nor at what stage aortic root surgery should be considered in patients after TOF repair (24).
2.5 Transposition of the great arteries
Prevalence and epidemiology
Transposition of the great arteries (TGA) is defined as atrial situs solitus, normal (concordant) 
connection between atria and ventricles and abnormal (discordant) ventriculo-arterial connections 
(27). The aorta arises from the right ventricle and the pulmonary artery arises from the left ventricle. It 
accounts for 4.5% of all congenital cardiac malformations (27). The arterial switch operation (ASO) has 
become the preferred method of surgery for transposition of the great arteries (TGA) (28). Although 
this technique has significantly reduced the number of sequelae associated with surgical correction of 
TGA, completion of the ASO may still predispose patients to aortic root dilatation and AR (28-30). 
Pathophysiology and follow-up 
Intrinsic aortic wall pathology in TGA has been reported due to abnormal aorticopulmonary 
septation, damage to the vasa vasorum, and surgical manipulations during the ASO, predisposing 
to aortic dilatation, aneurysm formation and even aortic dissection (Figure 6) (28,31,32). In 
addition, aortic distensibility may be reduced by impaired aortic elastogenesis as well as by scar 
formation at the site of anastomosis (28). High grade medial abnormalities in the ascending 
aorta have already been observed during the neonatal period, suggesting that they are inherited 
analogously to prototypical extremes such as in patients with Marfan syndrome or BAV (3,28). 
Figure 5 a-b.  (a) Coronal black-blood turbo spin-echo MR image of the ascending aorta in a 16-year old male with tetra-
logy of Fallot. The dilated ascending aorta has a maximum diameter of 4.0 cm. This patient has no aortic val-
ve regurgitation. (b) Coronal gadolinium-chelate enhanced maximum intensity projection angiographic 
MR image in a 36-year old male with tetralogy of Fallot after previous repair. The aortic root and ascending 
aorta are dilated (aortic root 4.8 cm, ascending aorta 4.4 cm wide). Patient has slight aortic regurgitation 




Others concluded that aortic wall abnormalities develop due to structural differences in wall 
composition between the 2 great arteries, as the former pulmonary arterial wall is exposed to 
higher systemic pressures after the ASO, posing increased stress on the neo-aortic wall which 
may ultimately lead to changes in structure and function of the neo-aortic root (32,33). Whether 
medial abnormalities are inherent or acquired remains therefore difficult to distinguish (3).
Figure 6.
Figure 6.  Oblique transverse black-blood turbo spin-echo MR image of the ascending aorta in a 19-year old male 
after the arterial switch operation with Lecompte procedure. The dilated aortic root (Ao) has a maxi-
mum diameter of 4.6 cm. Note the origin of the main coronary artery and note the anterior position of 
the pulmonary artery (P) to the aorta.
 A high incidence of AR has been reported after ASO (30% at 6 years after ASO) and is probably 
the result of a multifactorial process for which aortic root geometry, surgical techniques and 
preoperative size discrepancy between the 2 great arteries are involved (29,34). In addition, AR 
appears to be functionally correlated with aortic root dilatation and reduced elasticity of the 
proximal aorta (30). Whether or not (previous) existence of a VSD plays an additional role remains 
controversial, although its hemodynamic effect might contribute to a size discrepancy between 
the aorta and pulmonary artery (28). 
 A recent MRI report described not only frequent aortic root dilatation and AR, but also a 
cascade of events ultimately leading to LV systolic dysfunction in patients after ASO (30). Frequent 
aortic root dilatation and reduced proximal aortic wall elasticity were associated with degree of 
AR. AR subsequently lead to increased LV dimensions, which consequently resulted in decreased 
LV ejection fraction. Therefore, LV systolic dysfunction as the endpoint in a sequence of events 
poses a prognostic risk for patients after ASO (30). Further elucidation of the underlying pathogenic 
substrate of aortic wall abnormalities and its clinical repercussions for patients after ASO is however 
required, as ASO is still a relative new surgical procedure for patients with TGA (30).
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Validation and Reproducibility of Aortic Pulse Wave Velocity as 
assessed with Velocity-Encoded MRI.




Purpose: To validate magnetic resonance imaging (MRI) assessment of aortic pulse wave 
velocity (PWVMRI) with PWV determined from invasive intra-aortic pressure measurements 
(PWVINV) and to test reproducibility of the measurement by MRI. 
Materials and Methods: PWVMRI was compared with PWVINV in 18 non-consecutive patients 
scheduled for catheterization for suspected coronary artery disease. Reproducibility of PWVMRI 
was tested in ten healthy volunteers, who underwent repeated measurement of PWVMRI on a 
single occasion. Velocity-encoded MRI was performed in all participants to assess PWVMRI in the 
total aorta (Aototal), the proximal aorta (Aoprox) and distal aorta (Aodist).
Results: Results are expressed as mean ± SD, Pearson correlation coefficent (PCC) and intraclass 
correlation (ICC). Good agreement between PWVMRI and PWVINV was found for Aototal (6.5 ± 1.1 
m/s vs 6.1 ± 0.8 m/s; PCC = 0.53), Aoprox (6.5 ± 1.3 m/s vs 6.2 ± 1.1 m/s; PCC = 0.69) and for Aodist 
(6.9 ± 1.1 m/s vs 6.1 ± 1.0 m/s; PCC = 0.71). Reproducibility of PWVMRI was high for Aototal (4.3 ± 
0.5 m/s vs 4.6 ± 0.7 m/s; ICC = 0.90, P < 0.01), Aoprox (4.3 ± 0.9 m/s vs 4.7 ± 1.0 m/s; ICC = 0.87, P 
< 0.01) and Aodist (4.3 ± 0.6 m/s vs 4.4 ± 0.8 m/s; ICC = 0.92, P < 0.01).
Conclusion: MRI assessment of aortic pulse wave velocity shows good agreement with 
invasive pressure measurements and can be determined with high reproducibility.
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Introduction
The aortic wall structure undergoes degenerative changes with advancing age, which 
is associated with a decline of aortic elasticity (1-5). Numerous reports emphasize the 
importance of aortic pulse wave velocity (PWV) as an indicator of arterial stiffness and 
as a prognostic indicator for future cardiovascular events (2-12). PWV is defined as the 
velocity of the systolic wave front propagating through the aorta and is increased when 
atherosclerotic degeneration of the wall and concomitant reduction of the elastic recoil 
are present (10).
Intra-arterial pressure measurements provide the most accurate assessment of 
the aortic PWV (13,14), but this modality requires an invasive procedure and is therefore 
not suitable for widespread clinical use. Tonometry and ultrasound are established 
modalities for quantification of global vascular function, but both modalities only provide 
an estimation of the aortic PWV, due to the limited availability to obtain acoustic windows 
and the inability to spatially register the distance between the acquisition sites along the 
length of the aorta (4,5,6). In addition, as aortic wall condition may vary along the course 
of the aorta, regional assessment of aortic PWV is clinically desirable, for which both 
techniques or not suited. 
Velocity-encoded (VE) magnetic resonance imaging (MRI) allows for accurate 
assessment of the blood flow velocity with a sufficient temporal and spatial resolution to 
study the propagation of the aortic systolic flow wave (13-16). The true path length of the 
pulse wave along the aorta can directly be assessed with MRI, even in the presence of a 
tortuous course of the aorta, and regional elastic properties of the aorta can be studied, 
depending on the number of aortic segments studied.
To our knowledge, PWV-assessment using MRI has not been validated previously 
in vivo. The purpose of the current study was therefore to validate MRI assessment of aortic 
pulse wave velocity (PWVMRI) with PWV determined from invasive intra-aortic pressure 





The local medical ethics committee approved the study and informed consent was obtained 
from all participants prior to their enrollment in the study. Characteristics of the participant 
groups are listed in Table 1.
Table 1. Characteristics of participants.
                                                    
Characteristics group 1 (n = 18) group 2 (n = 10) 
male / female 15 / 3      7 / 3
age at MRI (years) * 59 ± 10 29 ± 8     
height (cm) * 174 ± 8 180 ± 10
weight (kg) * 83 ± 17 80 ± 13 
blood pressure systolic (mm Hg) during MRI * 131 ± 19 118 ± 14   
blood pressure diastolic (mm Hg) during MRI * 77 ± 13  73 ± 12
heart rate (beats per minute) during MRI * 66 ± 11 61 ± 8  
smoking (yes / no) 13 / 5 0 / 10
NYHA class II / III / IV 8 / 8 / 2
Group 1: patients for PWVMRI and PWVINV comparison.
Group 2: healthy subjects for reproducibility of PWVMRI-assessment.
Note: unless otherwise indicated, data are number of participants and data in parentheses are percentages.
* Data are mean ± standard deviation.
Abbreviations: MRI = magnetic resonance imaging; NYHA = New York Heart Association.
 Eighteen non-consecutive patients (15 male, 3 female; mean ± SD age 59 ± 10 years) 
with suspected coronary artery disease (group 1) - scheduled to undergo elective coronary 
angiography on clinical indication - were prospectively included to validate PWVMRI-
assessment by comparison with PWVINV. The mean interval between cardiac catheterization 
and MRI was 15 ± 12 days.
 Ten healthy non-smoking volunteers (7 male, 3 female; mean ± SD age 29 ± 8 years) 
without signs and symptoms of cardiovascular disease (group 2) were recruited to test 
reproducibility in PWVMRI-assessment. The volunteers were studied twice (with repositioning 
of the subjects between the two examinations) using the same MRI protocol.
 Exclusion criteria comprised of evidence of aortic valve stenosis (aortic velocity 
> 2.5 m/s on echocardiography), aortic coarctation and/or other forms of congenital 
heart disease, Marfan syndrome or a family history of Marfan syndrome and general 
contraindications to MRI.
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VE MRI for PWVMRI
MRI was performed in all participants on a 1.5-T MRI scanner with a mean acquisition time of 12 ± 
2 minutes (ACS-NT15 Intera, Philips Medical Systems, The Netherlands; software release 11, Pulsar 
gradient system with amplitude 33 mT/m and 100 mT/m/ms slew rate, 0.33 ms rise time).
 PWVMRI was assessed in the proximal aorta (Aoprox) between the ascending and proximal 
descending aorta, and in the distal aorta (Aodist) between the proximal descending aorta and the 
abdominal aorta (Figure 1A). PWVMRI of the total aorta (Aototal) was assessed using the datasets 
acquired at the ascending aorta and the abdominal aorta. Imaging sequences were previously 
described (18). In short, an oblique-sagittal single-slice segmented gradient-echo scout image 
was obtained to depict the full course of the aorta, with two transverse saturation-slabs applied 
perpendicular to the aorta (at the level of the pulmonary trunk and at the most distal level of the 
abdominal aorta depicted in the oblique sagittal scout) to indicate the location of the sites for 
subsequent through-plane VE MRI acquisition (18). One-directional through-plane non-segmented 
VE MRI using free breathing with retrospective ECG-gating was applied perpendicular to the aorta 
at the levels of the saturation-slabs in the scout image to assess the aortic flow at the 3 measurement 
sites (18). A maximal number of phases reconstructed during one average cardiac cycle resulted in 
a temporal resolution of 6-10 ms, depending on the heart rate. Arrhythmia rejection was used with 
an acceptance window of 15% of the set heart rate. Local phase correction filter was used to set 
velocity values in voxels with low magnitude to zero, in order to suppress background noise. 
Figure 1. Analysis of pulse wave velocity with MRI and invasive pressure measurements.
Figure 1 a-c.  (a) An oblique sagittal scout covering the full course of the aorta, indicating the sites for the through-
plane velocity-encoded PWVMRI assessments and the invasive pressure measurements for PWVINV: 
the ascending aorta (1), the proximal descending aorta just distal to the aortic arch (2), and the most 
distal level of the abdominal aorta depicted in the oblique sagittal scout (3). Determination of the 
onset of the three systolic flow waves for PWVMRI at the measurement sites are depicted in (b) while 
determination of the onset of the three systolic pressure waves for PWVINV at the measurement sites 
are depicted in (c). The distance between these sites and the transit time (∆t1 and ∆t2) between the 
individual onsets of the systolic flow waves (b,c) determine the PWV.
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 PWVMRI was calculated as ∆x/∆t (expressed in m/s), where ∆x is the aortic path length 
between the measurement sites and ∆t is the transit time between the arrival of the systolic 
wave front at these sites (Figure 1B) (14,18,19). The aortic path lengths between the three 
subsequent measurement sites were manually determined along the centerline of the aorta 
within the scout image by using the software package MASS (Medis, The Netherlands) (Figure 
1A) (18). Aortic velocity maps were analyzed with the software package FLOW (Medis, The 
Netherlands) (18,20). The onset of the systolic wave front was automatically determined using 
custom-made software from the resulting flow graph by the intersection point of the constant 
horizontal diastolic flow and upslope of the systolic wave front, modeled by linear regression 
along the upslope. The regression line was modeled from the flow values between 20% and 
80% of the total range.
Invasive pressure measurements for PWVINV
In the 18 patients with suspected coronary artery disease (group 1), invasive pressure-
time curves and simultaneous ECG recordings were obtained during catheterization 
immediately after vascular access, to avoid any interference by medication or performed 
procedures. Pressure measurements were acquired at three sites in the aorta, at similar 
locations as used for the PWVMRI-assessments (Figure 1A). A 6 French JR4 pressure tip 
catheter (Cordis Corporation, USA) was introduced through a 6 French sheet (Cordis 
Corporation, USA) into either one of the femoral arteries and advanced through the aorta 
until just distal to the aortic valve, for pressure measurements at the level of the ascending 
aorta. During pullback, pressure waves were recorded at multiple positions, 5.8 cm apart 
consecutively. After MRI acquisition, the pressure measurements nearest to the MRI 
measurement sites 2 and 3 were used for determining PWVINV. Pressure-time curves and 
ECG were recorded with a sampling resolution of 2 kHz during at least 10 cardiac cycles. 
The pressure-time curves recorded in the ascending and proximal descending aorta 
were used to calculate the PWVINV of the Aoprox, the pressure-time curves recorded in the 
proximal descending aorta and the abdominal aorta were used to calculate the PWVINV 
of the Aodist, and the pressure-time curves recorded in the ascending and the abdominal 
aorta were used to calculate the PWVINV of the Aototal (Figure 1C). PWVINV is similarly 
expressed by ∆x/∆t as for PWVMRI, although ∆t is the transit time between the arrival of 
the two corresponding systolic pressure wave fronts, relative to the R-wave (Figure 1C) 
(19). The onset of the systolic pressure wave front was automatically determined from 
the time point of minimal pressure prior to the upslope of the systolic pressure wave. To 
minimize variation induced by respiration for assessment of the time point of the onset 
of the systolic pressure wave, ten consecutive cardiac cycles were analyzed and these 
time points were averaged. Offline analysis of the pressure-time curves was performed 
using custom-made software. 
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Statistical analysis
Statistical analysis was performed using SPSS for Windows (version 12.0.1; SPSS, USA). All data 
are presented as mean values ± one standard deviation, unless stated otherwise. Variation 
between the PWVMRI-assessments for validation was studied using the Pearson’s correlation 
coefficient (PCC), while variation between the PWVMRI-assessments reproducibility was 
studied using the two-way mixed intraclass correlation (ICC) for absolute agreement and the 
coefficients of variation (defined as the standard deviation of the differences between the two 
series of measurements divided by the mean of both measurements). The approach described 
by Bland and Altman (21) was followed to study systematic differences. Statistical significance 
on all tests was indicated by P < 0.05.
Results
Results of PWVMRI and PWVINV assessment are listed in Table 2.
Table 2. Results of all participants.
Parameters group 1:   group 2:
first MRI acquisition second MRI acquisition
PWVMRI Aototal (m/s) 6.5 ± 1.1  4.3 ± 0.5 4.6 ± 0.7
PWVMRI Aoprox (m/s) 6.5 ± 1.3   4.3 ± 0.9 4.7 ± 1.0    
PWVMRI Aodist (m/s) 6.9 ± 1.1    4.3 ± 0.6 4.4 ± 0.8
PWVINV Aototal (m/s) 6.1 ± 0.8
PWVINV Aoprox (m/s) 6.2 ± 1.1
PWVINV Aodist (m/s) 6.1 ± 1.0
Group 1: patients for PWVMRI and PWVINV comparison.
Group 2: healthy subjects for reproducibility of PWVMRI-assessment.
Note: data are expressed as mean ± standard deviation.
Abbreviations: MRI = magnetic resonance imaging; PWVMRI = pulse wave velocity as assessed with MRI; PWVINV 
= pulse wave velocity as assessed with invasive pressure measurements; Aototal = total aorta; Aoprox = proximal 
aorta; Aodist = distal aorta.
Validation of PWVMRI
The mean distance for PWVMRI between site 1 (ascending aorta) and site 2 (proximal descending 
aorta) was 12.0 ± 1.7 cm, the mean distance between site 2 and site 3 (abdominal aorta)
was 25.1 ± 3.0 cm. In Figure 2A, values for PWVMRI assessed in the Aototal, Aoprox and Aodist are 
presented vs PWVINV. In Figure 2B, the differences between PWVMRI and PWVINV are presented 
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using Bland-Altman plots. Good agreement between PWVMRI and PWVINV was found (Aototal: PCC 
= 0.53; Aoprox: PCC = 0.69; Aodist: PCC = 0.71) (Figure 2A). No statistically significant bias was found in 
the Aototal and the Aoprox, except for the Aodist (mean differences between PWVMRI and PWVINV in Aototal: 
0.4 ± 1.0 m/s, P = 0.08; in Aoprox: 0.3 ± 1.0 m/s, P = 0.16; in Aodist: 0.8 ± 0.8 m/s, P < 0.01). Coefficient of 
variation was 16% in the Aototal (confidence interval (CI) between -2.4 and 1.5), 16% in the Aoprox (CI 
between -2.3 and 1.6) and 13% in the Aodist (CI between -2.4 and 0.8). In the Bland-Altman plots a 
trend is present: for high values of PWVINV, PWVMRI seems to be underestimated as compared to the 
pressure measurements. This trend occurs for the total aorta, as well as for both segments.
Figure 2. PWVMRI vs PWVinv for the proximal, distal and total aorta.
Figure 2 a-b.  (a) Values for PWVMRI assessed in the proximal, distal and total aorta are shown vs PWVINV. (b) The 
differences between PWVMRI and PWVINV are presented using a Bland-Altman plot.
Reproducibility of PWVMRI
Reproducibility of PWV-assessment with MRI was examined by repeating the examination on the 
same day. The mean distance between site 1 and 2 on the first MRI assessment was 9.4 ± 1.5 cm and 
on the repeated assessment 9.4 ± 1.3 cm, and both were not statistically significant different (P = 
0.84). The mean distance between site 2 and 3 was 23.0 ± 3.6 cm and on the repeated assessment 
22.3 ± 3.5 cm, and also these data were not statistically significant different (P = 0.38). The values 
for repeated PWVMRI-assessment in the Aototal, Aoprox and the Aodist are presented in Figure 3A; the 
differences are presented in Figure 3B. Reproducibility was high, as PWVMRI in the Aototal, Aoprox and 
Aodist showed good intraclass correlation between the repeated examinations (Aototal: ICC = 0.90, 
P < 0.01; Aoprox: ICC = 0.87, P < 0.01; Aodist: ICC = 0.92, P < 0.01), with no statistically significant bias 
(mean difference Aototal: 0.2 ± 0.4 m/s, P = 0.22; mean difference Aoprox: 0.4 ± 0.6 m/s, P = 0.06; mean 
difference Aodist: 0.1 ± 0.4 m/s, P = 0.60). Coefficient of variation was 9% in the Aototal (CI between -0.7 
and 1.5), 13% in the Aoprox (CI between -0.7 and 0.8) and 9% in the Aodist (CI between -0.6 and 0.9).
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Figure 3. Reproducibility of aortic Pulse Wave Velocity with MRI.
Figure 3 a-b.  (a) The values for PWVMRI assessment in the proximal, distal and total aorta for the repeated 
examination. (b) The differences using a Bland-Altman plot.
Discussion
The main findings of the current study are: 1. aortic pulse wave velocity as assessed with MRI 
(PWVMRI) is in good agreement with aortic pulse wave velocity determined from invasive intra-
aortic pressure measurements (PWVINV); 2. reproducibility is high for PWVMRI-assessment of the 
total aorta, the proximal aorta and the distal aorta.
 Despite numerous reports using MRI to assess the aortic pulse wave velocity (8,10,14,18,19), 
PWVMRI has not been previously validated in vivo. Bolster et al. (14) validated PWVMRI-
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assessment in a flow phantom, showing excellent agreement with PWVINV. However, these 
modelling conditions do not hold in vivo and limitations should be considered. As the aorta 
is not a straight tube, the bended shape of the proximal aorta and the multiple branches 
along the length of the aorta will produce wave reflections that may corrupt pulse wave 
velocity assessment, affecting both MRI and invasive pressure measurements (16,19). A similar 
phenomenon occurs in the abdominal aorta, with the abdominal bifurcation producing aortic 
wave reflections (19). In addition, the number of elastic components of the aorta is known to 
vary as a function of anatomic position, significantly decreasing from the elastic aortic root 
to the muscular peripheral vessels (15,22). In this study PWVMRI and PWVINV were acquired two 
weeks apart on average, so physiological variation as part of day-to-day differences in blood 
pressure, blood flow and sympathetic tone may have played a role in the found differences 
(23,24). Also, variation in the heart rate may result in a slight variation in velocity waveforms 
from cardiac cycle to cardiac cycle, causing errors in the assessed pulse wave velocity (14). 
Nevertheless, the agreement between PWVMRI and PWVINV was strong in our study, especially 
for the two measured aortic segments, indicating that PWVMRI is a reliable non-invasive imaging 
method especially to assess regional aortic PWV. The potential underestimation in PWVMRI due 
to the underestimation of the measured aortic distance in 2D and not in 3D, will increase for 
longer aortic segments. The curvature of the proximal aorta when compared to the more 
straight distal aorta is probably a similar potential source of error. Therefore, PWVMRI of the 
proximal and especially the distal aorta with a shorter aortic path length will probably show 
less underestimation and better correlation than for the total aorta. Interestingly, PWVMRI of 
all aortic segments but especially of the distal aorta underestimated the true PWV, as PWVMRI 
values showed a trend to be lower than the measured PWVINV values.
 In this study, the onset of the systolic wave front was used to determine the time interval 
between the subsequent flow and pressure waves. Stefanov et al. demonstrated that usage of 
the onset of the systolic wave front minimizes the disruptive effect of strong wave reflections 
close to aortic branches, as this feature maintains its identity in the propagating wave (19). 
Physiological widening of the aortic wave form and the decrease of the slope of the aortic 
wave form along the course of the aorta due to wave reflections and damping by the aortic 
wall will result in artificial prolonging of the time interval between two subsequent acquisition 
points when the half-heights of the rising systolic flow waveforms or peak-to-peak analysis are 
used (19).
 PWVMRI with repeated examination on the same day showed good agreement in our study, 
with an acceptable coefficient of variation (between 9% and 13%) and intraclass correlation 
(0.87 or higher). Differences can largely be attributed to physiological variation in PWV (22,23), 
as all subjects were studied under similar study conditions and our used PWVMRI-analysis 
method was almost operator independent with automatic depiction of the onset of systolic 
wave forms. Given the coefficient of variation between 9% and 13%, a single PWVMRI-acquisition 
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may over- or underestimate the representative individual PWVMRI by approximately 0.5 m/s. 
As an increase in aortic pulse wave velocity of 1 m/s is associated with a relative risk of all-
cause mortality of 1.39 (24), the variation in PWV seems of acceptable relevance in the clinical 
interpretation of individual results. PWVMRI should therefore preferably be used as an indicative 
value for clinical purposes, and should be combined with other parameters like elevated blood 
pressure and MRI-assessed variables such as left ventricular function and left ventricular mass 
to depict cardiovascular disease (15).
 Our study has limitations. PWVMRI-assessment is based on cross-sectional data acquisition 
of the aortic flow, whereas PWVINV data are acquired locally in the aorta, namely at the tip of 
the catheter. Another limitation is the difficulty to exactly co-register the acquisition sites 
for pressure measurements and MRI-acquisition, although predefined sites were checked 
under fluoroscopy guidance. A potential limitation of our used analysis approach for the MRI 
measurements is related to the used high VENC, as measuring low velocities during the onset 
of the systolic wave front may become inaccurate due to the increased noise level (25). The 
precise determination of the onset of the systolic wave form may have been affected, although 
the high temporal resolution of our used sequence provided a dense set of data points along 
the course of the resulting flow graph. Depiction of the full course of the aorta with the single-
slice scout image may be difficult in case of advanced stages of atherosclerosis or scoliosis due 
to elongation and a tortuous course of the aorta. Aortic imaging using 3-D MR angiography 
may be helpful in these cases. PWVMRI and PWVINV were acquired two weeks apart on average, 
so physiological variation as part of day-to-day differences in blood pressure, blood flow and 
sympathetic tone may have played a role in the found differences. Further studies are required 
to assess the value of aortic pulse wave velocity in larger cohorts of patients with vascular 
disease as well as in patients with different risk profiles. 
 In conclusion, non-invasive MRI assessment of regional and global aortic pulse wave velocity 
shows good agreement with the gold-standard as derived by invasive pressure measurements 
and can be determined with high reproducibility. In the future, evaluation with MRI of shorter 
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Reduced Aortic Elasticity and Dilatation Are Associated With 
Aortic Regurgitation and Left Ventricular Hypertrophy in Non-
stenotic Bicuspid Aortic Valve Patients.




Purpose: Intrinsic pathology of the aortic wall is a possible explanation for reduced aortic 
elasticity and aortic dilatation in patients with a bicuspid aortic valve (BAV), even in the 
absence of a stenotic aortic valve. The relationship between aortic wall elasticity, aortic 
dimensions, aortic valve competence and left ventricular (LV) function in patients with BAVs 
has not previously been studied with magnetic resonance imaging (MRI). This study sought to 
assess elasticity and dimensions of the aorta and their impact on aortic valve competence and 
LV function in patients with a nonstenotic BAV.
Materials and Methods: MRI was performed in 20 patients with nonstenotic BAVs (mean ± SD, 
age 27 ± 11 years) and 20 matched control patients.
Results: The BAV patients showed reduced aortic elasticity as indicated by increased pulse 
wave velocity in the aortic arch and descending aorta (5.6 ± 1.3 m/s vs 4.5 ± 1.1 m/s, P = 0.01; 
and 5.2 ± 1.8 m/s vs 4.3 ± 0.9 m/s, P = 0.03, respectively) and reduced aortic root distensibility 
(3.1 ± 1.2*10−3 mm Hg−1 vs 5.6 ± 3.2*10−3 mm Hg−1, P < 0.01). In addition, BAV patients showed 
aortic root dilatation as compared with control patients (mean difference 3.6 to 4.2 mm, P ≤ 
0.04 at all 4 predefined levels). Minor degrees of aortic regurgitation (AR) were present in 11 
patients (AR fraction 6 ± 8% vs 1 ± 1%, P < 0.01). The LV ejection fraction was normal (55 ± 8% 
vs 56 ± 6%, P = 0.61), whereas LV mass was significantly increased in patients (54 ± 12 g/m2 
vs 46 ± 12 g/m2, P = 0.04). Dilatation at the level of the aortic annulus (r = 0.45, p = 0.044) and 
reduced aortic root distensibility (r = 0.37, P = 0.041) correlated with AR fraction. Increased 
pulse wave velocity in the aortic arch correlated with increased LV mass (r = 0.42, P = 0.041).
Conclusion: Reduced aortic elasticity and aortic root dilatation were frequently present in 
patients with nonstenotic BAVs. In addition, reduced aortic wall elasticity was associated with 
severity of AR and LV hypertrophy.
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Introduction
The bicuspid aortic valve (BAV) is the most common congenital cardiac malformation, 
occurring in 1% to 2% of the population (1-3). Intrinsic pathology of the aortic wall has been 
reported because of accelerated degeneration of the aortic media, indicating that BAV disease 
extends beyond the aortic valve (1,4). Given that serious complications like progressive aortic 
dilatation, aneurysm formation and even aortic dissection will develop in at least one-third of 
patients with BAVs, the bicuspid valve may be responsible for more deaths and morbidity than 
the combined effects of all other congenital heart defects (4).
 Intrinsic aortic wall pathology in BAV disease is associated with aortic dilatation (2,4-7), but also 
may have a negative impact on aortic elasticity. In Marfan syndrome, increased aortic stiffness has 
been reported because of fragmentation of elastic wall components (8) as Marfan syndrome and 
BAV disease have many histological and clinical similarities (4,5), reduced aortic elasticity may be 
present in BAV patients as well. Distensibility and pulse wave velocity (PWV) in the aorta are markers 
of vessel wall integrity because they are dependent on the elastic properties of the aorta (1,9). 
Previous reports have indicated the clinical importance of both parameters: reduced distensibility 
of the aortic root increases leaflet stress and therefore predisposes for aortic valve dysfunctioning 
and subsequent impaired left ventricular (LV) function (10-12). Additionally, aortic PWV is an 
independent predictor of progressive aortic dilatation in Marfan syndrome (8) and when increased, 
directly leads to an increased afterload for the LV (9). Because intrinsic aortic wall abnormalities in 
BAV disease may be associated with impaired distensibility and PWV, both parameters might have 
a negative impact on aortic valve and LV function in patients with BAV disease.
 Recently, magnetic resonance imaging (MRI) has been established as an accurate 
noninvasive tool for assessment of aortic distensibility and PWV (13-16). To our knowledge, 
MRI has not been used previously to study the relationship between aortic wall elasticity, 
aortic dimensions, aortic valve competence and LV function in patients with BAVs.
 We hypothesized that intrinsic aortic wall pathology as measured by abnormal distensibility 
and PWV in nonstenotic BAV patients frequently occurs and that abnormal aortic elastic 
properties and aortic dilatation may negatively affect aortic valve and LV function. In the 
present study we excluded BAV patients with echocardiographic evidence of aortic valve 
stenosis to avoid the confounding effect on aortic elasticity of mechanical stresses placed on 
the aortic wall downstream of a stenotic valve (1,2).
 Accordingly, the purpose of the current study was to assess aortic wall elasticity and aortic 






Twenty patients with BAVs and 20 age- and gender-matched healthy subjects were 
prospectively studied with MRI at our institution. Twenty patients with BAVs were recruited 
from our local congenital heart disease database (mean ± SD, age 27 ± 11 years). Inclusion 
criteria consisted of BAV as diagnosed by echocardiography. Exclusion criteria were evidence 
of aortic valve stenosis (aortic velocity > 2.5 m/s on echocardiography) (17), aortic coarctation 
and/or other forms of congenital heart disease, Marfan syndrome or a family history of Marfan 
syndrome, previous surgery or intervention, usage of medication such as beta-blockers and 
general contraindications to MRI.
Table 1. Characteristics of BAV patients and healthy subjects.
Characteristics patients (n = 20)  healthy subjects (n = 20)
male / female 13 (65) / 7 (35)  13 (65) / 7 (35)
age at MRI (years) * 27 ± 11 27 ± 12
height (cm) * 175 ± 8 174 ± 11
weight (kg) * 69 ± 12 68 ± 15
Body Surface Area (m2) * and † 1.8 ± 0.2 1.8 ± 0.3
blood pressure systolic (mm Hg)  * 128 ± 8 121 ± 11
blood pressure diastolic (mm Hg) * 79 ± 7 70 ± 11
heart frequency (beats per minute) * 71 ± 9 66 ± 11
New York Heart Association class I 20 20
smoking (yes / no) 6 / 14 5 / 15
Note: unless otherwise indicated, data are number of patients, and data in parentheses are percentages.
* Data are mean ± standard deviation.
† According to the formula: √ (height (cm) x height (kg) / 3600).
Abbreviations: BAV = bicuspid aortic valve; MRI = magnetic resonance imaging.
 Age- and gender-matched healthy subjects were selected from our local database of 
subjects with an innocent heart murmur in the past, in whom congenital cardiac pathology 
had been excluded by physical examination and echocardiography. Characteristics and 
functional status as expressed as New York Heart Association class of the patients and 
healthy subjects were obtained from the patient records (Table1). The local medical ethics 
committee approved the study and informed consent was obtained from all participants 
before their enrollment in the study.
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MRI
The MRI studies were performed with a 1.5-T system (NT 15 Gyroscan Intera; Philips Medical 
Systems, The Netherlands).
 Aortic diameters and cross-sectional aortic areas were measured from transaxial images 
obtained with a gated steady-state free-precession sequence. Scan parameters encompassed field-
of-view 220 mm, rectangular field-of-view percentage 90%, repetition time 3.2 ms, echo time 1.23 
ms, gate width 34.2 ms, flip angle 50°, acquired voxel size 1.25 × 1.25 × 6.00 mm, reconstructed voxel 
size 0.43 × 0.43 × 6.00 mm, trigger delay 600 ms after the R-peak. Individual slices were obtained 
at the level of the annulus of the aortic valve, the sinus of Valsalva, the sinotubular junction and the 
proximal ascending aorta, the latter at the level of the pulmonary trunk (Figure 1).
Figure 1. Diameter Measurements of the Aortic Root.
Figure 1.  Oblique coronal image showing the 4 diameter measurements of the aortic root: at the level of the 
annulus of the aortic valve (1), the sinus of Valsalva (2), the sinotubular junction (3) and the ascen-
ding aorta at the level of the pulmonary trunk (4).
Aortic distensibility was measured at the level of the sinotubular junction. Distensibility (in mm Hg−1) 
is calculated according to the following formula: (Amax - Amin) / (Amin × (Pmax - Pmin)), with Amax and Amin as 
maximal and minimal lumen area (in mm2) of the sinotubular junction, and Pmax and Pmin as systolic 
and diastolic blood pressure (mm Hg) (15). Maximal lumen area is expected at the peak of aortic flow 
and minimal lumen area is expected before the systolic flow curve (coinciding with the isovolumetric 
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contraction phase) (16). Minimal and maximal lumen area MRI was performed after manually 
positioning the acquisition planes perpendicular to the aorta at the level of the sinotubular junction 
(Figure 2), at time points of minimal and maximal flow through the aortic root, respectively (16). This 
approach enabled correction for through-plane motion of the aortic root during contraction (16). 
Scan parameters were identical to the diameter measurements; gate delay was individually applied 
for optimal timing of the acquisition (16). For timing of aortic flow, a phase-contrast sequence was 
used at the level of the sinotubular junction with scan parameters: field-of-view 300 mm, rectangular 
field-of-view percentage 90%, repetition time 4.8 ms, echo time 2.8 ms, flip angle 20°, acquired voxel 
size 2.34 × 2.34 × 8.00 mm, reconstructed voxel size 1.17 × 1.17 × 8.00 mm, using retrospective gating. 
Temporal resolution was approximately 10 ms depending on the heart rate. The sequence was 
encoded for a through-plane velocity up to 200 cm/s (16). The same acquisition was also used for 
assessment of aortic valve competence and measurement of peak flow velocity across the aortic valve. 
Aortic regurgitation (AR) fraction was considered significant if the regurgitant fraction was > 5% of the 
systolic forward flow (16). Blood pressure was noninvasively obtained using a semiautomatic MRI-
compatible sphygmomanometer (Invivo Research, USA). In each patient, right brachial artery systolic 
and diastolic blood pressures were measured 3 times during the measurements for distensibility, and 
the average of the measurements was used for calculations (8).
Figure 2. Distensibility Measurements of the Aortic Root.
Figure 2 a-d.  (a-b) Taken in the oblique coronal plane, these images show the slice positioning of the acquisi-
tion planes at minimal and maximal aortic flow for distensibility measurements, respectively, thus 
correcting for through-plane motion of the aortic root during contraction. Note the difference in 
position of the aortic root in both images, because of cardiac motion. (c-d) The corresponding area 
measurements in the double oblique transverse orientation.
49
Reduced Aortic Elasticity and Dilatation Are Associated With Aortic Regurgitation and Left Ventricular 
Hypertrophy in Nonstenotic Bicuspid Aortic Valve Patients
 The PWV was measured between the ascending and proximal descending aorta, and 
between the proximal descending aorta and aortic bifurcation (Figure 3). A retrospectively 
ECG-gated gradient-echo pulse sequence with velocity encoding was applied at the level 
of the pulmonary trunk to measure through-plane flow in the ascending aorta and proximal 
descending aorta (Figure 3). A second acquisition plane was positioned just above the bifurcation 
of the abdominal aorta (Figure 3). Scan parameters were identical to the sequence used for the 
distensibility measurements. During the MRI acquisition, systolic and diastolic blood pressures 
were measured as described for the distensibility measurements. The PWV was calculated as: Δx/
Δt (expressed in m/s), where Δx is the aortic path length between 2 imaging levels and Δt is the 
time delay between the arrival of the foot of the pulse wave at these levels (18).
Figure 3. Measurements of Pulse Wave Velocity of the Aorta.
Figure 3 a-b.  (a) The sites for the through-plane MRI pulse wave velocity (PWV) measurements: the ascending 
aorta (AO Asc) (1), the proximal descending aorta (AO Desc) (2), and the distal aorta (AO Dist) (3) 
above the aortic bifurcation. On the corresponding velocity-encoded images (b) (indicated by 1, 
2 and 3), the arrival time of the aortic systolic pulse-wave front can be determined by measuring 
the through-plane flow. An example of determination of the arrival time at the site of the proximal 
descending aorta is depicted in (c). The distance between the sampling locations and the different 





 Systolic LV function was assessed with a steady-state free-precession cine sequence. 
Scan parameters were: field-of-view 400 mm, rectangular field-of-view percentage 80%, 
repetition time 3.2 ms, echo time 1.6 ms, flip angle 70°, acquired voxel size 1.92 × 2.41 
× 10.00 mm, reconstructed voxel size 1.56 × 1.55 × 10.00 mm, no slice gap (19). The 
following parameters were obtained after indexation for body surface area: LV end-
diastolic volume, LV end-systolic volume, LV stroke volume, LV ejection fraction and LV 
mass (16,19).
 All images were quantitatively analyzed on a workstation with a Pentium 4 processor 
(Intel, USA). The measurements for diameters and distensibility of the aortic root as well 
as the short-axis gradient-echo images of both ventricles were analyzed with the software 
package MASS (Medis, The Netherlands) (16,19). Aortic velocity maps were analyzed with 
the software package FLOW (Medis, The Netherlands) (20). All contours and diameters were 
manually drawn by one observer (3 years of experience) and were subsequently checked 
by a radiologist who was blinded to the patient conditions (9 years of experience).
Statistical analysis
Statistical analysis was performed using SPSS for Windows (version 12.0.1, SPSS Inc., USA). 
All data are presented as mean values ± 1 SD, unless stated otherwise. The Mann-Whitney U 
test was used to express differences in variables between the patients and healthy subjects. 
Correlation between variables was expressed with the Spearman rank correlation coefficient. 
Linear regression analysis was used to identify predictors of variables with backward elimination 
procedures. Statistical significance was indicated by a P value of < 0.05.
Results
Aortic dimensions and elasticity
Patients with BAVs showed significantly increased PWV in the aortic arch and descending aorta 
(Table 2). In addition, distensibility at the level of the sinotubular junction was diminished in 
patients with BAVs as compared with the healthy subjects group (Table 2). Diameters and areas 
of the aortic root were significantly increased at all 4 levels in BAV patients as compared with 
the healthy subjects (Table 2). Dilatation was most pronounced at the levels of the sinus of 
Valsalva and the proximal ascending aorta (Table 2). Dilatation at the level of the sinotubular 
junction was significantly correlated with decreased root distensibility (r = 0.56, P = 0.004) and 
increased PWV in the aortic arch (r = 0.45, P = 0.039). The presence of BAV and older age at time 
of MRI predicted reduced root distensibility and increased PWV in the aortic arch (r = 0.5 to 0.7, 
P ≤ 0.01 for all).
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Table 2. Results in 20 BAV Patients and 20 Age- and Gender-Matched Healthy Subjects.
Parameters patients healthy subjects P value mean difference
diameter annulus (mm) 30.1 ± 6.9 26.2 ± 3.3 0.03 3.9
area annulus (cm2) 7.4 ± 3.5 5.5 ± 1.4 0.03 1.9
diameter sinus of Valsalva (mm) 33.4 ± 5.7 29.2 ± 3.2 < 0.01 4.2
area sinus of Valsalva (cm2) 9.0 ± 3.4 6.8 ± 1.5 < 0.01 2.2
diameter sinotubular junction (mm) 30.4 ± 6.2 26.8 ± 3.4 0.04 3.6
area sinotubular junction (cm2) 7.5 ± 3.5 5.7 ± 1.5 0.04 1.8
diameter ascending aorta (mm) 30.0 ± 6.3 25.7 ± 3.1 < 0.01 4.3
area ascending aorta (cm2) 7.4 ± 3.4 5.2 ± 1.3 < 0.01 2.1
distensibility (in 10-3 mm Hg-1) * 3.1 ± 1.2 5.6 ± 3.2 < 0.01
PWV aortic arch (m/s) 5.6 4.5 0.01
PWV descending aorta (m/s) 5.2 4.3 0.03
aortic regurgitation fraction (%) 6 ± 8 1 ± 1  < 0.01
peak-flow velocity at STJ (m/s) 1.68 ± 0.26 1.67 ± 0.33 0.97
LV EF (%) 55 ± 8 56 ± 6 0.61
LV EDV (ml/m2) 101 ± 22 93 ± 16  0.29
LV ESV (ml/m2) 46 ± 17 41 ± 8 0.36
LV mass (g/m
2) 54 ± 12 46 ± 12 0.04
Note: data are expressed as mean ± standard deviation.
* Distensibility was measured at the level of the sinotubular junction.
Abbreviations: BAV = bicuspid aortic valve, PWV = pulse wave velocity, STJ = sinotubular junction, LV = left 
ventricle, EDV = end-diastolic volume indexed for body surface area, EF = ejection fraction, ESV = end-systolic 
volume indexed for body surface area.
Aortic valve competence
Patients with BAVs were characterized by frequent minor degrees of AR, as 11 of 20 
patients showed AR fraction ranging between 5% and 16%. In none of the healthy 
subjects did AR fraction exceed 5%. The AR fraction (expressed in percentages) (Table 2) 
was significantly correlated with dilatation at the level of the aortic annulus (r = 0.45, P 
= 0.044) and reduced aortic root distensibility (r = 0.37, P = 0.041). Peak flow velocities 
across the aortic valve were not increased in our patient group as compared with the 





Systolic function - expressed by LV ejection fraction and LV stroke volume - was not significantly 
different between patients with BAVs and healthy subjects (Table 2). Also, LV dimensions (LV 
end-diastolic and -systolic volume) were not significantly different between the 2 groups (Table 
2). Mean LV mass of the patient group was significantly larger compared with that value in 
healthy subjects (Table 2). Increased LV mass was significantly correlated with increased PWV in 
the aortic arch (r = 0.42, P = 0.041), suggesting that LV hypertrophy results from an increased LV 
afterload. Linear regression showed that increased PWV in the aortic arch predicted increased 
LV mass (r = 0.5, P < 0.01).
Discussion
The purpose of the current study was to assess aortic wall elasticity and aortic dimensions and 
their impact on aortic valve competence and LV function in patients with nonstenotic BAVs. 
This study showed frequently reduced aortic elasticity and aortic root dilatation in patients with 
nonstenotic BAVs. In addition, reduced aortic wall elasticity was associated with the severity of 
AR and the degree of LV hypertrophy. Monitoring of aortic elasticity and aortic dimensions, in 
conjunction with aortic valve competence and LV function, seems therefore indicated in the 
long-term follow-up of patients with BAVs.
Aortic dimensions
Significant dilatation of the aortic root was present in our patient group with BAVs. Dilatation 
was most pronounced at the levels of the sinus of Valsalva and of the proximal ascending 
aorta, which is in agreement with previous ultrasound reports (21,22). Aortic dilatation may be 
caused by intrinsic pathology of the aortic wall, or hemodynamic factors caused by a stenotic 
aortic valve: high velocity and turbulent flow downstream of the stenosis place mechanical 
stress on the aortic wall (1). In this study only nonstenotic BAV patients were included, so aortic 
dilatation caused by stenotic mechanical stress was not suspected.
 Intrinsic pathology of the aortic wall in patients with BAVs has been reported because of 
accelerated degeneration of the aortic media, indicating that BAV disease extends beyond the 
aortic valve (1,4). Inadequate production of fibrillin-1 during valvulogenesis may disrupt the 
formation of the aortic cusps, resulting in a bicuspid valve and a weakened aortic root (4). These 
lesions are similar in fibrillin-1-deficient aortas of patients with Marfan syndrome (4). The BAV 
should therefore be considered a disease of the entire aortic root (1,4,7).
 As a consequence of intrinsic aortic wall pathology, the presence of BAV has been reported 
to be an independent risk factor for progressive aortic dilatation, aneurysm formation and even 
dissection (4,7). For the risk of aortic rupture and dissection, aortic root replacement is more 
aggressively recommended for patients with BAVs (i.e., 4 to 5 cm) than for those of patients 
53
Reduced Aortic Elasticity and Dilatation Are Associated With Aortic Regurgitation and Left Ventricular 
Hypertrophy in Nonstenotic Bicuspid Aortic Valve Patients
with a tricuspid aortic valve (i.e., 5 to 6 cm) (4). Long-term surveillance of aortic dimensions is 
therefore required (4).
Aortic elasticity
Significantly reduced aortic elasticity in our patient group indicated that BAV disease is not 
only associated with aortic dilatation (2,4-7), but also with reduced aortic elasticity. In Marfan 
syndrome, increased aortic stiffness has been reported because of fragmentation of elastic 
wall components (8). Considering the many histological and clinical similarities between both 
entities (4,5), intrinsic aortic wall abnormalities in BAV disease are probably responsible for 
reduced aortic elasticity as well. Our patient group showed diminished elasticity of the entire 
aorta, suggesting not only that the proximal part of the aorta is affected in BAV disease (4,21), 
but also that aortic wall lesions extend into the entire aorta.
 In patients with Marfan syndrome, aortic stiffness has proven to be an independent predictor 
of progressive aortic dilatation (8). Evaluation of the elastic properties of the ascending aorta in 
patients with BAVs might be used analogously to identify patients who are at risk of progressive 
dilatation of the aorta and other aortic sequelae. Future longitudinal studies are needed to 
investigate whether the same predictive value of aortic stiffness is applicable for patients with 
BAV disease.
 Arterial stiffness has also been shown to be a cardiovascular risk factor on its own (9). 
Augmented arterial stiffening is associated with impaired coronary blood flow and LV 
dysfunction (9). In addition, a strong and independent association has been shown between 
increased arterial stiffness and the presence of coronary artery disease (23). Therefore, prognosis 
of patients with increased arterial stiffness in BAV disease may be worse as compared with 
healthy subjects because numerous other standard risk factors such as aging, smoking, lipid 
profiles and gender are cumulative over a lifetime (9). Early detection of disturbances in arterial 
stiffness may allow for early therapeutic intervention (24). In Marfan patients, beta-blockade 
has a beneficial effect on the progression rate of aortic dilatation with reduction of aortic 
complications (8,15). Whether this is applicable for BAV patients remains to be elucidated.
Aortic valve competence
In the current study, minor degrees of AR were a common finding in our patients with BAVs. Inherent 
structural weakness of the aortic valve cusps may lead to aortic valve prolapse and subsequent 
AR (4). In this study the degree of AR was correlated with dilatation of the aortic annulus and 
decreased aortic root distensibility. Dilatation of the aortic root has been reported to have the 
potential to cause AR (4,7,16). In addition, distensibility of the aortic root is crucial for aortic valve 
dynamics: aortic valve opening occurs in concert with root expansion during the beginning of 
systole (10,25). Disturbance of this interrelation greatly determines the stress on valve leaflets 
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(10,12). We therefore hypothesize that reduced aortic root distensibility in patients with BAVs 
increases leaflet stress, and thus predisposes to aortic valve dysfunction in BAV disease.
LV function
The LV systolic function was adequately preserved in patients with BAVs. However, a significantly 
larger LV mass was observed in our BAV patients, indicating hypertrophy of the LV. Often LV 
hypertrophy is compensatory to increased LV afterload (26), which in this study was related 
to reduced elasticity of the proximal aorta. Myocardial stiffening may occur as a consequence 
of sustained LV hypertrophy, which has a negative effect on diastolic filling (26). Clinical 
studies have confirmed the detrimental effect of diastolic LV dysfunction, having a major 
contribution to congestive heart failure and diminished exercise performance (26,27). Diastolic 
LV dysfunction also may precede LV systolic dysfunctioning (26). Aging contributes to any 
diastolic dysfunction by increasing ventricular mass and loss of elastic myocardial properties 
over time (26,27). Therefore, LV hypertrophy might pose a future risk for LV dysfunction in our 
BAV patient group (26,27).
 This study showed frequently reduced aortic elasticity and aortic root dilatation in patients 
with nonstenotic BAVs. In addition, reduced aortic wall elasticity was associated with severity 
of AR and degree of LV hypertrophy. Analogous to similar entities such as Marfan syndrome, 
intrinsic aortic wall abnormalities in BAV disease result in a negative cascade that affects aortic 
elasticity, aortic dimensions, aortic valve competence and LV function. Monitoring of aortic 
elasticity and aortic dimensions, in conjunction with aortic valve competence and LV function, 
seems therefore indicated in the long-term follow-up of patients with BAVs. Future longitudinal 
studies are required to investigate the predictive value of aortic stiffness in patients with BAV 
disease.
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Aortic Elasticity and Left Ventricular Function after Arterial 
Switch Operation: MR Imaging - Initial Experience.




Purpose: To prospectively assess aortic dimensions, aortic elasticity, aortic valve competence 
and left ventricular (LV) systolic function in patients after the arterial switch operation (ASO) by 
using magnetic resonance imaging (MRI). 
Materials and Methods: Informed consent was obtained from all participants for this local 
ethics committee - approved study. Fifteen patients (11 male patients, four female patients; 
mean age, 16 years ± 4 (standard deviation); imaging performed 16.1 years after surgery ± 
3.7) and 15 age- and sex-matched control subjects (11 male subjects, four female subjects; 
mean age, 16 years ± 4) were evaluated. Velocity-encoded MRI was used to assess aortic pulse 
wave velocity (PWV) and a balanced turbo-field-echo sequence was used to assess aortic root 
distensibility. Standard velocity-encoded and multisection-multiphase imaging sequences 
were used to assess aortic valve function, systolic LV function and LV mass. The two-tailed Mann-
Whitney U test and Spearman rank correlation coefficient were used for statistical analysis. 
Results: Patients treated with the ASO showed aortic root dilatation at three predefined levels 
(mean difference, 5.7 - 9.4 mm; P =  0.007) and reduced aortic elasticity (PWV of aortic arch, 5.1 
m/s ± 1.2 vs 3.9 m/s ± 0.7, P = 0.004; aortic root distensibility, 2.2*10–3 mm Hg–1 ± 1.8 vs 4.9*10–3 
mm Hg–1 ± 2.9, P < 0.01) compared with control subjects. Minor degrees of aortic regurgitation 
(AR) were present (AR fraction, 5% ± 3 in patients vs 1% ± 1 in control subjects; P < 0.001). 
Patients had impaired systolic LV function (LV ejection fraction (LV EF), 51% ± 6 vs 58% ± 5 
in control subjects; P = 0.003), in addition to enlarged LV dimensions (end-diastolic volume 
(EDV), 112 ml/m2 ± 13 vs 95 ml/m2 ± 16, P = 0.007; end-systolic volume (ESV), 54 ml/m2 ± 11 
vs 39 ml/m2 ± 7, P < 0.001). Degree of AR predicted decreased LV EF (r = 0.41, P = 0.026) and 
was correlated with increased LV dimensions (LV EDV: r = 0.48, P = 0.008; LV ESV: r = 0.67, P < 
0.001). 
Conclusion: Aortic root dilatation and reduced elasticity of the proximal aorta are frequently 
observed in patients who have undergone the ASO, in addition to minor degrees of AR, reduced 
LV systolic function and increased LV dimensions. 
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Introduction
The arterial switch operation (ASO) has become the preferred method of surgery for transposition 
of the great arteries (TGA) (1-3). The operation consists of transection and reanastomosis of the 
aorta and pulmonary trunk above the sinuses, as well as relocation of the coronary arteries (1). 
Although this technique has substantially reduced the number of sequelae associated with 
surgical correction of TGA, completion of the ASO may still leave patients with complications 
such as aortic root dilatation and aortic regurgitation (AR) (1-5). 
 Aortic wall abnormalities in TGA have been reported that are due to abnormal 
aorticopulmonary septation, damage to the vasa vasorum, and surgical manipulations 
during the ASO, predisposing patients to aortic dilatation, aneurysm formation and even 
aortic dissection (4-7). In addition, aortic distensibility may be reduced by impaired aortic 
elastogenesis, as well as by scar formation at the site of anastomosis (8,9). Distensibility and 
pulse wave velocity (PWV) in the aorta have been shown to be markers of vessel wall elasticity, 
as they are mainly related to the elastic properties of the aorta (10-12). 
 Both aortic distensibility and aortic dimensions are crucial for aortic valve dynamics. Aortic 
valve opening occurs in concert with root expansion during the beginning of systole (13,14). 
Decreased distensibility of the aortic root increases leaflet stress and therefore predisposes 
for aortic valve dysfunction (14-16). Aortic dilatation contributes to aortic valve dysfunction 
through loss of coaptation of the aortic valve leaflets (10,17). As a consequence, impaired 
distensibility and dilatation of the aorta may lead to aortic valve dysfunction and subsequent 
impairment of left ventricular (LV) function in patients after surgical repair of TGA (10,14-16). 
 Magnetic resonance imaging (MRI) has been established as an accurate noninvasive tool 
for assessment of aortic distensibility and PWV (10,12,18-20). To our knowledge, MRI has not 
previously been used to study the relationship between aortic dimensions, aortic wall elasticity, 
aortic valve competence and LV function in patients after the ASO. We hypothesized that 
intrinsic aortic wall dysfunction, as indicated by abnormal distensibility and PWV, in patients 
after the ASO frequently occurs and that abnormal aortic elastic properties and aortic dilatation 
may be associated with reduced aortic valve and LV function. Thus, the objective of our study 
was to prospectively assess aortic dimensions, aortic elasticity, aortic valve competence and LV 





The medical ethics committee of Leiden University Medical Center (Leiden, The Netherlands) 
approved this study and informed consent was obtained from all participants prior to their 
enrollment in the study. Fifteen patients who had undergone the ASO (mean age, 16 years 
± 4 (standard deviation); imaging performed 16.1 years after surgery ± 3.7) and 15 age- and 
sex-matched healthy control subjects (mean age, 16 years ± 4) were prospectively examined 
with MRI at our institution. Characteristics of all participants are listed in Table 1. None of the 
patients who had undergone the ASO used medication. 
Table 1. Characteristics of Patients Who Had Undergone the ASO and Healthy Control Subjects .
Characteristics  patients (n = 15) healthy controls (n = 15)
male / female *  11 (73) / 4 (27)  11 (73) / 4 (27)
age at MRI (years) 16 ± 4 16 ± 4
height (cm) 167 ± 14 168 ± 12
weight (kg) 55 ± 17 60 ± 15
body surface area (m2) † 1.6 ± 0.3 1.7 ± 0.3
blood pressure systolic (mm Hg) 116 ± 16 121 ± 13
blood pressure diastolic (mm Hg) 66 ± 12 68 ± 11
cardiac frequency (beats per minute) 71 ± 13 69 ± 9
New York Heart Association class (I/ II) 13 / 2 15 / 0
smoking (yes / no) 0 / 15 0 / 15
Note: Unless otherwise indicated, data are means ± standard deviations, with ranges in parentheses. No patient 
or control subject had a history of smoking. 
* Data are numbers of patients, with percentages in parentheses. 
† Calculated with the following formula: √ (height (cm) × weight (kg) / 3600).
 Twenty-three patients who had undergone the ASO, as reported in our local congenital 
heart disease database, were initially approached for this study. Inclusion criteria comprised 
TGA corrected with the ASO, current age between 12 and 25 years, willingness to comply 
with the study procedures and written informed consent. Exclusion criteria comprised 
TGA corrected with the Jatene procedure (this procedure includes insertion of an artificial 
tunnel to connect the right ventricle with the pulmonary artery, creating a different type of 
configuration of the great arteries) (n = 1), evidence of aortic valve stenosis (aortic velocity > 2.5 
m/s at echocardiography) (21), coarctation of the aorta and/or other forms of congenital heart 
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disease, Marfan syndrome or a family history of Marfan syndrome, repeat ASO or surgery and/
or intervention other than the ASO, usage of medication such as beta-blockers and general 
contraindications to cardiovascular MRI. Seven patients declined to participate for personal 
reasons. Age- and sex-matched healthy control subjects were selected from our database 
of individuals with a harmless heart murmur in whom congenital cardiac disease had been 
excluded in the past with physical examination and echocardiography. 
 Previously, data in the same patients who had undergone the ASO and control subjects 
were included in a report on right ventricular function and pulmonary flow analysis (22). 
Surgical technique
The ASO was performed in patients with TGA (median age at surgery, 7 days; range, 3 - 21 days) 
by using cardiopulmonary bypass and moderate hypothermia by one surgeon with 20 years of 
experience with the ASO. The operation included transection of the aorta above the sinotubular 
junction and the pulmonary trunk above the pulmonary root, transplantation of the coronary arteries 
into the root of the pulmonary trunk, switching of the aorta and pulmonary trunk and subsequent 
reconstruction of the pulmonary trunk with a pericardial patch (Figure 1). The Lecompte maneuver 
was performed in all 15 patients (23). Associated procedures during the ASO were ventricular septal 
defect closure in five patients, atrial septal defect closure in six patients and closure of the ductus 
arteriosus in 10 patients. No perioperative ischemic events were observed. 
Figure 1.
Figure 1a-b.  (a) Great artery configuration in TGA before surgical repair. Ao = aorta, P = pulmonary trunk, 
PR = pulmonary root. (b) Great artery configuration after the ASO, which involves transec-
tion of the aorta (Ao) above the sinotubular junction and the pulmonary trunk (P) above 
the pulmonary root, transplantation of the coronary arteries into the root of the pulmonary 
trunk, switching of the aorta and pulmonary trunk with anterior positioning of the pulmo-
nary trunk (Lecompte maneuver) and subsequent reconstruction of the former aortic root with 





MRI studies were performed with a 1.5-T system (NT 15 Gyroscan Intera; Philips Medical Systems, 
The Netherlands). 
 Aortic root dimensions were assessed by using double-oblique transverse images 
perpendicular to the aorta at the levels of the annulus of the aortic valve, the sinus of Valsalva, 
the sinotubular junction and the ascending aorta (the latter at the level of the crossing of the 
right pulmonary artery) (Figure 2) (10). Two sets of orthogonal scout cine images of the aortic 
root were initially obtained for planning of these acquisition planes. Imaging parameters with the 
ECG gated steady-state free precession (balanced turbo-field-echo) pulse sequence are listed in 
(Table 2) (10). Diameter measurements were acquired during diastole, with a trigger delay for all 
measurements set at 600 ms (10). 
Figure 2.
Figure 2.  MR image obtained with steady-state free precession cine sequence in 16-year-old healthy male con-
trol subject shows four diameter measurements of the aortic root performed at (1) the level of the 
annulus of the aortic valve, (2) the sinus of Valsalva, (3) the sinotubular junction and (4) the ascending 
aorta (at the level of the crossing of the right pulmonary artery).









  voxel size† flip angle
Diameter and distensibility 3.2 1.23 34.2 220 1.25×1.25×6.00 50°
measurements
Aortic flow measurement 4.8 2.8 300 1.17×1.17× 8.00 20°
Short axis imaging 3.2 1.6 34.2 400 1.60×1.60× 8.00 50°
* expressed in ms.
† expressed in mm.
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 Aortic distensibility was measured at the level of the sinotubular junction, at the site of 
anastomosis of the ASO, as previously described (10). Distensibility (in mm Hg–1) is defined by 
the following equation: (Amax -
 Amin) / (Amin × (Pmax - Pmin)), where Amax and Amin are
 the maximal 
and minimal lumen areas (in square mm) of the sinotubular junction, respectively, and Pmax 
and Pmin are the systolic
 and diastolic blood pressures (in mm of mercury), respectively (10,12). 
The minimal lumen area is to be expected early in the cardiac cycle during the isovolumetric 
contraction phase (just before the beginning of the systolic upslope), while the maximal area is 
to be expected when the peak of aortic flow passes through the ascending aorta (10). First, the 
aortic flow was measured just distal to the aortic valve with a velocity-encoded MRI sequence, 
for timing of the acquisition of the cross-sectional minimal and maximal area measurements. 
The velocity-encoded sequence was encoded for a fixed velocity-encoding sensitivity of up to 
200 cm/s (24). None of the participants showed aliasing on the acquired images, so the velocity-
encoded acquisition did not need to be repeated with a higher velocity-encoding sensitivity. 
 The high temporal resolution (ranging between 7 and 12 ms) enabled optimal timing of the 
acquisition of the minimal and maximal cross-sectional areas (10). The same acquisition was 
also used for determination of aortic valve competence (AR fraction) and the measurement 
of peak flow velocity across the aortic valve. The AR fraction was calculated with the following 
formula: RV / SFV × 100%, where RV is regurgitant volume in milliliters and SFV is systolic 
forward volume in milliliters. Minimal and maximal lumen area MRI was subsequently 
performed after the acquisition planes were manually positioned perpendicular to the aorta 
at the level of the sinotubular junction at time points of minimal and maximal flow through 
the aortic root, respectively (10). This approach enabled correction for through-plane motion 
of the aortic root during contraction. Gate delay was individually applied for optimal timing 
of the acquisition (10). 
 Simultaneous blood pressure measurements were noninvasively obtained by using a 
semiautomatic MRI-compatible sphygmomanometer (Invivo Research, USA) (25). 
 The PWV of the aorta was measured between the ascending and the proximal descending 
aorta and between the proximal descending aorta and the abdominal aorta just proximal to 
the iliac bifurcation (Figure 3). A retrospectively electrocardiographically gated gradient-echo 
pulse sequence with velocity encoding was applied at the level of the pulmonary trunk to 
measure through-plane flow in the ascending aorta and proximal descending aorta. A second 
section was prescribed in the abdominal aorta just proximal to the iliac bifurcation. Imaging 
parameters were identical to those of the phase-contrast sequence used for timing of the 
distensibility measurements (18). During MR image acquisition, systolic and diastolic blood 
pressures were measured as described for the distensibility measurements. PWV was calculated 
as Δx/Δt (expressed in meters per second), where Δx is the aortic path length between two 
imaging levels and Δt is the transit time between the arrival of the foot of the pulse wave at 




Figure 3 a-d.  PWV in the aorta. (a) Sagittal MR image shows sites for through-plane velocity-encoded PWV 
measurements in 16-year-old male healthy control subject: the ascending aorta (1), the proximal 
descending aorta just distal to the aortic arch (2), and the abdominal aorta just proximal to the 
iliac bifurcation (3). ΔX1 = distance between measurement sites 1 and 2, ΔX2 = distance between 
measurement sites 2 and 3. (b,c) On the corresponding velocity-encoded images, the arrival time 
of the aortic systolic pulse-wave front can be determined by measuring the through-plane flow. 
(d) Graph shows determination of the arrival times of the three systolic flow waves at the measure-
ment sites. The distance between the sampling sites (derived from a) and the transit times (Δt1 and 
Δt2) between the individual arrival times of the systolic flow waves (in d) determines the PWV.
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Systolic LV function was assessed with a steady-state free precession cine sequence 
in the short-axis plane by using breath holds. A total of 12 consecutive sections were 
obtained (40 phases per cardiac cycle) without a section gap (26). 
Postprocessing 
Diameter and distensibility measurements of the aortic root, as well as systolic LV function 
images, were analyzed by using the software package MASS (Medis, The Netherlands) 
(26). LV end-diastolic volume and end-systolic volume were assessed by drawing the LV 
endocardial contours at end-diastole and end-systole in all sections, as previously described 
(10,18,26). At end-diastole, the epicardial borders of the LV were drawn to obtain the LV 
mass with inclusion of the interventricular septum (10,18,26). Indexing was performed 
according to the Mosteller formula: BSA = √ (height (cm) × weight (kg) / 3600), where BSA 
is the body surface area in square meters. The following parameters were then determined: 
end-diastolic volume, end-systolic volume, stroke volume, LV ejection fraction (LV EF) and 
LV mass (10,26). 
 Flow velocity - encoded MRI data were analyzed with the software package FLOW 
(Medis, The Netherlands) (24). Flow curves were obtained with this method for aortic flow 
during the cardiac cycle. Contours were drawn for the aortic lumen and flow data were 
subsequently obtained from the velocity data of each voxel in all phases. Peak flow velocity 
was determined with a time-velocity analysis that revealed the voxel with maximum peak 
flow throughout the cardiac cycle. 
 The manual drawing of all MRI contours and analysis of the other results was performed 
by one researcher (H.B.G., with 3 years of experience in cardiac MRI); these results were 
subsequently checked by a radiologist (L.J.M.K., with 9 years of experience in cardiac MRI) 
who was unaware of the patients’ conditions. 
Statistical analysis
Statistical analysis was performed by using software (SPSS for Windows, version 12.0.1; 
SPSS, USA). All data are presented as mean ± 1 standard deviation, unless stated otherwise. 
The two-tailed Mann-Whitney U test was used to express differences between the patients 
and control subjects. Correlation between variables was expressed with the Spearman 
rank correlation coefficient. Linear regression analysis was used to identify predictors of 
variables with backward elimination procedures. Statistical significance was indicated by 




Aortic dimensions and elasticity
Diameters of the aortic root were significantly increased in patients after the ASO as compared 
with those in the healthy control subjects (Table 3). Dilatation was most pronounced at the 
level of the sinus of Valsalva, whereas diameters at the level of the ascending aorta were within 
normal limits. Elasticity of the proximal aorta was found to be reduced, as distensibility at the 
level of the sinotubular junction was significantly decreased and PWV in the aortic arch was 
significantly increased in patients after the ASO. PWV in the descending aorta was relatively 
normal. Aortic dilatation at the level of the sinus of Valsalva was significantly correlated with 
increased PWV in the aortic arch (r = 0.36, P = 0.049). 
Table 3. Results in 15 Patients Who Had Undergone the ASO and 15 Age- and Sex-matched 
Healthy Control Subjects .
Parameters patients healthy controls P value mean difference
diameter annulus (mm) 30.6 ± 5.3 24.3 ± 3.0 0.001 6.3
diameter sinus of Valsalva (mm) 36.4 ± 6.1 27.0 ± 3.6 < 0.001 9.4
diameter sinotubular junction (mm) 29.6 ± 6.0 23.9 ± 2.9 0.007 5.7
diameter ascending aorta (mm) 25.2 ± 5.3 22.6 ± 2.4 0.18 2.6
distensibility (in 10-3 mm Hg-1) * 2.2 ± 1.8 4.9 ± 2.9 < 0.01
PWV aortic arch (m/s) 5.1 ± 1.2 3.9 ± 0.7 0.004
PWV descending aorta (m/s) 4.1 ± 0.7 3.6 ± 0.3 0.06
aortic regurgitation fraction (%) 5 ± 3 1 ± 1   < 0.001
peak-flow velocity at STJ (m/s) 1.63 ± 0.21 1.50 ± 0.32 0.21
LV EF (%) 51 ± 6  58 ± 5  0.003
LV EDV (ml/m2) 112 ± 13 95 ± 16 0.007
LV ESV (ml/m2) 54 ± 11 39 ± 7 < 0.001
LV mass (g/m
2) 49 ± 11 43 ± 12 0.17
Note: data are expressed as mean ± standard deviation.
* Distensibility was measured at the level of the sinotubular junction.
Abbreviations: ASO = arterial switch operation, PWV = pulse wave velocity, STJ = sinotubular junction, LV = left 
ventricle, EF = ejection fraction, EDV = end-diastolic volume indexed for body surface area, ESV = end-systolic 
volume indexed for body surface area.
Aortic Valve Competence
Minor to mild degrees of AR were found in 6 of 15 patients after the ASO, with AR fraction 
ranging between 5% and 15%. In none of the healthy control subjects did AR fraction exceed 
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5%. Aortic root dilatation and reduced elasticity of the proximal aorta were associated with the 
degree of AR, as aortic root dilatation (r ranging between 0.32 and 0.66, P ≤ 0.01 for all four 
levels), reduced aortic root distensibility (r = 0.45, P = 0.01) and increased PWV in the aortic arch 
(r = 0.39, P = 0.03) were all correlated with degree of AR fraction. Peak flow velocities across the 
aortic valve were not increased in our patient group as compared with those in the healthy 
control subjects (Table 3), supporting the fact that none of the examined individuals had aortic 
valve stenosis. 
LV function
Systolic LV function - expressed by LV EF - was found to be significantly decreased in 
patients after the ASO as compared with that in the healthy control subjects (Table 3). Linear 
regression analysis revealed that degree of AR predicted decreased LV EF (r = 0.41, P = 0.026). 
LV dimensions (LV end-diastolic volume and LV end-systolic volume) were significantly 
enlarged in the patient group and were also related to AR fraction (r = 0.48, P = 0.008 and 
r = 0.67, P < 0.001, respectively). Mean LV mass in the patient group was slightly but not 
significantly larger than that in the healthy control subjects. Mean LV mass was significantly 
correlated with increased PWV at the level of the aortic arch (r = 0.48, P = 0.008) and 
increased LV end-diastolic and LV end-systolic volume (r = 0.81, P < 0.001 and r = 0.48, P = 
0.007, respectively). 
Discussion
Our study revealed aortic root dilatation and reduced elasticity of the proximal aorta, associated 
with minor degrees of AR, in patients after the ASO. AR was associated with reduced LV systolic 
function and enlarged LV dimensions in these patients. 
Aortic dimensions and elasticity
Patients after the ASO showed dilatation of the aortic root and reduced proximal aortic elasticity 
as compared with healthy control subjects; these findings are in agreement with those of previous 
studies (2-5,7). Structural differences between the walls of the two arterial roots have been reported 
to result in aortic root dilatation and reduced distensibility (7). After the ASO, the former pulmonary 
arterial wall (the neoaorta after the ASO) is exposed to higher systemic pressures, posing increased 
stress on the neoaortic wall that may ultimately lead to changes in the structure and function of 
the neoaortic root. Schoof et al.  (27) reported that dilatation was the result of a pulmonary wall 
adapting to higher systemic pressures. Others have observed structural neoaortic wall abnormalities 
in patients with TGA even during the neonatal period, suggesting that these wall abnormalities 
are inherited, analogous to prototypical extremes such as Marfan syndrome and bicuspid aortic 
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valve disease (5). Whether medial abnormalities of the neoaortic wall are inherent or acquired 
remains, however, difficult to distinguish (5). Murakami et al. (4) proposed a relationship 
between neoaortic dilatation and decreased distensibility and damage to the vasa vasorum. 
The vasa vasorum are a fine network of vessels that supply the outer wall of a larger blood 
vessel (4). During the ASO, the vasa vasorum are transected and blood flow is inhibited, causing 
necrosis that may be followed by dilatation and impaired distensibility of the neoaorta (4). 
Manipulations during the ASO - such as the reimplantation of the coronary arteries - can also 
lead to changes in the neoaortic root wall that may result in progressive aortic dilatation (7), 
whereas aortic distensibility may be reduced by impaired aortic elastogenesis, as well as by 
scar formation at the site of anastomosis (8,9). 
 Arterial stiffness has been shown to be a cardiovascular risk factor on its own (11). Augmented 
arterial stiffening is associated with impaired coronary blood flow and LV dysfunction (11). In 
addition, a strong and independent association has been demonstrated between increased arterial 
stiffness and the presence of coronary artery disease (28). Therefore, the prognosis of patients 
with increased arterial stiffness may be worse as compared with healthy control subjects, because 
numerous other standard risk factors, such as aging, smoking, lipid profiles and sex, act cumulatively 
over a lifetime (11,28). Early detection of disturbances in arterial stiffness may allow for early 
therapeutic intervention (29). In patients with Marfan syndrome, beta-blockade has a beneficial 
effect on the progression rate of aortic dilatation, with reduction of aortic complications (12,25). 
Whether this is applicable for patients who have undergone the ASO remains to be elucidated. 
Aortic Valve Competence
Aortic root dilatation and decreased aortic distensibility are closely related to aortic valve function, 
with the potential to cause AR (10,18,27,30). Although fewer than half of our patients who had 
undergone the ASO exhibited minor to mild degrees of AR, dilatation of the aortic root and 
reduced elasticity of the proximal aorta were found to be significantly correlated with degree of 
AR. Increased dimensions of the aortic annulus lead to loss of coaptation of the aortic valve leaflets, 
resulting in varying degrees of central AR (31-33). In addition, aortic valve dynamics are closely 
related to distensibility of the aortic root. During systole, as the aortic valve opens, the aortic root 
should expand simultaneously (13,14). Any disturbance in this synchronized process results in 
increased stress on the aortic valve leaflets (14-16), which will ultimately result in degeneration 
of the aortic valve leaflets and, consequently, AR. 
LV Function
LV systolic function was significantly reduced in our patients after the ASO, despite most patients 
having New York Heart Association class I cardiac function. LV dysfunction has been suggested 
to be related to ischemic damage caused by coronary insufficiency or perioperative ischemia. 
A previous study (3), however, demonstrated no areas of myocardial infarction in patients 
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after the ASO without ischemic events. As in our patient group, no previous ischemic events 
were reported, and myocardial scar and coronary imaging were not included in the imaging 
protocol. In our study, LV dysfunction and increased LV dimensions appeared to be associated 
with degree of AR, which may be considered as the end point in a sequence of events (30). As 
a consequence of AR, increased LV mass occurs to maintain normal LV filling pressures (30). A 
normal LV volume-to-mass ratio is initially maintained, with adequate preservation of LV EF 
because of the increased preload, but, as AR continues to progress and the LV continues to 
dilate, increased wall stress may result in LV systolic dysfunction and, consequently, decreased 
LV EF (30). AR also leads to a volume overload of the LV, hence increasing LV dimensions, which 
consequently results in decreased LV EF. 
 Our study had limitations. We used a limited number of patients and control subjects, 
although the low inter- and intraobserver variability of MRI allows relatively small sample sizes 
(34). No preoperative or follow-up measurements were available in our observational study, so 
progression of findings could not be documented. Future longitudinal follow-up studies with 
larger numbers of patients may further elucidate the predictive value of our findings in patients 
after the ASO, allowing for multivariate analysis and subgroup analysis, as other parameters 
may additionally be involved in our findings. 
 In conclusion, our study revealed aortic root dilatation and reduced elasticity of the proximal 
aorta in patients after the ASO, in addition to minor degrees of AR, reduced LV systolic function 
and enlarged LV dimensions. Therefore, despite the fact that the ASO has substantially reduced 
the number of sequelae associated with surgical correction of TGA, the current findings might 
pose a prognostic risk for patients after the ASO. Our study showed the feasibility of MRI as an 
integrated imaging tool for monitoring aortic and LV function parameters, which may facilitate 
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Right Ventricular Hypertrophy and Diastolic Dysfunction in 
Arterial Switch Patients without Pulmonary Artery Stenosis.




Purpose: To assess pulmonary flow dynamics and right ventricular (RV) function in patients 
without significant anatomical narrowing of the pulmonary arteries late after the arterial 
switch operation (ASO) by using magnetic resonance imaging (MRI). 
Materials and Methods: 17 patients (mean (SD), 16.5 (3.6) years after ASO) and 17 matched 
healthy subjects were included. MRI was used to assess flow across the pulmonary trunk, RV 
systolic and diastolic function and RV mass. 
Results: Increased peak flow velocity (> 1.5 m/s) was found across the pulmonary trunk in 
14 of 17 patients. Increased RV mass was found in ASO patients: 14.9 (3.4) vs 10.0 (2.6) g/m2 
in normal subjects (P < 0.01). Delayed RV relaxation was found after ASO: mean tricuspid 
valve E/A peak flow velocity ratio = 1.60 (0.96) vs 1.92 (0.61) in normal subjects (P = 0.03) and 
E-deceleration gradients = -1.69 (0.73) vs -2.66 (0.96) (P < 0.01). After ASO, RV mass correlated 
with pulmonary trunk peak flow velocity (r = 0.49, P < 0.01) and tricuspid valve E-deceleration 
gradients (r = 0.35, P =  0.04). RV systolic function was well preserved in patients (ejection 
fraction = 53 (7)% vs 52 (8)% in normal subjects, P = 0.72). 
Conclusions: Increased peak flow velocity in the pulmonary trunk was often observed late 
after ASO, even in the absence of significant pulmonary artery stenosis. Hemodynamic 
consequences were RV hypertrophy and RV relaxation abnormalities as early markers of 
disease, while systolic RV function was well preserved. 




The arterial switch operation (ASO) has become the standard procedure of choice for repair 
of transposition of the great arteries (1-3). The ASO consists of translocation of the pulmonary 
trunk and the aorta, and subsequent relocation of the coronary arteries in the neonatal period 
(4). The advantages of the ASO compared with the previous intra-atrial repair are related to 
creation of the left ventricle as the systemic ventricle and the maintenance of normal sinus 
node function (5-7).
 Supravalvar pulmonary artery stenosis is the most frequent complication after ASO (5-7). 
Reduction of the cross sectional area due to stretching of the pulmonary arteries is induced by 
the Lecompte maneuver (5-7), while compression of the proximal pulmonary branches may 
occur because of the close anatomical relation with the aorta (1,5,7,8). As a result, supravalvar 
pulmonary artery stenosis in ASO patients is associated with right ventricular hypertrophy and 
dysfunction from the increased afterload (9). These stenoses are well visualized by magnetic 
resonance imaging (MRI): a fixed stenosis can easily be recognized using spin-echo or gradient-
echo sequences, and increased peak flow velocity across a significant stenosis can be detected 
by velocity encoded MRI (1,7,9). 
 In patients with repaired coarctation, increased peak flow velocities across vascular 
segments may also be observed, because of scar formation at the site of anastomosis, even 
in the absence of overt narrowing (10,11). Scar tissue at the site of anastomosis may lead to 
decreased distensibility - thereby increasing local peak-flow velocity - as may also be the case 
in ASO patients (10,11). In addition, minor degrees of stenosis or hypoplasia of the pulmonary 
vascular bed may lead to increased flow velocities in the pulmonary trunk (10), thereby 
increasing the hemodynamic burden for the right ventricle. 
 We hypothesized that in ASO patients without significant pulmonary artery stenosis, 
increased peak flow velocities are present in the pulmonary trunk, with a potential negative 
impact on right ventricular function. In the present study we excluded ASO patients with 
significant pulmonary artery stenosis as shown by anatomical imaging. 
 We tested these hypotheses by studying pulmonary flow dynamics and right ventricular 
function in patients without significant anatomical narrowing of the pulmonary trunk 





The local medical ethics committee approved the study and informed consent was obtained from 
all participants before their enrollment. Twenty-two ASO patients and 22 healthy subjects were 
studied prospectively with MRI at our institution. All patients were recruited from our local pediatric 
cardiology database. Inclusion criteria included transposition of the great arteries corrected by ASO 
(including the Lecompte maneuver) in the past, current age between 10 and 20 years, willingness to 
comply with the study procedures and written informed consent. Exclusion criteria comprised ASO 
using the Jatene procedure, pulmonary stenting, general contraindications to MRI and pulmonary 
artery stenosis shown by echocardiography, based on local tailoring of the pulmonary trunk of at 
least 50% or a peak systolic gradient of at least 60 mm Hg in the pulmonary arteries, or both.
  Visual inspection of the pulmonary arteries on MRI confirmed that only ASO patients without 
pulmonary artery stenosis were enrolled in the study. A vessel diameter reduction of more than 
50% gives rise to a reduction in blood volume flow and was considered significant (12). Two patients 
who had a main pulmonary artery stenosis that was visually greater than 50% were thus excluded 
from further analysis. Three patients failed to complete the MRI study because of problems with 
breath holding. In all, 17 patients and 17 healthy subjects were included for final analysis. 
 Age and sex matched healthy subjects were selected from our database and comprised subjects 
in whom congenital cardiac pathology had been excluded in the past by physical examination and 
echocardiography. Characteristics of the two groups (Table 1) and their functional status, expressed 
as New York Heart Association functional class, were obtained from the patient records. 
Table 1: Patient and healthy subject characteristics.
Characteristics patients (n = 17) healthy subjects (n = 17)
male / female 13 (76%) / 4 (24%) 13 (76%) / 4 (24%)
age at ASO (days) * 16 ± 23
age at MRI (years) * 16.4 ± 3.2 16.5 ± 3.6
height at MRI (cm) * 169 ± 13 169 ± 12
weight at MRI (kg) * 61 ± 17 60 ± 13
body surface area at MRI (m2) * and † 1.7 ± 0.3 1.7 ± 0.2
systolic / diastolic BP at MRI (mm Hg) * 124 / 74 ± 20 / 18 121 / 69 ± 12 / 10
cardiac frequency (beats per minute) * 74 ± 16 69 ± 9
* Data are mean ± standard deviation.
† According to the Mosteller formula: √ (height (cm) × weight (kg) / 3600).
Abbreviations: ASO = arterial switch operation; MRI = magnetic resonance imaging; BP = blood pressure.




Nine patients had undergone balloon atrial septostomy (that is, the Rashkind procedure) and 
11 had received prostaglandin E1 infusions before the ASO. The ASO was carried out in patients 
with transposition of the great arteries (median age at surgery = 6 days) using cardiopulmonary 
bypass and moderate hypothermia. The operation included transection of the aorta and 
pulmonary trunk above their roots, transplantation of the coronary arteries into the root of the 
pulmonary trunk, switching of the aorta and pulmonary trunk and subsequent reconstruction 
of the pulmonary trunk with a pericardial patch. The Lecompte maneuver was undertaken in 
all 17 patients (8). Associated procedures during the ASO were closure of a ventricular septal 
defect in 5 patients, closure of an atrial septal defect in 7 and closure of the ductus arteriosus in 
12. No perioperative ischemic events were recorded. 
MRI
MRI studies were done using a 1.5-T system (NT 15 Gyroscan Intera; Philips Medical Systems, 
The Netherlands). Initial scout images were obtained in transverse, coronal and sagittal planes 
using a standard multislice turbo spin-echo sequence. 
 To visualize the pulmonary vessel anatomy a black-blood static sequence and contrast 
enhanced magnetic resonance angiography were used. Black-blood turbo spin-echo imaging 
using sensitivity encoding (13) was acquired in the double oblique transverse plane, axial to the 
pulmonary trunk, with the following scan parameters: field of view 350 mm, repetition time 
two heart beats, with actual time depending on the individual heart rate, echo time 8.6 ms, flip 
angle 90°, slice gap 0.8 mm, voxel size 1.37 × 2.12 × 8.00 mm (1). Contrast enhanced magnetic 
resonance angiography by using Magnevist (0.2 mmol/kg; Schering,  Germany) was carried out 
with the following scan parameters: field of view 400 mm, repetition time 5.1 ms, echo time 
1.44 ms, voxel size 1.56 × 3.13 × 4.00 mm. 
 Pulmonary valve function and flow dynamics across the pulmonary trunk were assessed 
using velocity encoded MRI in the proximal pulmonary trunk (14). Scan parameters were field 
of view 400 mm, repetition time 8.6 ms, echo time 5.3 ms, flip angle 20°, voxel size 2.34 × 2.61 
× 8.00 mm. The sequence was encoded for a through-plane velocity up to 150 cm/s. Temporal 
resolution was 25.6 ms. 
 Systolic right ventricular function was assessed using a prospectively ECG triggered 
balanced gradient-echo sequence. A short-axis stack of 14 to 18 contiguous slices was used, 
covering the base of the heart to the apex (14), with the following scan parameters: field of 
view 350 mm, repetition time 3.2 ms, echo time 1.62 ms, flip angle 70°, voxel size 2.19 × 1.62 × 
8.00 mm. 
Velocity mapping across the tricuspid valve was used for assessment of diastolic right 
ventricular function (14,15). Scan parameters were: field of view 300 mm, repetition time 
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9.4 ms, echo time 6 ms, flip angle 20°, voxel size 2.34 × 2.61 × 8.00 mm. The sequence was 
encoded for a through-plane velocity up to 100 cm/s. Temporal resolution was 25.6 ms. 
Postprocessing
All images were quantitatively analyzed on a workstation with a Pentium 4 processor (Intel, 
USA). Contrast enhanced magnetic resonance angiography and black-blood images of 
the pulmonary vessels were used to exclude significant pulmonary artery stenoses. The 
gradient-echo right ventricular dataset was analyzed with the software package MASS 
(Medis, The Netherlands) (14). Flow velocity encoded MRI data were analyzed using the 
software package FLOW (Medis, The Netherlands) (14). All contours were manually drawn 
by two observers (both with one year of experience) and were subsequently checked by a 
radiologist (with nine years of experience), who was unaware of the patient conditions. 
 Vascular contours were drawn for the pulmonary trunk to generate flow curves 
throughout the cardiac cycle (16). The presence of substantial pulmonary valve regurgitation 
was assessed (> 5%). Increased peak flow velocity in the pulmonary trunk was defined as 
maximum blood flow velocity (Vmax) exceeding 1.5 m/s (1).  The
 duration of the forward 
flow wave during systole across the pulmonary trunk was divided in a first and second half, 
with subsequent comparison of the flow/volume ratios (flow through first half of systole 
divided by flow through second half of systole) as a marker of flow propagation (17). 
 Right ventricular systolic function was assessed by drawing endocardial right ventricular 
contours at end-diastole and end-systole in all sections of the cine short axis data (16). 
Right ventricular end-diastolic volumes (RV EDV) and right ventricular end-systolic volumes 
(RV ESV) were obtained and indexed for body surface area according to the Mosteller 
formula: √ (height (cm) × weight (kg) / 3600). Right ventricular stroke volume indexed for 
body surface area (RV SV) was calculated by subtracting RV ESV from RV EDV. The right 
ventricular ejection fraction (RV EF) was calculated by dividing RV SV by RV EDV. Right 
ventricular mass was calculated as previously described after drawing right ventricular 
endocardial and epicardial contours, with subsequent indexation for body surface area 
(indicated by right ventricular mass) (16).
 For evaluation of right ventricular diastolic function, tricuspid valve contours were 
drawn throughout the cardiac cycle (18). Flow vs time curves of the tricuspid flow were 
subsequently analyzed using Microsoft Excel (version 2003) (19) for calculation of the 
following indices of diastolic right ventricular function: early filling phase (E), atrial kick 
phase (A) and E/A peak flow velocity ratios (18).  Analysis of E slopes was done by calculation 
of mean deceleration gradients of E (18). Times of E, A and diastasis were also measured 
(18).




Statistical analysis was carried out by using SPSS for Windows (version 12.0.1; SPSS, USA). 
All data are expressed as mean (SD), unless stated otherwise. The Mann-Whitney U test was 
used to express differences in variables between patients and healthy subjects. Correlations 
between variables are expressed using Spearman’s rank correlation coefficient. Statistical 
significance was indicated by a probability P value of less than 0.05. 
 
RESULTS 
Patients and healthy subjects were matched for age and sex. Subject characteristics were 
comparable between both groups (Table 1). All patients were in New York Heart Association 
functional class 1, without drug treatment. 
Pulmonary artery characteristics
Cross sectional diameters of the pulmonary trunk were slightly smaller in the ASO patients 
than in the controls, with a mean difference of 3.5 mm between the two groups (Table 2). In 
14 of the 17 ASO patients (82%), the pulmonary trunk Vmax exceeded
 1.5 m/s, compared with 
none in the healthy subject group, indicating frequently increased peak flow velocities at 
the level of the pulmonary trunk (Table 2). In the ASO patients, the ratio of pulmonary trunk 
forward flow volume during the first half of systole to that in the second half was significantly 
smaller than in the healthy subjects, reflecting delayed propagation of pulmonary flow 
through the pulmonary trunk. Within the patient group, a positive correlation was found 
between this pulmonary trunk forward flow volume ratio and the pulmonary trunk Vmax
 
(r = -0.42, P = 0.02), indicating that delayed flow propagation was associated with higher 
maximum flow velocities. No substantial pulmonary regurgitation (> 5%) was present in any 
patient or healthy subject. 
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Table 2: Results in 17 ASO patients and 17 age/gender matched healthy subjects.
Parameters  patients healthy subjects P value   
PT crossectional diameter (mm) 25.6 ± 3.4 29.1 ± 3.5 0.01
PT Vmax (m/s) 1.88 ± 0.56 0.93 ± 0.19  < 0.01
PT volume-ratio systole1 / systole2 1.16 ± 0.15 0.35 ± 0.26 0.01
RV EF (%) 53 ± 7 52 ± 8 0.84
RV SV (ml/m²) 56 ± 8 50 ± 13 0.06
RV EDV (ml/m2) 108 ± 18 96 ± 16 0.06
RV ESV (ml/m2) 51 ± 14 46 ± 10 0.41
RV mass (gr/m
2) 14.9 ± 3.4 10.0 ± 2.6 < 0.01
TV E/A peak-flow ratio 1.60 ± 0.96 1.92 ± 0.61 0.03
TV mean dec gradient of E phase (l/s2) -1.69 ± 0.73  -2.66 ± 0.96 < 0.01
TV diastasis time (ms) 19 ± 30 53 ± 64 0.04
Note: data are expressed as mean ± standard deviation.
Abbreviations: ASO = arterial switch operation; PT = pulmonary trunk; Vmax = maximum velocity; RV = right ven-
tricle; EF = ejection fraction; SV = stroke volume indexed for body surface area; EDV = end-diastolic volume 
indexed for body surface area; ESV = end-systolic volume indexed for body surface area; TV = tricuspid valve; E = 
early filling phase; A = atrial kick phase; dec = deceleration.
Right ventricular function
Systolic function, expressed by RV EF and RV SV, did not differ between ASO patients and 
healthy subjects (Table 2). Right ventricular dimensions (RV EDV and RV ESV) were also not 
different between the two groups (Table 2). 
 Mean right ventricular mass in the ASO patient group was significantly greater than in the 
healthy subjects (Table 2). In the patient group a significant correlation was found between right 
ventricular mass and pulmonary trunk Vmax (r = 0.49, P < 0.01), indicating
 that right ventricular 
hypertrophy is associated with increased peak flow velocities in the pulmonary trunk. 
 A significantly reduced mean tricuspid valve E/A peak flow velocity ratio, decreased tricuspid 
valve mean deceleration gradient in the E phase and loss of diastasis time were all present in 
our ASO patient group, indicating delayed right ventricular relaxation during diastole (Table 2, 
Figure 1). In addition, the tricuspid valve mean deceleration gradient in the E phase and loss of 
diastasis were positively correlated with right ventricular mass (r = 0.35, P = 0.04 and r = 0.45, 
P < 0.01, respectively), as would be expected because delayed relaxation is associated with 
hypertrophy accompanying stiffening of the right ventricular myocardium. 




Figure 1.  Right ventricular inflow curves across the tricuspid valve in an ASO patient and a matched healthy 
subject. The biphasic inflow pattern consists of two peaks, representing the early inflow (E) and the 
late atrial kick (A). Note the decreased mean deceleration gradient after the E peak in the ASO patient 
compared with the matched healthy subject.
Discussion
Cardiac MRI was used to assess pulmonary flow dynamics and right ventricular function in 
patients late after the arterial switch operation without significant anatomical narrowing of the 
pulmonary arteries, as compared with matched healthy subjects. This study revealed frequently 
increased peak flow velocities in the pulmonary trunk, even in the absence of significant 
anatomical narrowing of the pulmonary arteries. Further hemodynamic consequences were 
delayed pulmonary flow propagation, right ventricular hypertrophy and right ventricular 
relaxation abnormalities as early markers of disease, whereas systolic right ventricular function 
remained well preserved. 
Pulmonary artery characteristics
ASO patients often have increased peak flow velocities at the level of the pulmonary trunk 
compared with healthy subjects. Various reasons for this have been postulated. Reduction of 
cross sectional area is induced by stretching of the pulmonary arteries following the Lecompte 
maneuver (2,5,7). The non-spiral configuration of the pulmonary arteries after this maneuver 
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has been reported to promote the formation of stenotic plaques through an altered wall shear 
stress distribution (2), while scarring at the anastomosis site often results in circumferential 
narrowing (5-7,9). Recent reports of patients with repaired coarctation also indicate that, even 
in the absence of significant stenosis at the site of anastomosis, loss of distensibility because 
of stiff scar tissue is a major contributor to an increased peak flow velocity (10,11). It is likely 
that local scar tissue with loss of distensibility made a major contribution to increased peak 
flow velocities in our ASO patients, in addition to possible minor degrees of narrowing at the 
site of anastomosis or peripheral pulmonary branches. In this study the pulmonary trunk 
was slightly smaller in the ASO patient group than in the matched healthy subjects. Previous 
studies indicated normal dimensions of the pulmonary trunk and peripheral pulmonary 
branches before the ASO, excluding a congenital deformity (5,6). 
Right ventricular function
In this study, systolic right ventricular function was well preserved late after the ASO. These 
findings are supported by previous reports (1,20). 
 The right ventricular mass was significantly greater in the ASO patients than in the healthy 
controls, indicating right ventricular hypertrophy. This often occurs as a compensatory 
mechanism for increased right ventricular afterload (9,21), which in this study was reflected 
by increased peak flow velocities across the pulmonary trunk. Increased right ventricular 
afterload was also indicated by the delayed propagation of the systolic pulmonary flow 
(17). Ischemic damage caused by coronary insufficiency has been suggested as another 
explanation for compensatory right ventricular hypertrophy after ASO (20). However, none 
of our patients had perioperative ischemic events according to the available patient records, 
so ventricular hypertrophy from ischemic damage was not suspected. 
 Delayed right ventricular relaxation was indicated by decreased tricuspid valve E/A peak 
flow velocity ratio, reduced tricuspid valve mean deceleration gradient of the E phase and 
loss of diastasis time in our ASO patient group. In contrast to mild to moderate degrees of 
isolated pulmonary stenosis, which have little impact on right ventricular function (9), a 
supravalvar increase in peak flow velocity proved to have negative repercussions for right 
ventricular function in this study. Delayed right ventricular relaxation is related to hypertrophy 
accompanying stiffening of the myocardium (20) and can be seen as an early marker of 
diastolic dysfunction which may precede right ventricular systolic dysfunction (20,22). The 
impact of right ventricular diastolic dysfunction is considerable, as published reports suggest 
that its prognostic value is equal to impaired left ventricular diastolic function (20,22,23). 
Impaired left ventricular diastolic function is a major contributor in one third of patients 
with congestive heart failure (16,22,24) and causes diminished exercise performance (24,25). 
Aging contributes to diastolic dysfunction by an increase in ventricular mass and a loss of 
elastic myocardial properties over time (16,24). Thus impaired right ventricular relaxation 
Right ventricular hypertrophy and diastolic dysfunction in arterial switch patients without pulmonary 
artery stenosis
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might pose a future risk for right ventricular dysfunction in our patient group, with negative 
implications for prognosis. 
 The evaluation by MRI of right ventricular function and pulmonary flow dynamics late 
after the ASO revealed an increased peak flow velocity across the pulmonary trunk, even 
in the absence of significant pulmonary stenosis at the surgical anastomosis. Further 
hemodynamic consequences were right ventricular hypertrophy and right ventricular 
relaxation abnormalities as early markers of disease, though systolic right ventricular function 
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Aortic Elasticity and Size are associated with Aortic Regurgi-
tation and Left Ventricular Dysfunction in Tetralogy of Fallot 
after Pulmonary Valve Replacement.




Purpose: Aortic wall pathology and concomitant aortic dilatation have been described in 
tetralogy of Fallot (TOF) patients, which may negatively affect aortic valve and left ventricular 
(LV) systolic function. In this study, aortic dimensions, aortic elasticity, aortic valve competence 
and biventricular function were assessed in repaired TOF patients after pulmonary valve 
replacement (PVR) by using magnetic resonance imaging (MRI).
Materials and Methods: MRI was performed in 16 patients with TOF after PVR (10 male; mean 
age ± standard deviation: 31 years ± 15) and 16 age- and gender matched healthy subjects.
Results: TOF patients showed aortic root dilatation (mean difference 7.8 - 8.8 mm, P < 0.01 at 
all 4 predefined levels) and reduced aortic elasticity (pulse wave velocity in aortic arch: 5.5 m/s 
± 1.2 vs 4.6 m/s ± 0.9, P = 0.04; aortic root distensibility: 1.4*10-3 mm Hg-1 ± 1.7 vs 5.7*10-3 mm 
Hg-1 ± 3.6, P < 0.01). Minor degrees of aortic regurgitation (AR) (AR fraction 6% ± 8 vs 1% ± 1, P 
< 0.01) and reduced LV ejection fraction were present (51% ± 8 vs 58% ± 6, P = 0.01), whereas 
right ventricular (RV) ejection fraction was within normal limits (47% ± 8 vs 52% ± 7, P = 0.06). 
Degree of AR fraction was associated with dilatation of the aortic root (r = 0.39 - 0.49, P < 0.05) 
and reduced aortic root distensibility (r = 0.44, P = 0.02), while reduced LV ejection fraction was 
correlated with degree of AR and RV ejection fraction (r = 0.41, P = 0.02, and r = 0.49, P < 0.01, 
respectively). 
Conclusion: Aortic root dilatation and reduced aortic elasticity are frequently present in 
patients with TOF, in addition to minor degrees of AR and reduced LV systolic function. Aortic 
wall pathology in repaired TOF patients may therefore represent a separate mechanism leading 
to LV dysfunction, in addition to adverse right-to-left ventricular interaction.
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Introduction
Aortic root dilatation frequently occurs in tetralogy of Fallot (TOF) patients, ranging in incidence 
between 15% and 88% depending on the definition (1-5). Aortic root dilatation may lead 
to serious complications such as aortic regurgitation, aneurysm formation and even aortic 
dissection, necessitating aortic valve and aortic root surgery (3,5,6). Therefore, meticulous non-
invasive follow-up of the aorta is clinically highly desirable (2,3,5,6). 
 Recent reports indicate that aortic dilatation and concomitant reduced aortic elasticity 
may have a negative effect on aortic valve function, by loss of central coaptation and increased 
stress on the aortic valve leaflets during opening and closing, respectively (7-14). Reduced aortic 
elasticity is also associated with LV dysfunction and impaired coronary blood flow (15,16). Aortic 
wall pathology in repaired TOF patients may therefore represent a separate mechanism leading 
to LV dysfunction, in addition to possible adverse right-to-left ventricular interaction (17-19).
 Distensibility and pulse wave velocity (PWV) in the aorta have been shown to be markers 
of aortic vessel wall condition, since they are mainly due to the elastic properties of the aorta 
(15,20,21), for which magnetic resonance imaging (MRI) has been established as an accurate non-
invasive imaging tool (7,8,22). In addition, MRI is a reliable and accurate method for assessment 
of aortic dimensions, aortic valve competence and biventricular function (19,23,24). 
 We hypothesized that aortic root dilatation in patients after repair of TOF can be attributed 
to aortic wall pathology, as measured by abnormal aortic distensibility and PWV, and that 
abnormal aortic elastic properties may negatively affect aortic valve and LV systolic function. 
In our study we examined TOF patients after pulmonary valve replacement (PVR), to minimize 
the possible confounding effect of adverse right-to-left ventricular interaction due to pulmonary 
regurgitation (PR) (17-19). Accordingly, the purpose of the current study was to prospectively 
assess aortic dimensions, aortic elasticity, aortic valve competence and biventricular systolic 
function in repaired TOF patients after PVR by using MRI.
Materials and Methods
Patients
The local medical ethics committee approved the study and informed consent was obtained 
from all participants prior to enrollment in the study.  
 Sixteen patients with TOF and 16 age- and gender matched healthy subjects were 
prospectively studied with MRI at our institution. All TOF patients (10 male, 6 female; mean age 
± standard deviation:  31 years ± 15) were recruited from our local congenital heart disease 
database. Inclusion criteria consisted of diagnosis of TOF, previous history of PVR, willingness 
to comply with the study procedures and written informed consent. Exclusion criteria 
comprised of evidence of aortic valve stenosis (aortic velocity > 2.5m/s on echocardiography) 
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(25), pulmonary regurgitation exceeding 10% (1 patient), aortic coarctation and/or other forms 
of congenital heart disease than TOF, Marfan syndrome or a family history of Marfan syndrome, 
usage of medication such as beta-blockers and general contraindications to MRI.
 Age- and gender-matched healthy subjects were selected from our local database of healthy 
subjects. Characteristics and functional status as expressed as New York Heart Association class 
of the patients and healthy subjects were obtained from the patient records (Table 1).  
Table 1: Characteristics of tetralogy of Fallot patients and healthy subjects
Characteristics patients (n = 16)    healthy subjects (n = 16)
male / female 10 / 6    10 / 6     
age at MRI (years) *   31 ± 15 31 ± 16
height (cm) * 172 ± 10 179 ± 10
weight (kg) * 70 ± 14 73 ± 16
body surface area (m2) * and † 1.7 ± 0.2 1.9 ± 0.4
blood pressure systolic (mm Hg) * 118 ± 14 121 ± 13
blood pressure diastolic (mm Hg) * 72 ± 7 73 ± 12
cardiac frequency (beats per minute) * 65 ± 8 67 ± 9
New York Heart Association class I / II 15 / 1 16 / 0
age at shunt procedure, median (years) 1.2 (0.8 to 2.4)
age at initial TOF repair, median (years) 2.1 (1.8 to 3.0)
age at PVR, median (years) 27 (23 to 35)
interval surgery - PVR (years) * 24 ± 4
interval PVR - MRI (years) * 4 ± 4
* Data are expressed as mean ± standard deviation.
† According to the formula: √ (height (cm) × weight (kg) / 3600).
Abbreviations: MRI = magnetic resonance imaging; TOF = tetralogy of Fallot; PVR = pulmonary valve replace-
ment.
Surgical technique
Initial repair was performed in TOF patients with a transatrial-transpulmonary approach, using 
cardiopulmonary bypass and moderate hypothermia. A transannular patch was used in 10 patients. 
Fourteen patients had previously undergone Blalock-Taussig shunt insertion and 1 patient had 
received a Potts shunt prior to initial repair. 
 Pulmonary valve replacement in all TOF patients was performed using cryopreserved 
pulmonary homografts. Homografts were inserted in the orthotopic pulmonary position with 
maximal resection of the RV outflow tract patch material.
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MRI
MRI was performed with a 1.5-T system (NT 15 Gyroscan Intera; Philips Medical Systems, The 
Netherlands) by one researcher (with 4 years experience in cardiac MRI). Imaging sequences were 
previously described (7,8).
 Aortic root dimensions were assessed by acquisition of double-oblique transverse images 
perpendicular to the aorta, at the levels of the annulus of the aortic valve, the sinus of Valsalva, 
the sinotubular junction and the ascending aorta; the latter at the level of the crossing of the right 
pulmonary artery (7,8). 
 Aortic distensibility was measured at the level of the sinotubular junction (7,8). Distensibility 
(mm Hg-1) is defined as: (Amax - Amin) / (Amin × (Pmax - Pmin)), with Amax and Amin the maximal and 
minimal lumen areas (mm2) of the sinotubular junction, and Pmax and Pmin the systolic and diastolic 
blood pressures (mm Hg) (7,8). The minimal lumen area was obtained during the iso-volumetric 
contraction phase (just before the beginning of the systolic upslope) and the maximal lumen area 
was obtained at the peak of aortic flow passing through the ascending aorta (7,8). Simultaneous 
blood pressure measurements were non-invasively obtained using a semiautomatic MRI-
compatible sphygmomanometer (Invivo Research, USA) (26). 
 A velocity-encoded MRI sequence was performed just distal to the aortic valve for timing of the 
acquisition of the cross-sectional minimal and maximal area measurements and for determination 
of aortic valve regurgitation (AR fraction). AR fraction was calculated with the following formula: 
regurgitant volume / systolic forward volume × 100%, where volume is measured in milliliters. 
A similar flow sequence was used for assessment of pulmonary valve regurgitation (PR), with a 
through-plane velocity encoded of up to 150 cm/s (27). 
 PWV of the aorta was measured between the ascending and proximal descending aorta, and 
between the proximal descending aorta and the abdominal aorta just proximal to the bifurcation 
(8). A transverse velocity-encoded MRI sequence was applied at the level of the pulmonary trunk 
to measure through-plane flow in the ascending aorta and proximal descending aorta, while a 
second slice was prescribed in the abdominal aorta just proximal to the bifurcation (8). PWV was 
calculated as Δx/Δt (expressed in m/s), where Δx is the aortic path length between the measurement 
sites and ∆t is the transit time between the arrival of the systolic wave front at these sites (8). 
 Systolic biventricular function was assessed with a steady-state free-precession cine sequence 
in the short-axis plane by using breath holds. A total of 12 consecutive slices were obtained (40 
phases per cardiac cycle) without slice gap (28).
Postprocessing
Diameter- and distensibility measurements of the aortic root, as well as systolic biventricular 
function images were analyzed with the software package MASS (Medis, The Netherlands) (28). 
The following parameters were determined for both ventricles: end-diastolic volume (EDV), end-
systolic volume (ESV), stroke volume (SV), ejection fraction (EF); and LV mass (7,8,28). Indexation 
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was performed according to the Mosteller formula (BSA = √ (height (cm) × weight (kg) / 3600)), 
where BSA is the body surface area in square meters (7,28). 
 Flow velocity-encoded MRI data were analyzed with the software package FLOW (Medis, The 
Netherlands) (29). Flow curves were obtained with this method for aortic flow and pulmonary flow 
during the cardiac cycle.
 The manual drawing of all MRI contours and analysis of the other results was performed by 
one researcher (with 4 years experience in cardiac MRI), which was subsequently checked by a 
radiologist (with 10 years experience in cardiac MRI), who was unaware of the clinical condition of 
the examined TOF patients. 
Statistical analysis
Statistical analysis was performed using software (SPSS for Windows, version 12.0.1; SPSS, USA). 
All data are presented as mean values ± standard deviation, unless stated otherwise. Two-tailed 
Mann-Whitney U test was used to express differences between the patient and healthy subjects. 
Correlation between variables was expressed with Spearman rank correlation coefficient. Statistical 
significance was indicated by a P value of less that 0.05.
Results
Results of the TOF patients and healthy subjects are summarized in Table 2.
Aortic dimensions and elasticity
Diameters of the aortic root at all 4 levels were significantly increased in TOF patients as 
compared to the healthy subjects (P < 0.01 for all). Dilatation was most pronounced at the 
level of the sinus of Valsalva, with a decrease in mean difference towards the level of the 
ascending aorta (Figures 1 and 2). Elasticity of the proximal aorta was found to be reduced 
in TOF patients, as PWV in the aortic arch was significantly increased and distensibility at the 
level of the sinotubular junction was significantly reduced. PWV in the descending aorta was 
relatively normal. Dilatation at all levels of the aortic root was significantly correlated with 
reduced distensibility of the aortic root (r = 0.66 - 0.72, P < 0.01 for all). 
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Figure 1. Aortic dilatation.
Figure 1 a-b.  Coronal (a) and transverse (b) black-blood turbo spin-echo MRI images of the ascending aorta 
in a 46-year old male with repaired tetralogy of Fallot, showing a dilated ascending aorta with a 
maximum diameter of 4.2 cm.
Figure 2. Aortic insufficiency.
Figure 2 a-b.   Oblique coronal (a) and sagittal (b) gradient-echo images of the ascending aorta in the same 
46-year old male with repaired tetralogy of Fallot, showing a dilated ascending aorta and central 
aortic valve regurgitation.
Aortic and pulmonary valve competence
In 7 of 16 TOF patients minor degrees of AR were found, with AR fraction ranging between 
5% and 12% (Figure 2). In none of the healthy subjects AR fraction exceeded 5%. Dilatation 
and reduced elasticity of the aortic root were associated with the degree of AR, as aortic 
root dilatation (r ranging 0.39 - 0.49, P ≤ 0.04 for all 4 levels) and reduced distensibility of the 
aortic root (r = 0.44, P = 0.01) were all correlated with degree of AR fraction. Minor degrees of 
PR were present in 4 patients, with PR fraction ranging between 6% and 10%.
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LV and RV function 
Systolic LV function - expressed by LV EF - was found to be significantly decreased in patients 
after TOF as compared to the healthy subjects, whereas RV ejection fraction was within 
normal limits. Reduced LV ejection fraction was correlated with degree of AR and RV ejection 
fraction (r = 0.41, P = 0.02, and r = 0.49, P < 0.01, respectively). LV and RV dimensions (EDV 
and ESV) were within normal limits in the TOF patient group, although RV ESV of the TOF 
patient group was significantly larger as compared to the healthy subjects. Mean LV mass 
was normal in the patient group as compared to the healthy subjects.
Table 2: Results of tetralogy of Fallot patients and healthy subjects.
Parameters patients healthy subjects P value mean difference
diameter annulus (mm) 36.0 ± 4.6 27.2 ± 3.2  < 0.01 8.8 
diameter sinus of Valsalva (mm) 39.3 ± 5.4 30.4 ± 3.1  < 0.01 8.8
diameter sinotubular junction (mm) 35.9 ± 4.9 27.7 ± 3.6 < 0.01 8.2
diameter ascending aorta (mm) 33.6 ± 5.6 25.8 ± 3.8  < 0.01 7.8
distensibility at STJ (in 10-3 mm Hg-1) 1.4 ± 1.7 5.7 ± 3.6 < 0.01
PWV aortic arch (m/s) 5.5 ± 1.2 4.6 ± 0.9 0.04
PWV descending aorta (m/s) 4.9 ± 1.9 4.5 ± 1.1 0.48
aortic regurgitation fraction (%) 6 ± 8  1 ± 1  < 0.01
LV EF (%) 51 ± 8    58 ± 6 < 0.01
LV EDV (m/m2) * 99 ± 25 98 ± 29 0.87
LV ESV (m/m2) * 47 ± 15 41 ± 14  0.28
LV SV (m/m2) * 53 ± 15 57 ± 18 0.51
LV mass (g/m
2) * 55 ± 16 51 ± 15 0.46
pulmonary regurgitation fraction (%) 4 ± 4 2 ± 2 < 0.01
RV EF (%) 47 ± 8 52 ± 7 0.06
RV EDV (ml/m2) * 117 ± 36 101 ± 28 0.17
RV ESV (ml/m2) * 63 ± 25 48 ± 13 0.04
Note: data are expressed as mean ± standard deviation.
* indexed for body surface area, according to the formula: √ (height (cm) × weight (kg) / 3600).
Abbreviations: STJ = sinotubular junction; PWV = pulse wave velocity; LV = left ventricle; EF = ejection fraction; 
EDV = end-diastolic volume indexed for body surface area; ESV = end-systolic volume indexed for body surface 
area; SV = stroke volume indexed for body surface area; RV = right ventricle.
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Discussion
The main findings of our study are: 1. patients after TOF repair show aortic root dilatation and 
reduced elasticity of the proximal aorta; 2. aortic root dilatation and reduced elasticity of the 
proximal aorta are associated with minor degrees of aortic regurgitation; 3. reduced LV systolic 
function is present in TOF patients clinically doing well after pulmonary valve replacement, 
and is associated with the degree of aortic regurgitation and RV ejection fraction.
Aortic dimensions
Significant dilatation of the aortic root was present in our patient group with repaired TOF, 
being most pronounced at the levels of the annulus and the sinus of Valsalva. Increased blood 
flow from both ventricles to the overriding aorta before surgical repair may pose increased 
stress on the aortic wall, which may lead to aortic root dilatation (1,3,5,6). In addition, 
histological changes of the aortic media have been reported resembling those observed in 
Marfan syndrome (5,6,30). Strong correlation between histological aortic wall changes and 
the ascending aortic circumference suggests a causative mechanism for subsequent aortic 
root dilatation (5). Whether aortic wall pathology results from an intrinsic medial abnormality 
inherent to TOF itself, is secondary to the antecedent volume load through the aorta before TOF 
repair, or perhaps a combination of the two, remains however difficult to distinguish (1,3,5,6). 
 Aortic dilatation has been reported to be progressive in TOF patients with aortic dilatation, 
with an increase of aortic dilatation at a rate of 1.7 mm/year, in contrast to 0.03 mm/year in a 
control TOF patient group without aortic dilatation (1). Of even greater concern are recent case 
reports of aortic dissection late after repair of TOF in two adults whose aortic roots exceeded 
6.0 cm in diameter (31,32). Close monitoring of aortic dimensions is therefore mandatory 
during follow-up - especially when a dilated ascending aorta is present - although clear 
guidelines for an exact timeframe of follow-up are not available (1,32). Evaluation of aortic 
dilatation may be performed every 6 months to determine the rate of progression, which can 
be extended to annual evaluation when the aortic size is stable over time, analogue to patients 
with Marfan syndrome (33). As MRI is already a well-accepted imaging modality for follow-up 
of RV function in TOF patients, assessment of aortic and LV parameters may be included in the 
imaging protocol. Aortic root surgery may be considered for patients with repaired TOF in case 
of progressive AR and aortic root dilatation exceeding 5.5 cm, particularly when the primary 
indication for surgery is PVR (1). At present, there is no clear consensus to our knowledge 
on beta-blocker administration for prevention of progressive dilatation of the aortic root in 
repaired TOF patients such as in patients with Marfan syndrome, nor at what stage aortic root 




Reduced elasticity of the proximal aorta in our patient group indicated that TOF is not only 
associated with aortic dilatation (1,3,5), but also with reduced aortic elasticity. In Marfan 
syndrome and bicuspid aortic valve disease, increased aortic stiffness has been reported due to 
fragmentation of elastic wall components (26). Considering the many histological similarities 
between these entities and TOF (6), aortic wall abnormalities in TOF patients may be responsible 
for reduced aortic elasticity as well (1,3,5,6,30). Our patient group showed diminished elasticity 
of the aortic root and the aortic arch, suggesting that only the proximal part of the aorta is 
affected in TOF patients. In patients with Marfan syndrome, aortic stiffness has proven to be an 
independent predictor of progressive aortic dilatation (26). Evaluation of the elastic properties 
of the ascending aorta in patients with TOF might therefore be used analogously to identify 
patients who are at risk of progressive dilatation and other aortic sequelae.
 Arterial stiffness has been shown to be a cardiovascular risk factor on its own, being 
associated with impaired coronary blood flow and LV dysfunction (15). In addition, a strong 
and independent association has been demonstrated between increased arterial stiffness 
and the presence of coronary artery disease (34). Senzaki et al. recently described augmented 
aortic wave reflections and increased aortic and peripheral arterial stiffness in a group of TOF 
patients, which contributes to pulsatile load on the LV and adversely affects LV ejection (30). 
Prognosis of patients with increased arterial stiffness in patients with TOF may therefore be 
worse as compared to healthy subjects, since other cardiovascular risk factors act cumulatively 
over a lifetime (15,34).
Aortic valve competence
Aortic root dilatation and decreased aortic distensibility are closely related to aortic valve 
function, with the potential to cause AR (7-9). Though fewer than half of our TOF patients 
exhibited mild degrees of AR, dilatation and reduced elasticity of the aortic root were 
associated with the degree of AR. Increased dimensions of the aortic annulus may lead to loss 
of coaptation of the aortic valve leaflets, which may subsequently result in varying degrees of 
central AR (2,9,10). In addition, aortic valve dynamics are related to distensibility of the aortic 
root. During systole, as the aortic valve opens, the aortic root should expand simultaneously 
(11,12). Any disturbance in this synchronized process results in increased stress on the aortic 
valve leaflets (12-14), which may ultimately result in degeneration of the aortic valve leaflets 
and consequent AR. 
LV function
LV systolic function was significantly reduced in our TOF patients. In a recent study of 
Geva et al., moderate to severe LV dysfunction was the strongest independent variable 
associated with impaired clinical status in long-term survivors of TOF repair (19). 
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Despite the fact that most of our patients were identified as New York Heart Association 
functional class I, reduced LV ejection fraction may therefore be of negative prognostic 
value. LV dysfunction has been explained by adverse right-to-left ventricular interaction: 
longstanding PR in repaired TOF patients will lead to RV dilatation, which is associated 
with increased LV end-systolic volume and impaired septal contractility, having an 
adverse effect on LV systolic performance (17-19). In our study, TOF patients after PVR 
were investigated with only minor degrees of PR, to minimize the possible confounding 
effect of adverse right-to-left ventricular interaction. 
 In this study, LV systolic dysfunction was also associated with the degree of AR, which 
may be considered as the endpoint in a sequence of events. Increased LV mass may occur 
as a consequence of AR, to maintain normal LV filling pressures (9). In the case of limited 
AR, the increased preload will lead to a normal LV volume/mass ratio with adequate 
preservation of LV EF (9). When AR progresses, the concomitant increased wall stress will 
result in LV systolic dysfunction and reduced LV ejection fraction (9). Therefore, aortic 
dilatation  and increased aortic stiffness due to aortic wall pathology in repaired TOF 
patients may have a contributive effect on the development of AR and LV dysfunction, in 
addition to adverse right-to-left ventricular interaction (17-19).
 Our study has limitations. First, our study design is observational and therefore 
longitudinal follow-up studies are required to define the prognostic value of our findings. 
Secondly, relatively weak correlation coefficients between the investigated variables 
were found, so other contributive factors may play a role as well.
 In conclusion, our study findings revealed frequent aortic root dilatation and reduced 
elasticity of the proximal aorta in patients after repair of TOF, associated with minor 
degrees of aortic regurgitation and reduced LV systolic function. Aortic wall pathology 
in repaired TOF patients may therefore represent a separate mechanism leading to LV 
dysfunction, in addition to adverse right-to-left ventricular interaction. Our study showed 
the feasibility of MRI as an integrated imaging tool to monitor aortic and LV function 
parameters, which may facilitate the early detection of LV dysfunction in patients after 
repaired TOF. Assessment of aortic and LV function parameters should be part of already 
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Results of the Ross operation in a Paediatric Population.




Purpose: To analyse the results of the mid-term clinical and echocardiographic follow-up of 
the pediatric Ross operation. 
Materials and Methods: Echo-Doppler follow-up of 53 consecutive pediatric Ross 
procedures was performed between 1994 and 2003. Median age was 9.7 years at time of 
operation (2 weeks - 17.7 years). Six patients were younger than 3 months. Median age at 
follow-up was 15.6 years. Aortic valve/left ventricular outflow tract (LVOT) anomalies were 
congenital in 49 (92%). Seventy percent had previous surgery or balloon valvuloplasty. 
Root replacement was used in all. Thirteen patients (25%) had LVOT enlargement. Mean 
cross-clamp time was 113 (69 - 189) minutes. 
Results: Early mortality occurred in 3 patients after emergency surgery following balloon 
failure (n = 1) and extended Ross following interrupted arch / VSD repair (n = 2). Late 
mortality was due to LV fibroelastosis in 2 patients and complicated pulmonary artery 
stenting in another. RVOT reoperations were required because of late homograft obstruction 
in 2 patients and because of pulmonary artery stenosis in another. Five patients (9.4%) were 
reoperated for pulmonary autograft dilatation (n = 3) and for leaflet fibrosis or perforation 
(n = 2). Autografts were repaired in two patients, while a mechanical valve was inserted in 3 
cases. At 9 years the actuarial survival and event free survival were 89% and 74%, respectively. 
At last follow-up 90% of autograft diameters indexed to body surface area was above the 
90th percentile of normal aortic root diameters. LVOT and RVOT gradients were low and 
autograft insufficiency was trivial to mild in 84% and mild to moderate in 16%. Autograft 
stenosis was not noticed. 
Conclusion: The pediatric Ross procedure remains an important tool but autograft 
dilatation also occurs in the pediatric population. The significance of this finding has yet to 
be determined.
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Introduction
The use of the pulmonary autograft was first reported in 1967 by Ross for the treatment of 
aortic valve disease in adults (1). Since that time, the Ross procedure has been increasingly 
applied to the pediatric population, including neonates and infants (2-6). Several advantages 
of the pulmonary autograft are of benefit for both the adult and pediatric patient group: the 
high rates of freedom of reoperation and the lack of need for anticoagulation (2-6). Especially 
for the pediatric population there are additional beneficial effects, like the potential for growth 
of the autograft and the ready availability of an inherently proper sized pulmonary autograft 
(2,3,5-9). However, pulmonary autograft growth and dilatation cannot be easily distinguished 
from each other and several reports indicate that both dilatation and growth occur in the 
growing subject (10). Despite conflicting reports about autograft dilatation causing aortic 
insufficiency, excess dilatation necessitating reoperation is one of the main concerns following 
the Ross operation (3-8).
 We have reviewed our consecutive Ross operations in all patients younger than 18 year 
with an emphasis on maximal pulmonary autograft diameters in relation to body surface. Part 
of our experience has been described previously (11).
Material and methods
Patient population
From February 1994 to March 2003, 53 consecutive Ross procedures have been performed 
in patients younger than 18 years in our institution. The preoperative indication for the 
Ross procedure was aortic stenosis (AS) in 12 patients (23%), aortic regurgitation (AR) in 
14 patients (26%) and a combination in 27 patients (51%). The underlying left ventricular 
outflow tract (LVOT) pathology was congenital in 48 patients (90%) while 3 patients had a 
pulmonary autograft procedure as a consequence of rheumatic heart disease and 2 following 
endocarditis of the aortic valve (AV). Bicuspid aortic valve was present in 64% of all cases. 
Median age at operation was 9.7 years (range: 2 weeks - 17. 7 years), with a mean age of 9.15 
± 5.07 years. Six patients were operated at an age of 3 months or less. Forty-six patients were 
male (87%).
 Thirty-seven patients (70%) had undergone surgery or percutaneous intervention(s) prior 
to the Ross procedure (Table 1). Of this group 11 patients (20%) had undergone more than one 
procedure prior to the pulmonary autograft procedure.
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 Informed consent was obtained from all included patients, with approval of the institutional 
ethics committee.




Resection subaortic stenosis 13
Aortic valve repair 3
VSD closure 8
Coarctation or interrupted arch repair 9
Arterial switch operation 1
Operative technique
In all patients the pulmonary autograft was implanted using the root replacement technique. 
Reinforcement of proximal and distal suture lines with a strip of autologous pericardium 
was used in most patients. Continuous sutures were used in all. In all cases cardiopulmonary 
bypass with moderate hypothermia was used. Autograft harvesting was usually performed 
after aortic cross-clamping and antegrade administration of St Thomas cardioplegic solution. 
The mean cross-clamp time was 113 min (range: 69 - 189 min). Right ventricular outflow tract 
(RVOT) reconstruction was performed with cryopreserved pulmonary homografts (n = 47; 
mean diameter 22 mm), cryopreserved aortic homografts (n = 3; mean diameter 15 mm) or 
Contegra bovine jugular vein grafts (Medtronic Inc., USA) (n = 3; mean diameter 15 mm). The 
distal RVOT suture line was usually done during myocardial arrest while the proximal suture 
lines were performed on beating heart.
 In 13 patients (25%) the aortic annular or LVOT diameter was considered as being too small 
and annular enlargement was performed in association with septal muscle myectomy and/or 
resection of subaortic fibrous tissue. In 3 of these 13 patients the LVOT was further enlarged by 
septal patch insertion (Ross-Konno procedure).
 Associated procedures during the Ross operation were enucleation or resection of a discrete 
subaortic stenosis in 8 patients, ventricular septal defect (VSD) closure in 2 patients and mitral 
valve replacement in 1 patient. One patient with a VSD and aortic insufficiency repaired has 
previously been described elsewhere (12).
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Follow-up
Follow-up was performed by analysis of operative reports, patient records and echo-Doppler 
studies at last follow-up. Body weight and height data at the time of last follow-up were collected 
and used to determine body surface area (BSA expressed in m2). The maximal diameter of the 
pulmonary autograft at sinus of Valsalva (SOV) level obtained by echocardiography was noted 
at the same last visit. Maximal autograft diameters were indexed for BSA and compared to 
normal values for aortic SOV diameters in relation to body surface area and age, as indexed by 
Roman (13). The degrees of pulmonary autograft and RVOT conduit insufficiency were indexed 
as being trivial, mild, moderate or severe. Gradients over the LVOT and RVOT were expressed in 
maximal Doppler gradients (mm Hg).
 Of the 47 surviving patients 5 were lost to follow-up. Four of these patients came from 
non-European countries. With the exception of these 5 patients, recent follow-up data were 
available in all other patients.
Statistical analysis
Statistical analysis was performed with the use of SPSS-11. Descriptive statistics are expressed 
as median and range. Means are provided with standard deviations. Unpaired student t-test 
was used for comparison of unpaired data. P < 0.05 was considered to indicate statistically 




In the postoperative period 5 patients required a resternotomy for bleeding, while late 
pericardial effusions needed drainage in 3 patients. Complete heart block requiring pacemaker 
implantation occurred in 2 patients.
Early mortality
Early mortality occurred in 3 patients (5.6%) at the age of 1, 2 and 4 months. One neonate with 
critical valvular AS developed massive AR directly after balloon dilatation and underwent a 
Ross procedure on an emergency basis. This patient died in the intensive care unit as a result 
of multiple organ failure. Two other infants had been referred with LVOT obstruction following 
previous repair of interrupted aortic arch and VSD, 1 and 3 months before the Ross operation. 
One of them died as a result of preoperative poor left ventricular (LV) function. The other 





Three patients died 13 months, 5 and 6 years after the Ross operation (5.6%). One patient with 
valvular AS received a Ross procedure at the age of 2.5 months following a failed attempt of 
balloon dilatation. Severe pulmonary hypertension persisted after surgery and this patient died 
13 months later. A second patient received a Ross procedure at the age of 7 years but suddenly 
died at 5 years of follow-up. Pulmonary hypertension had been diagnosed in this patient several 
years postoperatively. In these 2 patients autopsy showed severe LV endocardial fibroelastosis. 
LV dimensions were within normal limits at the time of the Ross procedure. A third patient had a 
Ross operation at the age of 16 years. Pulmonary artery patch augmentation was performed after 
one year to relief distal RVOT homograft stenosis. Complications of stent placement for recurrent 
RVOT obstruction subsequently led to mortality 6 years after the Ross procedure.
Reoperation
A total of 8 patients required reoperation. Five patients (9.4%) were reoperated for insufficiency 
and/or dilatation of the pulmonary autograft. Two patients were reoperated for valvular failure 
of the pulmonary autograft. One patient presented with a valvular insufficiency 3 years after the 
Ross procedure: at reoperation a delineated perforation near the hinge of the right coronary 
autograft cusp was observed and subsequently repaired with an autologous pericardial patch. A 
second patient returned with fibrosis and shortening of one of the autograft leaflets 2 years after 
the Ross procedure. In this patient who had undergone an arterial switch operation in the past, 
an insufficient aortic valve had been replaced by the pulmonary autograft that in fact was the 
aortic valve before the arterial switch operation (14). At reoperation the autograft was replaced 
by a mechanical prosthesis.
 Autograft dilatation with mild to severe AR led to reoperation in 3 patients. Maximal autograft 
diameter (at sinus Valsalva level) was 63 mm in one patient. This patient underwent a Bentall 
procedure with insertion of a mechanical valve prosthesis. Mechanical valve replacement was 
performed in a second patient and valve sparing root remodelling was done in the third patient. 
The age at the time of the Ross procedure had been 5.5, 3 and 6 years, respectively.
 Three patients were reoperated for right-sided homograft obstruction. Two homografts were 
replaced 5 and 8 years after the Ross operation (Ross performed at the age of 1 month and 4.8 
years, respectively). In a third patient distal homograft obstruction required patch enlargement 1 
year after the Ross procedure.
Midterm survival
Kaplan-Meyer analysis showed a survival and event free survival rate of 89 and 74% at 9 years of 
follow-up, respectively (Figure 1).
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Figure 1. Survival and event free survival.
Functional status
The mean follow-up was 5.5 years (range: 0.9 - 8.2 years). At last follow-up all survivors were in 
New York Heart Association class I, without using medication.
Autograft function
Maximal autograft diameters (at sinus level) were indexed to body surface area (m2) and 
compared to normal values for aortic root diameters in infants, children and young adults 
(Figure 2). At last follow-up 90% of autograft diameters indexed to body surface area was 
above the 90th percentile of normal aortic root diameters. Median diameter was 37 mm 
(range: 22 - 45 mm). Bicuspid aortic valve vs tricuspid valve showed no significant difference 
for risk of developing aortic root dilatation (P = 0.218).
Figure 2. Autograft diameter vs body surface area.
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In all patients mean LVOT gradients were less than 5 mm Hg, including all patients with an 
extended Ross or Ross-Konno procedure. Moderate pulmonary autograft insufficiency 
at last follow-up was observed in 6 patients (11%), while 17 patients had mild autograft 
regurgitation.
Homograft function
RVOT obstruction was rare in our patients; in only 3 cases a moderate degree of stenosis 
was noticed, with a maximum Doppler RVOT gradient ranging between 37 and 45 mm Hg. 
Mean maximal RVOT gradient of the entire population was 23 mm Hg, ranging between 7 
and 45 mm Hg. Moderate homograft insufficiency was observed in only 4 patients, while 13 
patients had only trivial to mild homograft regurgitation.
Discussion
In the pediatric group aortic valvular disease can frequently be treated without the need for 
valve replacement. Balloon dilatation, open commissurotomy, cusp shaving as well as repair 
procedures for insufficient valves are the first choice. Subaortic obstruction is also frequently 
amenable to resection of fibrous or muscular tissue. Valve replacement may be postponed for 
years in this way. Seventy percent of our patients had undergone one or more procedures prior 
to their Ross operation (Table 1) leading in this series to a mean age of 9.15 years at the time of 
the autograft procedure.
 When aortic valve replacement in children can no longer be postponed, replacement with 
the pulmonary autograft has important advantages. The use of anticoagulants can be avoided 
as well as the occurrence of early failure as observed with homografts in children. Above all the 
autograft increases in size commensurate with body growth (10). Therefore, the pulmonary 
autograft is superior to any other available aortic valve substitute for the growing child. 
 Alternative surgical options to the Ross procedure should however, always be considered. 
Mechanical valves can be used in older children if a size of 21 mm or larger can be inserted. 
Severe LVOT obstruction can be repaired sometimes without the need for aortic valve 
replacement. However, in our series aortic valve pathology or hypoplastic annulus was 
present in all Ross-Konno patients.
 During our 10-year experience we came across some additional technical benefits 
of the Ross procedure. Enlargement of annulus or septum which is often required in 
congenital aortic valve disease, is easily accomplished when the root is removed and may 
be accomplished without the insertion of patch material, using the extended muscular 
rim of the autograft. Moreover, any associated subaortic VSD can be addressed in a similar 
fashion by using the muscular rim of the autograft to make an extended inflow anastomosis 
including the VSD (12). In tunnel-form LVOT obstruction incision of the muscular septum 
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and subsequent enlargement with patch material (Ross-Konno procedure) will provide a 
satisfactory solution in almost all cases.
 In 1 patient with neo-aortic valve insufficiency following the arterial switch operation 
a ‘switch-back’ procedure was performed. The valve was replaced with the neopulmonary 
valve, which originally was the anatomic aortic valve. Bringing back the native aortic valve 
to the LV certainly has a lot of intuitive appeal (14).
 Early mortality in our series occurred only in neonatal patients or young infants. Six 
patients underwent the Ross procedure at an age of 3 months or less. Mortality in this 
age group was relatively high with 4 of 6 patients dying (3 in-hospital deaths and 1 late 
death). One patient died as a result of multiple organ failure following an emergency Ross 
procedure. Balloon dilatation had resulted in severe aortic valve insufficiency and cardiac 
arrest. Two patients had valvular and subvalvular LVOT obstruction following repair of 
interrupted aortic arch type B and VSD 1 and 3 months earlier. One of them had severely 
depressed LV function and died of low output failure following the Ross procedure. 
Ischemia probably caused by unrecognized left coronary artery kinking led to mortality in 
the other patient with previous IAA/VSD repair. Finally, one patient died 13 months after a 
Ross procedure (performed at the age of 2 months) due to severe pulmonary hypertension 
and LV failure. Autopsy confirmed the presence of severe LV fibroelastosis. Prior to the Ross 
operation diastolic LV dysfunction with a minor suspicion of fibroelastosis was present. LV-
dimensions were within normal ranges.
 LVOT obstruction following IAA/VSD repair is common and the use of the Ross-Konno 
procedure is very attractive. Care should be taken with coronary artery transfer as the 
diameter of the pulmonary autograft will usually be considerably larger than that of 
the aortic root. Starnes et al. reported their experience with the pulmonary autograft 
procedure for residual LVOT obstruction following IAA/VSD repair with good results. They 
even suggest that for IAA/VSD and small LVOT a primary Ross-Konno procedure with arch 
repair may be the procedure of choice (2,15-17).
 Endocardial fibroelastosis has been reported as being a risk factor for an adverse 
outcome in neonatal critical aortic stenosis (18). Biventricular repair may not always be the 
ideal solution for this subgroup and the Norwood procedure and subsequent univentricular 
repair can be a better option.
 Dilatation and autograft valve failure as has been described in several series of adult 
patients (3-8) also occurred in our pediatric population. The majority of patients showed 
annular diameters in excess of 90th percentile of normal aortic root diameters and 3 
patients were even reoperated for valve failure in association with excessive root dilatation. 
The meaning of this observation is not clear, as progression of autograft dilatation was not 
common in this series. Serial assessment by echocardiography and careful clinical follow-
up will provide more insight in the coming years. Although exact criteria for reoperation 
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because of dilatation are not available, the rate at which dilatation occurs and maximal 
diameter related to body surface area should be taken in consideration.
 In some patients the superior capacity of juvenile tissues to remodel appears to be 
inadequate to prevent aneurysmal dilatation and valve failure of the pulmonary autograft. 
Although one might believe that a Ross procedure performed in the neonatal period would 
suffer less from autograft dilatation than a Ross performed at a later age, some evidence 
exists that autograft dilatation can also occur following a neonatal Ross operation (Ziemer, 
personal communication 2003). Initial bicuspid aortic valve appeared to be no risk factor 
for developing dilatation either; despite suggestions in literature our study showed no 
difference in dilatation between the two groups (19).
 Reinforcing proximal and distal autograft suture lines with autologous pericardial 
strips was used in most of our patients, but apparently did not provide protection from 
dilatation. The use of large coronary buttons to replace the native pulmonary sinuses and 
reinforcement of the ‘non-coronary’ sinus wall of the pulmonary autograft by leaving the 
noncoronary aortic sinus in situ, have been reported to be of benefit (20).
 Root dilatation is not the only mechanism of autograft failure. In one of our patients 
leaflet fibrosis occurred leading to replacement by a mechanical prosthesis. Leaflet 
dysfunction without associated root dilatation has been described by others before (21). 
The mechanism of autograft leaflet shortening by fibrosis is not known. It may be the 
result of improper tissue handling at the time of operation but autograft leaflet failure may 
also be the result of a (connective) tissue disorder.
 In summary, we believe that the Ross procedure is of great use in the pediatric population 
as it provides a unique growing aortic valve substitute together with the above-described 
additional technical advantages such as an adequate solution for otherwise difficult to 
treat obstructive LVOT’s. Nevertheless, in our opinion the Ross procedure should only be 
considered when valve-sparing techniques can no longer provide a solution for pediatric 
aortic valve disease.
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Aortic Root Dysfunctioning and its Effect on Left Ventricular 
Function in Ross Procedure Patients assessed with Magnetic 
Resonance Imaging.




Purpose: This study evaluated the diameters and distensibility of the aortic root as well as the 
degree of aortic regurgitation (AR) and its effect on left ventricular (LV) function in patients 8.2 
± 3.1 years after they underwent the Ross procedure, with a comparison of these parameters 
between patients and matched healthy subjects.
Materials and Methods: Eighteen Ross procedure patients (16 male patients, age (mean ± 
SD) 19.2 ± 3.8 years) and 18 matched healthy subjects (16 male patients, age (mean ± SD) 
19.7 ± 4.2 years) underwent magnetic resonance imaging (MRI). Measurements for diameters 
(at 4 levels) and the distensibility of the aortic root were performed using a steady-state 
free precession sequence. Aortic flow was assessed with a velocity-encoded phase-contrast 
sequence. Left ventricular systolic function was assessed with a gradient-echo sequence in 
the short-axis plane. Comparison of parameters was performed using the Mann-Whitney U 
test. Correlations between diameters, distensibility, AR fraction and LV systolic function were 
expressed with Spearman rank correlation coefficients. Linear regression analysis was used to 
identify predictors of LV systolic dysfunction.
Results: Aortic root diameters were increased in Ross procedure patients as compared with 
healthy subjects (mean difference 6.3 - 11.6 mm, P ≤ 0.02 at all 4 levels). Distensibility of the 
aortic root was lower in patients (1.9 ± 1.1 vs 7.8 ± 3.3 mm Hg−1, P < 0.01). An AR fraction > 
5% was present in 14 of the 18 patients (mean AR fraction 8% ± 5% vs 1% ± 1%, P < 0.01). 
Left ventricular ejection fraction was lower in patients (50% ± 6% vs 57% ± 6%, P < 0.01). 
Dilatation, decreased distensibility and AR fraction were correlated with impaired LV systolic 
function (P < 0.05 for all). The AR fraction predicted impaired LV systolic function (P < 0.01).
Conclusion: MRI shows dilatation and decreased distensibility of the aortic root, AR, and 
consequent impaired LV systolic function in patients after the Ross procedure.
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Introduction
The first successful clinical application of a pulmonary autograft for aortic valve replacement 
was performed by Donald Ross (1) in 1967. During this procedure, the stenotic or insufficient 
aortic valve is replaced by a pulmonary autograft whereas the right ventricular outflow tract 
is reconstructed using a pulmonary homograft. This so-called Ross procedure is nowadays 
widely used in the pediatric population because of the associated excellent survival, the 
low rate of reoperation and the lack of need for lifelong anticoagulation therapy (2-4). The 
procedure’s additional beneficial effects are the potential for growth of the autograft and the 
ready availability of an inherently proper-sized pulmonary autograft (2-4).
 Recent reports indicate that not only growth but also dilatation of the autograft frequently 
occurs during follow-up (4,5). Excessive dilatation in patients, which necessitates a reoperation, 
is therefore one of the main concerns after the Ross procedure (4). The effect of dilatation 
on autograft wall integrity and its implications for a possible reoperation are unknown. 
Distensibility reflects the condition of the vascular wall because distensibility directly depends 
on the elastic properties of the vascular wall (6,7). Furthermore, aortic valve dynamics relates 
to the distensibility of the aortic root (8,9). Decreased distensibility of the aortic root increases 
leaflet stress, predisposing patients to the risk of aortic valve dysfunction (10-12).
 Echocardiography, currently used in clinical routine to study aortic dimensions and 
distensibility, has limitations, including restricted imaging quality with increasing patient age. 
Another important drawback of echocardiography when applied to measure the diameter 
of the aortic root is the fixed imaging plane, which does not correct for aortic and cardiac 
motion (13). The sinus of Valsalva of the aortic root will move through the fixed acquisition 
plane during physiologic motion, which may result in unreliable diameter measurements over 
the cardiac cycle (13).
 Magnetic resonance imaging (MRI) is a well-accepted imaging tool for postsurgical 
congenital heart disease that provides unlimited field of view (FOV) and accurate assessment 
of cardiac anatomy and cardiac function (13,14). Moreover, MR measurements can be corrected 
for through-plane motion to improve the assessment of aortic root distensibility (13).
 Accordingly, motion-corrected MRI was used in the current study for evaluating the 
dimensions and distensibility of the aortic root in relationship with autograft valve competence 
and left ventricular (LV) systolic function in Ross procedure patients as compared with age- 





The study was approved by the local ethics committee and informed consent was obtained 
from all participants before their enrollment in the study. Between October 2004 and March 
2005, 18 Ross procedure patients and 18 matched healthy subjects were prospectively studied 
with MRI at our institution. Patients aged between 12 and 25 years (n = 29) were selected from 
our local database of 53 Ross procedure patients. Patient inclusion criteria included having an 
aortic valve pathology corrected with the Ross procedure in the past, being between 12 and 25 
years old, being willing to comply with the study procedures and providing written informed 
consent. Patient exclusion criteria composed of having had a Konno extension to the Ross 
procedure (ie, relief of LV outflow obstruction by septal patch insertion) (3 patients), undergoing 
reoperation and/or reintervention in the autograft area between the Ross procedure and MR 
investigation (1 patient) and having other general contraindications to a cardiovascular MR 
examination. Seven patients denied participation for personal reasons.
 Age- and sex-matched healthy subjects were selected from our database of subjects 
in whom cardiac pathology had been excluded in the past by physical examination and 
echocardiography. The characteristics of the 2 groups and functional status as expressed in 
New York Heart Association class were obtained from patient records (Table 1).
Table 1. Patient and volunteer characteristics.
Characteristics patients (n = 18)    healthy subjects (n = 18)
male / female 16 (89) / 2 (11) 16 (89) / 2 (11)
age at Ross operation (years) * 11.3 ± 5.3
interval between the operation and the MRI (years) * 8.2 ± 3
height (cm) * 173 ± 12 179 ± 10
weight (kg) * 66 ± 15 71 ± 16
Body Surface Area (m2) * and † 1.8 ± 0.9 1.9 ± 1.0
bicuspid aortic valve before Ross 14 (78) none
preoperative:  AR / AS / combined AR and AS 3 / 1 / 14 (17 / 6 / 78)
Note: unless otherwise indicated, data are number of patients, and data in parentheses are percentages.
* Data are mean ± standard deviation.
† According to the Mosteller formula: √ (height (cm) × weight (kg) / 3600).
MRI = magnetic resonance imaging; AR = aortic regurgitation; AS = aortic stenosis.
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Operative technique
The Ross procedure was performed on patients with an aortic valve pathology (median age at 
surgery 10.8 years, age (mean ± SD) 11.3 ± 5.3 years) using cardiopulmonary bypass with moderate 
hypothermia. In all patients, the pulmonary autograft was implanted using the root replacement 
technique (15). Reinforcement of proximal and distal suture lines with a strip of autologous 
pericardium was used for most patients. Autograft harvesting was usually performed after aortic 
cross-clamping. Associated procedures during the Ross procedure were enucleation or resection of 
a discrete subaortic stenosis (3 patients) and ventricular septal defect closure (2 patients).
MRI
MRI studies were performed with a 1.5-T system (NT 15 Gyroscan Intera, Phillips Medical 
Systems, The Netherlands). Scout images were obtained in transverse, coronal and sagittal 
planes using a standard multislice turbo spin-echo sequence.
 Two sets of orthogonal scout cine images of the aortic root were obtained for planning of the 
acquisition planes for diameter measurements of the aortic root. Four diameter measurements 
were subsequently obtained at the levels of the annulus of the aortic valve, the sinus of Valsalva, the 
sinotubular junction and the ascending aorta (AA), with the AA at the level of the pulmonary trunk 
(Figure 1). A steady-state free precession sequence (balanced turbo field-echo pulse sequence) was 
used, with the following scan parameters: FOV 220 mm; voxel size 1.25 × 1.25 × 6.00 mm; flip angle (FA) 
50°; repetition time (TR) 3.2 ms; echo time (TE) 1.23 ms; gate width 34.2 ms. Diameter measurements 
were acquired during diastole, with a trigger delay for all measurements set at 600 ms.
Figure 1. 
Figure 1.  Four diameter measurements of the aortic root using a steady-state free precession cine sequence 
were performed at the level of the annulus of the aortic valve (1), the sinus of Valsalva (2), the sinotu-
bular junction (3) and the AA at the level of the pulmonary trunk (4).
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Distensibility is defined as follows (16):
Dist (mm Hg-1) = ((Amax - Amin) / (Amin × (Pmax - Pmin))) 
with Amax and Amin as the maximal and minimal cross-sectional lumen areas (in mm squared) 
of the aortic root, respectively, and Pmax and Pmin as the systolic and diastolic blood pressures 
(in mm of mercury), respectively. In our study, the maximal and minimal cross-sectional lumen 
areas were obtained at the level of the sinotubular junction (Figure 2). Imaging at this level 
ensured optimal imaging quality as a result of the absence of aortic valve movements, in 
comparison with the aortic annulus and the sinus of Valsalva. 
 Blood pressure was noninvasively obtained using a semiautomatic MRI-compatible 
sphygmomanometer (Invivo Research, USA). In each patient, right brachial artery systolic and 
diastolic blood pressures were measured 3 times during the measurements for distensibility, 
and the average of the measurements was used for calculations (17). In all investigated subjects, 
the used cuff size depended on patient size.
 A pilot study on 5 healthy subjects showed that the minimal lumen area is to be expected 
early in the cardiac cycle during the isovolumetric contraction phase, whereas the maximal 
area is to be expected when the peak of aortic flow passes through the AA (Figure 2). For this, 
cross-sectional lumen area measurements were obtained throughout the cardiac cycle at the 
level of the sinotubular junction.
 Accordingly, first, the flow was measured at the level of the AA with a phase-contrast 
sequence for timing of the acquisition of the cross-sectional minimal and maximal area 
measurements. The phase-contrast study consisted of a gradient-echo sequence, with the 
following scan parameters: FOV 300 mm; matrix size 128 × 128 mm (with a reconstructed 
voxel size of 1.17 × 1.17 × 8.00 mm); FA 20°; TR 4.8 ms; TE 2.8 ms; velocity encoding value 1.5 
m/s (using retrospective gating). The high temporal resolution ranging between 7 and 12 ms 
enabled optimal timing of the acquisition of the minimal and maximal cross-sectional area 
measurements. The same study was also used for determination of aortic valve competence 
(aortic regurgitation (AR) fraction).
 Minimal and maximal lumen area MRI studies were performed after manually positioning 
the acquisition planes perpendicularly to the aorta at the level of the sinotubular junction, 
at time points of minimal flow and maximal flow through the aortic root, respectively. This 
approach enabled correction for through-plane motion of the aortic root during contraction. 
The scan parameters were identical to the diameter measurements; gate delay was individually 
applied for optimal timing of the acquisition. Examples of the positioning of the acquisition 
plane at minimal and at maximal aortic flow are respectively shown in Figure 2.
 Left ventricular systolic function was assessed with a steady-state free precession cine 
sequence. A short-axis stack of 14 to 18 contiguous slices was used (FOV 400 mm, voxel 
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Figure 2.
Figure 2a-e.  Aortic root distensibility. (a,b) MR images show section positioning at minimal and maximal aortic 
flow for distensibility measurements; in this way, we corrected for through-plane motion of the 
aortic root during contraction. Note the difference in position of the aortic root in both images due 
to cardiac motion. Gate delay is 35 ms in a and 120 ms in b. (c) Graph shows aortic flow curve - ob-
tained by using a phase-contrast study - and corresponding lumen areas at the level of the sinotu-
bular junction throughout the cardiac cycle in 17-year-old female healthy control subject. Minimal 
lumen area (1) is obtained at isovolumetric contraction, and maximal lumen area (2) is obtained at 
moment of peak flow. (d,e) Gated steady-state free precession MR images show the minimal aortic 
lumen area (to be expected early in the cardiac cycle during the isovolumetric contraction phase)
(1) and the maximal aortic lumen area (to be expected when the peak of aortic flow passes through 
the ascending aorta) (2), respectively. Lumen areas are manually traced (circles).
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size 1.6 × 1.6 × 8.00 mm, no slice gap, FA 70°, TR 3.2 ms and TE 1.6 ms), covering the base 
of the heart to the apex.
Postprocessing
All images were quantitatively analyzed on a Sun workstation (Sun Microsystems, USA) with 
2 software packages that were previously validated (18,19). All contours were manually 
drawn by 2 independent observers (HBG, with 2 years of experience and LJMK, with 8 years 
of experience).
 The diameter measurements, measurements of the distensibility of the aortic root and 
the short-axis gradient-echo images of both ventricles were analyzed with the software 
package MASS (Medis, The Netherlands) (18). Diameters of the aortic root were obtained 
by direct measurement of the lumen at each level of the aortic root. A dilated aortic root is 
defined as the diameter at the level of the sinus of Valsalva > 4.0 cm (20). Endovascular aortic 
contours were drawn for minimal and maximal lumen area measurements. Intraobserver 
and interobserver variations of our image analyses of the minimal and maximal lumen area 
measurements were determined in 10 of our Ross procedure patients by repeated analysis 
by one observer (blinded to the first analysis with an interval > 2 weeks) and by additional 
image analysis of a second observer (blinded to the results obtained by the first observer).
 Left ventricular end-diastolic volume (LV EDV) and LV end-systolic volume (LV ESV) 
were obtained by drawing contours around the lumen of the LV at end-diastole and at 
end-systole in all sections of the cine sequence (18) and were subsequently indexed for 
body surface area (BSA) according to the Mosteller formula: √ (height (cm) × weight (kg) 
/ 3600) (indicated by LV EDVi and LV ESVi, respectively). Left ventricular ejection fraction 
(LV EF) was calculated by dividing the LV stroke volume by the LV EDV (18). Left ventricular 
mass was calculated as previously described after drawing LV endocardial and epicardial 
contours (21) and was subsequently indexed for BSA (indicated by LV massi).
 Aortic velocity maps were analyzed by using the software package FLOW (Medis, The 
Netherlands) (19). Endovascular contours were drawn for the aorta, and flow data were 
obtained from the velocity data of each voxel in all phases. Flow curves were obtained with 
this method for flow in the aorta during a cardiac cycle. The aortic regurgitant fraction was 
calculated with the following formula: Regurgitant Flow Volume / Systolic Forward Flow 
Volume × 100%. Aortic regurgitation was considered to be significant if the regurgitant 
fraction was > 5% of the systolic forward flow.
Statistical analysis
Statistical analysis was performed with the use of SPSS for Windows (version 12.0.1, SPSS, 
USA). All data are presented as mean value ± 1 SD, unless stated otherwise. The Mann-
Whitney U test was used to express differences in variables between patients and healthy 
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subjects. Correlations between variables were expressed with Spearman rank correlation 
coefficients. Intraobserver and interobserver variations were studied for the analysis 
of minimal and maximal lumen area measurements (for distensibility calculations) by 
calculating the coefficient of variation (defined as the standard deviation of the differences 
between the 2 series of measurements divided by the mean of both measurements) with 
CI. The Wilcoxon signed rank test was used to express any difference between the mean 
differences of the distensibility measurements. Linear regression analysis was used to 
identify predictors of impaired LV systolic function with backward elimination procedures. 
Statistical significance was indicated by a P value < 0.05.
Results
The Ross procedure patients and healthy subjects were matched for age and sex. Other 
parameters such as height, mass and BSA were not significantly different between the 
groups (Table 1). All patients were in New York Heart Association class I. Results are 
summarized in Table 2.
Table 2. Results for the 18 Ross procedure patients and 18 age- and sex-matched healthy 
subjects.
Parameters patients healthy subjects P value mean difference
diameter annulus (mm) 33.6 ± 6.9 26.3 ± 2.7 < 0.01 7.3
diameter sinus of Valsalva (mm) 41.4 ± 5.7 29.8 ± 3.1 < 0.01 11.6
diameter sinotubular junction (mm) 34.2 ± 6.9 26.2 ± 2.7 < 0.01 8.0
diameter ascending aorta (mm) 31.0 ± 6.2 24.7 ± 3.0 < 0.01 6.3
distensibility (in 10-3 mm Hg-1) * 1.9 ± 1.1 7.8 ± 3.3 < 0.01
aortic regurgitation fraction (%) 8 ± 5 1 ± 1 < 0.01
LV EF (%) 50 ± 6 57 ± 6 < 0.01
LV EDVi (ml/m
2) 67 ± 17 56 ± 11 0.03
LV ESVi (ml/m
2) 34 ± 8 33 ± 34 0.09
LV massi (g/m
2) 33 ± 8 28 ± 6 0.04
Note: data are expressed as mean ± standard deviation.
* Distensibility was measured at the level of the sinotubular junction.
Abbreviations: LV = left ventricle, EF = ejection fraction, EDVi = end-diastolic volume indexed for body surface 
area, ESVi = end-systolic volume indexed for body surface area.
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 The Ross procedure patients showed increased diameters of the aortic root at all 4 levels as 
compared with the healthy subjects (Table 2, Figure 3). Dilatation of the sinus of Valsalva > 4 cm 
was present in 11 of the 18 patients. It was most pronounced at the level of the sinus of Valsalva, 
which decreased toward the AA (Table 2, Figure 3). Dilatation at the level of the sinus of Valsalva was 
significantly correlated with younger age at surgery: the diameter difference between the sinus of 
Valsalva and the annulus significantly increased when the patient was younger at operation (r = 0.57, 
P < 0.01). The preoperative presence of a bicuspid aortic valve, AR, aortic stenosis (AS), or combined 
AR and AS was not related to dilatation of the aortic root (r = 0.27 - 0.42 for all 4 levels, P > 0.05).
Figure 3.
Figure 3 a-d.  (a-d) show the diameter measurements for the Ross procedure patients and healthy subjects at 
the 4 levels of the aortic root: annulus; sinus of Valsalva; sinotubular junction; and AA. Diameters 
are expressed in mm.
 Distensibility at the level of the sinotubular junction was clearly decreased in Ross procedure 
patients as compared with the healthy subjects (Table 2, Figure 4). A significant correlation 
was found between the dilatation at the level of the sinotubular junction and decreased 
distensibility at the same level (r = 0.70, P < 0.01). The preoperative presence of a bicuspid 
aortic valve, AR, AS, or combined AR and AS were not related to impaired distensibility (r = 0.05 
- 0.36, P > 0.05).
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Figure 4.
Figure 4.  Distensibility of the aortic root in the Ross procedure patients as compared with that in the healthy 
subjects. Distensibility is expressed in 10−3 mm Hg−1.
Ross procedure patients were characterized by the frequent presence of AR, as 14 of the 18 
patients showed an AR fraction > 5%. The AR fraction ranged from 5% to 17%, representing 
mild degrees of AR. Aortic regurgitation fraction (expressed in percentages, Table 2) was 
significantly correlated with increased diameters of the aortic root at all 4 levels (r = 0.46-0.63, 
P < 0.01 for all) and with impaired distensibility (r = 0.66, P < 0.01). The preoperative presence 
of a bicuspid aortic valve, AR, AS, or combined AR and AS did not predispose patients to AR 
(r = 0.02 - 0.50, P > 0.05).
 Left ventricular systolic function expressed as LV EF was significantly lower in Ross 
procedure patients as compared with healthy subjects (Table 2). Mean LV EDVi was significantly 
increased in patients as compared with healthy subjects (Table 2) and significantly correlated 
to the AR fraction (r = 0.41, P = 0.02). The mean LV ESVi values were not significantly different 
between Ross procedure patients and healthy subjects (Table 2). Left ventricular massi was 
significantly increased in Ross procedure patients as compared with healthy subjects (Table 
2). Increased LV massi was correlated with increased LV EDVi (r = 0.67, P < 0.01).
 Decreased LV EF was correlated with the degree of dilatation at the level of the sinus of 
Valsalva (r = 0.47, P < 0.01), the degree of reduced distensibility of the aortic root (r = 0.43, 
P = 0.01) and the AR fraction (r = 0.57, P <0.01). Linear regression showed that AR fraction 
predicted reduced LV systolic function (r = 5.0, P < 0.01).
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 Intraobserver and interobserver variations of our image analyses of the distensibility 
measurements were determined: mean differences for intraobserver and interobserver 
results of the minimal and maximal lumen area measurements ranged from 0.03 to 0.12 
mm2 (SD 0.19 - 0.28, P = 0.31 - 0.78). The coefficient of variation never exceeded 1% for both 
intraobserver and interobserver variations (CI 0.4 - 0.6).
Discussion
In this study, cardiac MRI was used to evaluate the dimensions and distensibility of the 
aortic root (autograft) as well as aortic valve (autograft) competence in relation to LV systolic 
function in Ross procedure patients as compared with age- and sex-matched healthy 
subjects. The main findings of the current study revealed dilatation of the aortic root, 
decreased distensibility of the aortic root, frequent mild AR and reduced LV systolic function 
in the Ross procedure patients at a mean of 8 years after they had their operation. Impaired 
LV systolic function was significantly correlated with dilatation and decreased distensibility 
of the aortic root, as well as the AR, indicating a relationship between autograft dysfunction 
and decreased LV systolic function. Furthermore, AR appeared to predict the presence of 
decreased LV systolic function.
Autograft dilatation
Significant dilatation of the aortic root was found in our Ross procedure patient group as 
compared with the control group. After a mean follow-up period of 8 years, 11 of the 18 
patients showed dilatation, with a diameter > 4.0 cm at the level of the sinus of Valsalva, 
which is in line with the findings of Simon-Kupilik et al. (22), who found a 7-year freedom 
from dilatation of 45%. Our patients were however significantly younger; therefore, 
absolute diameters of the aortic root could underestimate the diameter as compared with 
body size. Dilatation was most pronounced at the level of the sinus of Valsalva, with a 
decrease of dilatation toward the AA. This has been reported before; however, relative loss 
of anatomical landmarks of the aortic root caused by dilatation hampered definition of 
aortic root levels when using echocardiography (20). In this study, MRI allowed to overcome 
this practical limitation as a result of optimal planning of the acquisition planes.
 Younger age at operation also predisposed patients to aortic root dilatation. This 
observation is in accordance with the results of previous studies (12,20,22). Possible 
explanations are the greater likelihood of a mismatch of aortic and pulmonary roots and 
physiologic dilatation (i.e., root growth) in children who undergo the Ross procedure 
(4,20). The latter process is supported by animal studies and similar observations of the 
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behavior of an autologous pulmonary root late after the repair of other congenital cardiac 
lesions (5,23).
 The association between the initial presence of a bicuspid aortic valve and autograft 
dilatation is a matter of controversy (4,20,24-26). We found no supportive evidence for such 
a possible association, suggesting that other factors could play a role in the appearance of 
autograft dilatation. Degenerative lesions of the pulmonary artery media could occur after 
autograft implantation as a result of an altered microvascular supply, its exposure to the 
hemodynamic stress of the systemic circulation, severity of prior AR and variables related 
to the operative technique (26).
Autograft distensibility
Distensibility of the aortic root was evaluated in this study with a motion-corrected MR 
approach. We found a significantly decreased mean distensibility of the aortic root in 
the Ross procedure patient group. Reduced distensibility of the aortic root reflects an 
impaired condition of the vascular wall because distensibility directly depends on the 
elastic properties of the vessel wall (6,7,13,16). This study revealed that dilatation of the 
aortic root was the most important cause of impaired distensibility, as can be observed in 
elderly individuals and patients with the Marfan syndrome (16).
Aortic regurgitation
In the current study, mild degrees of AR were a common finding in the Ross procedure patient 
group. Both increased diameter of the aortic annulus and decreased distensibility of the aortic 
root were significantly correlated with AR fraction. David et al. (27) pointed out that dilatation 
of the aortic root has the potential to cause AR in adults; in our study, this relationship was 
found in children after the Ross procedure. The dynamics of the aortic valve is related to the 
distensibility of the aortic root (12). Aortic valve opening occurs in concert with root expansion 
during the beginning of systole (8,9,12). Disturbance of this interrelation greatly determines the 
stress on valve leaflets (10-12). In contrast to a recent echocardiography study (12), this study 
showed that decreased distensibility of the aortic root was correlated with the AR fraction. 
We therefore hypothesize that decreased aortic root distensibility in Ross procedure patients 
increases leaflet stress and thus predisposes the patients to aortic valve dysfunction.
Left ventricular systolic function
In this study, decreased LV systolic function in the Ross procedure patient group was 
significantly correlated with dilatation of the aortic root, impaired distensibility of the aortic 
root and AR fraction, whereas the AR fraction proved to predict reduced LV systolic function. 
The AR fraction was correlated with increased LV EDVi, indicating increased diastolic filling of 
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the LV as a result of the AR. Increased LV EDVi was also correlated with increased LV massi, which 
might suggest compensatory LV hypertrophy caused by the volume overload of the LV.
 We hypothesize that the dysfunctioning autograft negatively influences LV systolic function: 
dilatation of the aortic root appears to result in decreased aortic distensibility and aortic valve 
dysfunctioning, subsequently leading to reduced LV systolic function and compensatory LV 
hypertrophy. We therefore suggest that impaired LV systolic function as a result of autograft 
dysfunction may be a long-term consequence of the Ross procedure.
 MRI allows for comprehensive evaluation of aortic root function, aortic valve function and 
LV systolic function in patients after the Ross procedure, especially when motion-corrected MR 
is applied for the evaluation of the distensibility of the aortic root.
Limitations
Preoperative and follow-up measurements were not available; therefore, progression of 
findings could not be documented.
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MR Imaging of Right Ventricular Function after the Ross Proce-
dure for Aortic Valve Replacement - Initial Experience.




Purpose: To prospectively assess right ventricular (RV) function after the Ross procedure by 
using magnetic resonance imaging (MRI). 
Materials and Methods: The local ethics committee approved the study and informed 
consent was obtained from all participants prior to enrollment in the study. Seventeen patients 
(15 male, two female; mean age ± standard deviation, 19 years ± 3.9; imaging performed 
8.3 years after surgery ± 3.2) and 17 matched controls (15 male, two female; mean age ± 
standard deviation, 20 years ± 3.9) were studied by using MRI. Standard velocity-encoded and 
multisection multiphase imaging sequences were used to assess homograft valve function, 
systolic and diastolic RV function, and RV mass. The two-tailed Mann-Whitney U test and the 
Spearman rank correlation coefficient were used for statistical analysis. 
Results: Minor degrees of homograft stenosis (peak flow velocity between 1.5 and 3.0 m/s 
across the homograft valve) were found in 12 of 17 patients but not in controls (P < 0.001). 
A larger RV mass was present in Ross procedure patients than in controls (17.0 g/m2 ± 4.8 vs 
10.9 g/m2 ± 5.6, P = 0.004). In addition, impaired diastolic RV function was found, as shown by 
a decreased mean tricuspid valve early filling phase-atrial contraction phase (E/A) peak flow 
velocity ratio (1.56 ± 0.75 vs 2.05 ± 0.58, P = 0.03). Peak velocity across the homograft valve 
correlated with RV mass (r = 0.38, P = 0.03) and tricuspid valve E/A peak flow velocity ratio (r = 
0.39, P = 0.02). RV systolic function was normal in Ross procedure patients (mean RV ejection 
fraction, 52% ± 8 vs 51% ± 5; P = 0.74). 
Conclusion: RV hypertrophy and RV diastolic dysfunction are frequently observed in patients 
after the Ross procedure, even in the absence of overt homograft stenosis. RV systolic function 
is still preserved. 
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Introduction
Aortic valve replacement, according to the Ross procedure, is frequently performed in the 
pediatric population (1,2). During this operation, the stenotic or regurgitant aortic valve is 
replaced by a pulmonary autograft, while a homograft valve is inserted in the pulmonary 
position (1). Potential advantages of this procedure are the use of the patient’s own valve 
with favorable hemodynamic characteristics, avoidance of anticoagulant therapy, and 
the alleged growth potential of the autograft valve in children (2,3). Long-term survival 
is satisfactory, although frequent dilatation of the autograft in the aortic position and 
diminished left ventricular (LV) function have been reported (2-4). 
 The longevity of the homograft valve in pulmonary position is reported to be limited 
owing to frequent homograft stenosis: shrinkage of the homograft annulus occurs because 
of a postoperative immune-mediated response to the homograft, as well as calcification 
and thickening of the valve leaflets (2,3,5-10). As a result, homograft stenosis is the main 
cause for a reoperation after the Ross procedure, necessary in approximately 10% of all 
cases at long-term follow-up (2,3,10,11). 
 Little is known about the effect of early homograft stenosis on right ventricular (RV) 
function. Insight into this relationship is relevant as RV function has prognostic value 
concerning patient survival and exercise tolerance (12,13) and may contribute to optimal 
timing for replacement of a dysfunctioning homograft valve. 
 Echocardiography is a widely used imaging tool in clinical practice but has limitations 
in assessment of RV function owing to the complex RV geometry (12). Magnetic resonance 
imaging (MRI) has been established as an accurate noninvasive tool for the assessment of 
the pulmonary valve and RV function (14-16). To our knowledge, MRI has not previously 
been used to study the relationship between homograft valve function and systolic and 
diastolic RV function in patients after the Ross procedure. 
 We hypothesized that minor degrees of homograft stenosis occur frequently in patients 
after the Ross procedure and that the associated increased RV afterload may negatively 
affect RV function. Thus, the objective of our study was to prospectively assess RV function 





The medical ethics committee of Leiden University Medical Center (Leiden, The Netherlands) 
approved the study and informed consent was obtained from all participants prior to their 
enrollment in the study. Seventeen Ross procedure patients (mean age ± standard deviation, 19 
years ± 3.9; imaging performed 8.3 years after surgery ± 3.2) and 17 age- and gender-matched 
healthy controls were prospectively studied with MRI at our institution (Table 1). 
Tabel 1. Characteristics of patients and controls.
Characteristics patients (n = 17)  controls (n = 17)
male / female 15 / 2 15 / 2
range of age at MRI by birth sex (years) 12.9 - 25.1/13.8 - 20.6 12.8 - 25.8/14.1 - 21.2
age at Ross procedure (years) * 10.8 ± 5.2
interval between the operation and the MRI (years) * 8.3 ± 3.2
height (cm) * 174 ± 13 179 ± 10
weight (kg) * 65 ± 15 72 ± 16
Body Surface Area (m2) * and † 1.8 ± 0.3 1.9 ± 0.3
* Data are mean ± standard deviation.
† According to the Mosteller formula: √ (height (cm) × weight (kg) / 3600).
Abbreviations: MRI = magnetic resonance imaging.
 Ross procedure patients were recruited from our local database of 53 Ross procedure 
patients. The inclusion criterion was aortic valve previously corrected with the Ross procedure. 
Exclusion criteria included age younger than 12 years and older than 25 years (n = 25), a Konno 
extension to the Ross procedure (i.e., relief of LV outflow obstruction by using septal patch 
insertion, n = 3), repeat operation and/or intervention in the homograft area between the Ross 
procedure and MR investigation (n = 1) and general contraindications to a cardiovascular MR 
examination. Seven patients declined to participate for personal reasons. 
 Age- and gender-matched healthy controls were selected from our database of individuals 
with a harmless heart murmur in which congenital cardiac disease had been excluded in the 
past by physical examination and echocardiography. Patient characteristics and functional 
status, as classified on the basis of the New York Heart Association functional class standards, 
were obtained from the patient records (Table 1). All patients were identified as New York Heart 
Association functional class I, without using medication.
  LV function analysis of the patient group used in this study and their matched healthy 
controls have previously been described (4). 
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Operative technique
The Ross procedure was performed in patients with aortic valve disease (median age at surgery, 10.8 
years; mean age, 10.8 years ± 5.2) by using cardiopulmonary bypass with moderate hypothermia 
by 2 surgeons (P.H.S. and a nonauthor, with 11 years experience each with the Ross procedure) (3). 
In all patients the pulmonary autograft was implanted by using the root replacement technique 
(17). Reinforcement of proximal and distal suture lines with a strip of autologous pericardium was 
used in all patients except 1. Autograft harvesting was performed after aortic cross-clamping. 
The RV outflow tract was reconstructed with a cryopreserved pulmonary homograft valve in all 
patients. Associated procedures during the Ross procedure were enucleation or resection of a 
discrete subaortic stenosis in 3 patients and ventricular septal defect closure in 2. 
MRI
MRI studies were performed with a 1.5-T system (NT 15 Gyroscan Intera; Philips Medical 
Systems, The Netherlands). 
 Flow dynamics across the homograft valve were assessed by using velocity-encoded MRI 
just distal to the homograft valve. In the control group, velocity-encoded MRI was performed 
just distal to the pulmonary valve (15). Imaging parameters were: repetition time in ms / echo 
time in ms, 8.6 / 5.3; field of view, 400 mm; flip angle, 20°; voxel size, 2.34 × 2.61 × 8.00 mm. The 
sequence was encoded for a through-plane velocity of up to 150 cm/s. In case of aliasing owing 
to flow velocity exceeding 150 cm/s, the imaging was repeated with through-plane velocity 
encoding up to 300 cm/s. Temporal resolution was 25.6 ms. 
 Systolic biventricular function was assessed with a steady-state free precession cine 
sequence in the short-axis plane by using breath holds (15). Imaging parameters were: 
repetition time in ms / echo time in ms, 3.2 / 1.6; field of view, 400 mm; flip angle, 70°; voxel size, 
1.6 × 1.6 × 8.00 mm; and no section gap (14,15). 
 Diastolic RV function was assessed by using velocity-encoded MRI across the tricuspid valve 
(15,18). Imaging parameters were: repetition time in ms / echo time in ms, 9.4 / 6; flip angle, 20°; 
voxel size, 2.34 × 2.61 × 8.00 mm. The sequence was encoded for a through-plane velocity of up 
to 100 cm/s. Temporal resolution was 25.6 ms. 
Postprocessing  
All images were quantitatively analyzed on a workstation with a Pentium 4 processor (Intel, USA). 
 Systolic RV and LV function were analyzed with the software package MASS (Medis, The 
Netherlands) (14,15). Biventricular end-diastolic volume (EDV) and end-systolic volume (ESV) 
were assessed by drawing the RV and LV endocardial contours at end-diastole and end-systole 
in all sections, as described previously (14). At end-diastole, epicardial borders of the RV free 
wall were drawn to obtain the RV mass (15). The interventricular septum was included in the 
LV analysis. Indexation was performed according to the Mosteller formula (BSA = √ (height 
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(cm) × weight (kg) / 3600)), where BSA is the body surface area in square meters. The following 
parameters were then determined: EDV, ESV, stroke volume, ejection fraction (EF) and 
ventricular mass (14). 
 Flow velocity-encoded MR data were analyzed with the software package FLOW (Medis, 
The Netherlands) (15,16). Flow curves were obtained with this method for homograft or 
pulmonary artery flow during the cardiac cycle. Contours were drawn for the homograft 
(patients) or pulmonary artery (controls) lumen, and flow data were subsequently obtained 
from the velocity data of each voxel in all phases. Peak flow velocity was determined with a 
time-velocity analysis that revealed the voxel with maximum peak flow throughout the cardiac 
cycle. Peak flow velocity across the homograft valve or pulmonary valve was considered 
substantially increased if maximum blood flow velocity (Vmax) exceeded
 1.5 m/s (19). 
 Pressure gradients across the homograft and pulmonary valves were subsequently 
calculated by using the simplified Bernoulli equation: ∆P = 4V2, where ∆P is the pressure 
gradient across the valve (mm of mercury), 4 is the estimated loss coefficient, and V is the 
peak flow velocity (m/s) (20). The regurgitant fraction was calculated with the following 
formula: regurgitant flow / systolic forward flow × 100%, where flow is measured in mm. Valve 
regurgitation was considered substantial if the regurgitant fraction exceeded 5% of the systolic 
forward flow (14). 
 Analysis of diastolic RV function by measuring flow through the tricuspid valve was 
performed by using the same method (14). Peak flow velocity curves were obtained for 
calculation of early filling phase, atrial contraction phase and early filling phase / atrial 
contraction phase (E/A) peak flow velocity ratios. Calculation of mean deceleration gradients 
of the early filling phase was used for analysis of the early filling phase slopes. The times of the 
early filling phase, atrial contraction phase and diastasis were also measured (16). 
 The manual drawing of all MR contours and analysis of the other results were performed by 
one researcher (H.B.G., with 3 years experience in cardiac MRI) and were subsequently checked 
by a radiologist (L.J.M.K., with 9 years experience in cardiac MRI), who was unaware of the 
patient’s conditions. 
Statistical analysis
Statistical analysis was performed by using software (SPSS for Windows, version 12.0.1; SPSS, 
USA). All data are expressed as mean value ± 1 standard deviation, unless stated otherwise. 
The Mann-Whitney U test was used to express differences in variables between the patients 
and controls. Correlation between variables was expressed with the Spearman rank correlation 
coefficient. Statistical significance was indicated by a P value of less than 0.05. 
143
MR imaging of right ventricular function after the Ross procedure for aortic valve replacement - 
initial experience
Results
Homograft and pulmonary valve characteristics 
In 12 (82%) of 17 Ross procedure patients, the homograft valve Vmax exceeded
 1.5 m/s 
(compared with none from the control group), indicating minor degrees of homograft 
stenosis (Figure 1, Table 2). Calculated pressure gradients derived from these peak flow 
velocities were 16.8 mm Hg ± 9.0 in patients (range: 4.3 - 36.0 mm Hg) and 4.0 mm Hg ± 1.5 in 
controls (range: 2.1 - 7.6 mm Hg; P < 0.001). No regurgitant flow across the homograft valve 
in any patient or the pulmonary valve in any control was present.
Figure 1. 
Figure 1a-d.  Graphs show peak flow velocity curves across pulmonary homograft valve in (a) Ross patient and 
(b) control. Time between surgery and MR was 7.5 years. Note markedly increased peak flow ve-
locity during systole in Ross patient (maximum velocity, 300 cm/s), indicating homograft stenosis 
(derived pressure gradient, 36 mm Hg). RV inflow curves across tricuspid valve in (c) Ross patient 
and (d) control. Biphasic inflow pattern has early filling and atrial contraction phase peaks. Note 
decreased tricuspid valve E/A peak flow velocity ratio and decreased mean deceleration gradient in 
early filling phase in Ross patient as compared with control, indicating delayed RV relaxation.
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Table 2. Results in Ross procedure Patients and Controls. 
parameters patients controls P value
Vmax (m/s)* 1.97 ± 0.56 0.99 ± 0.18 < 0.001
pressure gradient (mm Hg)* 16.8 ± 9.0 4.0 ± 1.5 < 0.001
RV EF (%) 52 ± 8 51 ± 5 0.74
RV SV (ml/m²) 54 ± 8 52 ± 8 0.84
RV EDV (ml/m2) 106 ± 13 107 ± 16 0.64
RV ESV (ml/m2) 53 ± 14 52 ± 8 0.69
RV mass (g/m
2) 17.0 ± 4.8 11.7 ± 4.9 0.004
TV E/A peak-flow ratio 1.56 ± 0.75 2.05 ± 0.58 0.03
TV mean dec gradient of E phase (l/s2) -2.67 ± 1.09 -3.05 ± 1.03 0.39
TV diastasis time (ms) 46 ± 54 74 ± 89 0.55
LV EF (%) 50 ± 6 57 ± 5 0.001
LV EDV (ml/m2) 67 ± 16 56 ± 11 0.03
LV ESV (ml/m2) 34 ± 8 33 ± 4 0.99
LV mass (g/m
2) 33.0 ± 8.6 28.4 ± 5.9 0.04
   
Note: data are expressed as mean ± standard deviation.
* homograft and pulmonary artery in patients and controls, respectively. 
Abbreviations: Vmax = maximum velocity, RV = right ventricle; EF = ejection fraction; SV = stroke volume in-
dexed for Body Surface Area; EDV = end-diastolic volume indexed for Body Surface Area; ESV = end-systolic 
volume indexed for Body Surface Area; TV = tricuspid valve; E = early filling phase; A = atrial contraction phase; 
dec = deceleration; LV = left ventricle.
Biventricular Function
Systolic function - expressed as RV EF and RV stroke volume - was not found to be different 
between Ross procedure patients and controls (Table 2). Also, RV dimensions (EDV and 
ESV) were not found to be different between the two groups (Table 2). Mean RV mass 
of the Ross patient group was significantly larger than in controls (Table 2). In addition, 
a significantly lower mean tricuspid valve E/A peak flow velocity ratio in Ross procedure 
patients as compared with the controls reflected a delayed RV relaxation (Figure 1, Table 
2). Mean deceleration gradients of the early filling phase, and the times of the early filling 
phase, atrial contraction phase, and diastasis were not significantly different between the 
two groups (Table 2). In the Ross patient group, higher peak flow velocities across the 
homograft valve were significantly correlated with RV mass (r = 0.38, P = 0.03) (Figure 2) 
and with the E/A peak flow velocity ratio across the tricuspid valve (r = 0.39, P = 0.02) 
(Figure 3). 
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Figure 2. Figure 3.
Figure 2.  Scatterplot shows distribution of relationship between peak flow velocity across homograft or pul-
monary valve vs indexed RV mass in Ross procedure patients and controls. Mild degrees of homograft 
stenosis represented by higher peak flow velocities across homograft valve were responsible for RV 
hypertrophy as compensatory mechanism owing to increased RV afterload.
Figure 3.  Scatterplot shows distribution of relationship between peak flow velocity across homograft or pul-
monary valve vs E/A peak flow ratio across tricuspid valve in Ross procedure patients and controls. 
Diastolic RV dysfunction in Ross group (lower mean tricuspid valve E/A peak flow velocity ratio) results 
from increased RV afterload and concomitant RV hypertrophy.
 LV systolic function, expressed as LV EF, was diminished in the Ross procedure patients as 
compared with controls (Table 2). Mean LV EDV and LV mass were significantly larger in the Ross 
procedure patients as compared with controls (Table 2), while mean LV ESV was not significantly 
different between the two groups. RV EF and LV EF were not significantly correlated in the Ross 
patient group (r = 0.21, P = 0.12). In addition, LV mass was not significantly correlated with RV 





Our study findings revealed RV hypertrophy and diastolic dysfunction in patients after the Ross 
procedure, in the presence of mild degrees of homograft stenosis. Systolic RV function was 
preserved. 
 Ross procedure patients showed higher peak flow velocities across the homograft valve, with 
calculated pressure gradients up to 36 mm Hg reflecting mild degrees of homograft stenosis (19), 
whereas all values were below 8 mm Hg in our controls. Despite favorable survival rates and low 
incidence of reoperation when compared to other valve substitutes such as mechanical valves 
and xenografts, degeneration and calcification of the homograft valve can cause homograft 
stenosis (2,3,5-10). 
 Homograft valve regurgitation occurs only in a minority of cases (2,5), as is consistent with 
our data. Homograft stenosis is caused by an early postoperative immune-mediated response 
to the homograft that leads to shrinkage of the homograft annulus (2,3,5-10) and calcification 
and thickening of the valve leaflets (2,3,8,10). Stenosis predominantly occurs during the first 2 
years after surgery (9,10), although others have reported progression at a later stage (2,3,5,6). A 
gradient exceeding 9 mm Hg at 1 year follow-up could be used to predict the late occurrence of 
homograft stenosis (10). 
 Other predictive variables for homograft valve durability are related to homograft antigenicity 
and to the size of the inserted homograft valve (6,10). Reduced viability of the donor cells within 
the homografts has been shown to be favorable; older donor age and a longer duration of graft 
cryopreservation were associated with a lower rate of homograft stenosis (6,10). Oversizing 
of the homograft by 2 - 3 mm facilitates homograft valve performance (6,10). Nevertheless, 
somatic outgrowth remains an important contributor to homograft valve failure in the pediatric 
population (2,10), as may have been the case in our patient group with a mean age at surgery of 
10.8 years. 
 Systolic RV function was adequately preserved in our patients after the Ross procedure and 
all were identified as New York Heart Association functional class I. However, mean RV mass was 
significantly higher as compared with that in the controls, indicating RV hypertrophy in the Ross 
patient group. RV hypertrophy often occurs as a compensatory mechanism owing to increased 
RV afterload (21), which in our study was related to mild degrees of homograft stenosis, as 
represented by higher peak flow velocities across the homograft valve. 
 As homograft stenosis can progress over time owing to continuing degeneration of the 
homograft valve or somatic outgrowth, RV hypertrophy may increase during follow-up. In 
addition, higher LV mass may have contributed to RV hypertrophy (22), although LV mass and 
RV mass were not significantly correlated in our Ross patient group. Also, a direct correlation was 
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found between homograft peak flow velocity and RV mass, but not with LV mass, illustrating the 
functional effect of homograft stenosis on the RV. 
 Impaired RV diastolic function was reflected by a significantly lower mean tricuspid valve 
E/A peak flow velocity ratio as compared with those values in controls. RV diastolic dysfunction 
is a consequence of hypertrophy owing to stiffening of the myocardium and may precede RV 
systolic dysfunction (21). Impaired diastolic function is a primary cause in 30 - 40% of patients 
with congestive heart failure (18,21) and is associated with diminished exercise performance 
(13). As physiologic loss of elastic myocardial properties and increasing ventricular mass during 
lifetime contribute to diastolic dysfunction (18,21), current RV diastolic dysfunction in our Ross 
patient group might pose a future risk for progressive RV dysfunction. Further studies are needed 
to address the long-term effects of our results. 
 Homograft replacement is suggested from a pressure gradient of 50 mm Hg or more or when 
signs of RV dysfunction are present (3). Therefore, serial follow-up assessment of homograft valve 
and RV function with noninvasive imaging techniques is useful for early detection of homograft 
valve dysfunction, which may facilitate selecting patients for possible reoperation. In addition, 
exercise testing may help assess the functional implications of homograft and RV dysfunction. 
Although transthoracic echocardiography is the most commonly used imaging technique, it has 
limitations such as a reduced acoustic window with increased patient age and difficulty helping 
to assess RV function, owing to the complex RV geometry. 
 MRI overcomes these limitations, as accurate assessment of homograft valve function and 
systolic and diastolic RV function can be achieved in one imaging session with low inter- and 
intraobserver variability (15,23,24). MRI should primarily be used for patient follow-up owing 
to its good reproducibility (15,23,24), as identification of patients with RV dysfunction remains 
difficult considering the variation in RV function parameters as depicted in Figures 2 and 3 and 
the fact that clear cut-off values for RV dysfunction are still lacking. Although MRI will not replace 
transthoracic echocardiography as the imaging technique of choice owing to higher costs and 
reduced availability, it should be considered when echocardiographic imaging is difficult or when 
actual homograft replacement is considered. 
 Our study had limitations. We used a limited number of patients and controls, although the 
low inter- and intraobserver variability of cardiac MRI allowed for relatively small sample sizes 
(25). No preoperative or follow-up measurements were available in our observational study, so 
progression of findings could not be documented. Further research is required to define cut-
off values of homograft valve and RV function for optimal timing of homograft replacement in 
patients after the Ross procedure. 
 In conclusion, cardiac MRI revealed mild degrees of homograft stenosis in patients after 
the Ross procedure, as evidenced by higher peak flow velocities across the homograft valve. 
Hemodynamic consequences were RV hypertrophy and diastolic dysfunction, whereas systolic 
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RV function was preserved. Our study showed the feasibility of MRI as an integrated imaging 
tool to monitor homograft valve and RV function in patients after the Ross procedure, which 
may facilitate the early detection of homograft valve dysfunction. MRI may facilitate better 
selection of patients who need reoperation after the Ross procedure for homograft valve 
dysfunction.
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The aim of this thesis was to evaluate the functional implications of aortic wall pathology 
on aortic valve competence and left ventricular (LV) function in patients with a bicuspid 
aortic valve, transposition of the great arteries, tetralogy of Fallot and patients after the Ross 
procedure, using magnetic resonance imaging (MRI) techniques. MRI was also used to test 
whether a similar interaction is present between pulmonary artery dynamics and the right 
ventricle (RV) in the above mentioned entities.
 Chapter 1 provides a general introduction to the thesis, with a short description of the 
potential negative interaction between aortic wall disease and aortic valve- and LV function in 
the above mentioned entities. 
 Chapter 2 reviews the 5 most commonly affected entities of inherited connective tissue 
disorders and classical congenital heart disease with intrinsic aortic wall abnormalities, 
with description of the potential role of MRI in their evaluation and management. Marfan 
syndrome is the prototype for aortic wall disease, which is associated with complications 
like aneurysm formation and aortic dissection. Recent reports in the literature indicate that 
aortic wall abnormalities are also present in a wide range of other entities like transposition 
of great arteries and tetralogy of Fallot, each with its own pathogenic substrate and clinical 
repercussions. Using MRI for the assessment of aortic dimensions and elasticity (as indicators 
for aortic wall pathology), as well as aortic valve competence and LV function, allows for 
accurate monitoring of aortic and LV conditions.
 Chapter 3 describes in vivo validation and testing of reproducibility of aortic pulse wave 
velocity as assessed with MRI (PWVMRI). In this study, PWVMRI and pulse wave velocity as assessed 
by invasive pressure recordings (gold-standard) were compared in 18 patients scheduled 
for diagnostic catheterization. Non-invasive PWVMRI assessment of the proximal aorta, distal 
aorta and total aorta appeared to be in good agreement with the gold-standard as derived by 
invasive pressure measurements. Reproducibility of PWVMRI was tested in 10 healthy volunteers, 
who underwent repeated measurement of PWVMRI on a single occasion. Reproducibility of 
PWVMRI was high despite a substantial physiological variation in aortic pulse wave velocity. 
PWVMRI results should therefore be considered in combination with other parameters like 
blood pressure and MRI-assessed variables such as LV function and LV mass for depiction of 
cardiovascular disease.
 
 Chapter 4 describes the effects of aortic wall pathology on aortic valve and LV function in 
patients with a non-stenotic bicuspid aortic valve. In this study, twenty patients with bicuspid 
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aortic valve disease and 20 age- and gender-matched healthy subjects were prospectively 
studied with MRI. Reduced aortic elasticity and aortic root dilatation were frequently 
observed, as indicators of proximal aortic wall disease. Furthermore, reduced aortic wall 
elasticity was associated with severity of aortic regurgitation and degree of LV hypertrophy, 
indicating that intrinsic aortic wall abnormalities in bicuspid aortic valve disease result in a 
negative cascade that affects aortic elasticity, aortic dimensions, aortic valve competence 
and LV function. 
 Chapter 5 describes the interaction between aortic elasticity and dimensions, aortic valve 
competence and LV function in 15 patients after the arterial switch operation and 15 age- 
and sex-matched control subjects. A similar cascade as in the previous chapter was observed, 
revealing frequent aortic root dilatation and reduced elasticity of the proximal aorta, associated 
with minor degrees of aortic regurgitation, reduced LV systolic function and enlarged LV 
dimensions. Therefore, despite the fact that the arterial switch operation has significantly 
reduced the number of sequelae associated with surgical correction of transposition of the 
great arteries, the current findings might pose a prognostic risk for patients after the arterial 
switch operation.
 Chapter 6 describes the results of pulmonary flow dynamics in relationship with RV 
function in 17 patients with transposition of the great arteries, late after the arterial switch 
operation and 17 matched healthy controls. Supravalvar pulmonary artery stenosis has been 
reported to be the most frequent complication after arterial switch operation. This study 
reveals that increased peak-flow velocities are present across the pulmonary trunk even in 
patients without significant stenosis at the surgical anastomosis. Loss of distensibility due to 
local scar-tissue as well as minor degrees of narrowing at the site of anastomosis or peripheral 
pulmonary branches are probably the underlying reason. RV hypertrophy and RV relaxation 
abnormalities were found to be hemodynamic consequences, whereas systolic RV function is 
well preserved.
 
 Chapter 7 reports on the relationship between the aorta, aortic valve and LV function 
in patients with repaired tetralogy of Fallot. In our study we examined 16 tetralogy of Fallot 
patients after pulmonary valve replacement, to minimize the possible confounding effect of 
adverse right-to-left ventricular interaction due to pulmonary regurgitation, and 16 matched 
healthy controls. This study revealed frequent aortic root dilatation and reduced elasticity 
of the proximal aorta, associated with minor degrees of aortic regurgitation and reduced 
LV systolic function. The current findings suggest that aortic wall pathology in repaired 




 Chapter 8 describes the outcome of 53 consecutive patients who have previously 
undergone the Ross procedure in our institution for a dysfunctioning aortic valve. During the 
Ross procedure, a stenotic or insufficient aortic valve is replaced by a pulmonary autograft, 
with reconstruction of the right ventricular outflow tract using a pulmonary homograft. Early 
mortality occurred in 3 patients (5.6%), while 3 patients died 13 months, 5 and 6 years after the 
Ross operation, respectively (5.6%). Functional status of all survivors was excellent, although 
the majority of our patients showed autograft dilatation with concomitant aortic regurgitation. 
Therefore, the Ross procedure is considered to be of use especially in the pediatric population 
as it provides a growing aortic valve substitute, but should only be considered when valve-
sparing techniques can no longer provide a solution for pediatric aortic valve disease.
 Chapter 9 studies aortic dimensions and elasticity, aortic valve competence and LV function 
in 18 patients after the Ross procedure and 18 age- and sex-matched healthy subjects. Frequent 
dilatation of the autograft has been reported in literature during follow-up. The current study 
reveals not only dilatation, but also decreased distensibility of the aortic root, concomitant 
aortic regurgitation and reduced LV ejection fraction at a mean of 8 years of follow-up. Long-
term sequelae after the Ross are therefore not only limited to the aorta, but extend towards 
the aortic valve and LV.
 Finally, Chapter 10 evaluates the relationship between pulmonary flow dynamics and RV 
function in 17 patients after the Ross procedure and 17 age- and gender matched healthy 
subjects. Pulmonary homograft stenosis is the main cause for re-operation after the Ross 
procedure, necessary in approximately 10% of all cases at long-term follow-up. Little is however 
known about the effect of early homograft stenosis on RV function. In this study, MRI revealed 
mild degrees of homograft stenosis in most patients after the Ross procedure at a mean of 
8.3 years of follow-up, with hemodynamic consequences like RV hypertrophy and RV diastolic 
dysfunction. Systolic RV function was still preserved. Therefore, as MRI is able to detect even 
subtle homograft valve and RV dysfunction, it may facilitate better selection of patients who 
need re-operation after the Ross procedure for homograft valve dysfunction.
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General conclusions
The MRI studies described in this thesis aimed to clarify the relation between aortic wall 
pathology, as expressed by measurements of aortic elasticity and dimensions, and aortic valve 
and LV function in different entities with intrinsic aortic wall abnormalities. MRI was also used 
to test whether a similar interaction is present between pulmonary artery dynamics and the 
right ventricle.
We have shown that:
1.  non-invasive MRI assessment of the pulse wave velocity of the aorta is in good 
agreement with the gold-standard as derived by invasive pressure measurements 
and can be assessed with high reproducibility.
2.  intrinsic aortic wall abnormalities result in a negative cascade of reduced aortic 
elasticity and increased aortic dimensions, and associated aortic valve- and LV 
dysfunction. 
3.  disturbed pulmonary flow dynamics by local stenosis or loss of distensibility result in 
pulmonary valve- and right ventricular dysfunction.
4.  integrated MRI assessment of aortic elasticity and aortic dimensions, as well as aortic 
valve competence and LV function may be useful in the work-up of patients with 
intrinsic aortic wall abnormalities like bicuspid aortic valve disease, transposition of 




Dit proefschrift beschrijft de rol van MRI (Magnetic Resonance Imaging) bij het in kaart 
brengen van de relatie tussen de dimensies en elasticiteit van de aorta en de aortaklep- en 
linker hartkamerfunctie bij patiënten met een bicuspide aortaklep, transpositie van de grote 
vaten, tetralogie van Fallot en patiënten na de Ross operatie. Tevens werd met behulp van MRI 
gekeken naar de interactie tussen de pulmonaal arterie en de rechter hartkamer bij dezelfde 
ziektebeelden. 
 
 Hoofdstuk 1 biedt algemene achtergrondinformatie over de interactie tussen de aorta, de 
aortaklep- en linker hartkamerfunctie bij bovengenoemde ziektebeelden. 
 In hoofdstuk 2 wordt de huidige stand van zaken besproken bij de 5 meest 
voorkomende aangeboren hartafwijkingen en bindweefselaandoeningen met intrinsieke 
aortawandafwijkingen, met beschrijving van de potentiële rol van MRI bij het vaststellen en 
de follow-up van deze ziektebeelden. Het is bekend dat veranderingen in de aortawand bij 
patiënten met de ziekte van Marfan kunnen leiden tot complicaties zoals aneurysma vorming en 
dissectie van de aorta. De ziekte van Marfan kan daarbij worden beschouwd als een prototype 
voor andere aangeboren hartafwijkingen waarbij veranderingen in de aortawand optreden. Als 
gevolg van deze aortawandafwijkingen kan er een cascade op gang komen, met uiteindelijk 
linker hartkamerdisfunctie tot gevolg: verlies van matrixstructuur en elastische componenten 
in de aortawand leidt tot dilatatie en een afgenomen elasticiteit van de aorta. De negatieve 
effecten zijn een versnelde aortaklepdegeneratie en een verhoging van de afterload voor de 
linker hartkamer. Progressie van deze cascade zal uiteindelijk resulteren in een overbelasting 
van de linker hartkamer. Met behulp van MRI kan op betrouwbare en nauwkeurige wijze deze 
cascade in kaart worden gebracht, hetgeen van nut kan zijn bij een verbeterde selectie van 
patiënten voor chirurgische interventie en voor het meten van veranderingen in aortafunctie 
tijdens farmacotherapie.
 In hoofdstuk 3 wordt de in vivo validatie beschreven van metingen van de polsgolfsnelheid 
in de aorta gemeten met behulp van MRI (PWVMRI). PWVMRI en de polsgolfsnelheid gemeten met 
behulp van invasieve drukmetingen werden met elkaar vergeleken bij 18 patiënten die een 
diagnostische hartkatheterisatie ondergingen. Non-invasieve PWVMRI van de proximale aorta, 
distale aorta en totale aorta bleken goed overeen te komen met de invasieve drukmetingen. 
Daarnaast werd de reproduceerbaarheid getest van PWVMRI door bij 10 gezonde vrijwilligers 
de PWVMRI tweemaal te meten op dezelfde dag. De reproduceerbaarheid bleek hoog te zijn, 
ondanks een fysiologische variatie van de aortale polsgolfsnelheid. Geconcludeerd wordt dat 
MRI een betrouwbare methode is voor het meten van polsgolfsnelheid in de aorta. MRI heeft 
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bovendien de voordelen dat de methode niet-invasief is en dat er geen gebruik wordt gemaakt 
van röntgentechnieken.
 In hoofdstuk 4 wordt de relatie beschreven tussen de dimensies en de elasticiteit van de aorta 
en de aortaklep- en linker hartkamerfunctie bij patiënten met een niet-stenotische bicuspide 
aortaklep. In deze MRI-studie werden 20 patiënten met een bicuspide aortaklep vergeleken 
met 20 gezonde vrijwilligers. Bij een groot deel van het aantal onderzochte patiënten werd een 
afgenomen elasticiteit en dilatatie van de aorta vastgesteld, hetgeen was geassocieerd met 
de mate van aortaklepinsufficiëntie en linker hartkamerhypertrofie. Aangezien deze laatste 
twee factoren op de lange termijn zijn gerelateerd aan diastolische en systolische disfunctie 
van de linker hartkamer, kunnen deze bevindingen prognostische betekenis hebben voor het 
optreden van hartfalen op latere leeftijd. Follow-up van dimensies en elasticiteit van de aorta, 
in combinatie met aortaklep- en linker hartkamerfunctie wordt daarom aanbevolen voor deze 
groep van patiënten.
 In hoofdstuk 5 wordt de interactie beschreven tussen de aorta, de aortaklep en de linker 
hartkamer bij 15 patiënten geboren met transpositie van de grote vaten, bij wie ter correctie 
een arteriële switch operatie (ASO) werd uitgevoerd. Een vergelijkbare cascade zoals in het 
vorige hoofdstuk wordt bij de ASO patiëntengroep beschreven: aortawortel dilatatie en 
afgenomen aorta-elasticiteit zijn geassocieerd met aortaklep- en linker hartkamerdisfunctie. 
Ondanks het feit dat het gebruik van de ASO een duidelijke afname heeft gegenereerd van het 
aantal complicaties in vergelijking met de in het verleden gebruikte chirurgische technieken, 
kunnen de genoemde factoren mogelijk leiden tot het optreden van hartfalen op latere leeftijd 
bij de onderzochte groep ASO patiënten.
 
 In hoofdstuk 6 wordt de relatie beschreven tussen de pulmonale circulatie en de 
rechter hartkamerfunctie, bij 17 patiënten die geboren zijn met transpositie van de 
grote vaten - gecorrigeerd middels de ASO - en 17 gezonde vrijwilligers. Supravalvulaire 
pulmonaalklepstenose is de meest frequente complicatie na de ASO. Deze studie toont 
aan dat verhoogde snelheden van het bloed in de pulmonaal arterie in patiënten aanwezig 
kunnen zijn zonder een significante stenose. Verlies van elasticiteit van de pulmonaal arterie 
ten gevolge van lokaal littekenweefsel en een lichte mate van vernauwing ter plaatse van de 
pulmonalis hoofdstam en de perifere takken worden verondersteld als meest waarschijnlijke 
oorzaken. Rechter hartkamerhypertrofie en diastolische disfunctie werden vastgesteld als 
vroege aanwijzingen van rechter hartkamerdisfunctie, terwijl de systolische functie van de 
rechter hartkamer relatief was gespaard.
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 In hoofdstuk 7 wordt de relatie behandeld tussen de aorta, de aortaklep en de linker 
hartkamer bij tetralogie van Fallot patiënten na een pulmonaalklepvervanging. Deze studie 
toonde frequente dilatatie en een afgenomen elasticiteit van de aorta aan, welke zijn 
geassocieerd met aortaklepinsufficiëntie en een afgenomen linker hartkamerfunctie. Linker 
hartkamerdisfunctie bij tetralogie van Fallot patiënten werd tot op heden voornamelijk 
verklaard door een zogenaamde ‘negatieve rechts-links interactie’. Hierbij zou een gedilateerde 
rechter hartkamer als gevolg van langdurig bestaande pulmonaalklepinsufficiëntie kunnen 
leiden tot linker hartkamerdisfunctie. Uit deze studie blijkt dat, naast deze verklaring, ook de 
aortawandpathologie bijdraagt aan aortaklep- en linker hartkamerdisfunctie bij patiënten na 
chirurgische correctie van tetralogie van Fallot.
 In hoofdstuk 8 wordt de lange termijn uitkomst beschreven van 53 patiënten met 
een disfunctionerende aortaklep die de Ross operatie hebben ondergaan. Gedurende 
de Ross operatie wordt de lekkende, dan wel vernauwde, aortaklep vervangen door de 
eigen pulmonaalklep van de patiënt, met plaatsing van een donorklep op de opengevallen 
pulmonaalklep-positie. In totaal overleden 6 patiënten, van wie 3 patiënten postoperatief 
(5.6%) en 3 patiënten overleden na respectievelijk 13 maanden, 5 jaar en 6 jaar na de Ross 
operatie (5.6%). De klinische toestand van de resterende patiënten was weliswaar uitstekend, 
maar bij de meerderheid was er sprake van dilatatie en insufficiëntie van de pulmonaalklep 
in aortaklep-positie. De Ross operatie wordt daarom beschouwd als een goed chirurgisch 
alternatief vooral voor kinderen: de nieuwe klep kan immers meegroeien met het kind. De 
Ross operatie dient alleen te worden overwogen als klepsparende chirurgische technieken 
niet mogelijk zijn.
 In hoofdstuk 9 wordt de relatie beschreven tussen dimensies en elasticiteit van de aorta en 
de aortaklep- en linker hartkamerfunctie bij 18 patiënten na de Ross operatie en 18 gezonde 
vrijwilligers. Dilatatie van de nieuwe aortawortel wordt frequent beschreven in de literatuur. 
Deze studie toont aan dat niet alleen dilatatie, maar ook een afgenomen elasticiteit van de 
aortawortel vaak voorkomt, samen met geassocieerde aortaklepinsufficiëntie en systolische 
linker hartkamerdisfunctie. Nadat de pulmonaalklep in aortaklep-positie is geplaatst, leiden 
een verstoorde lokale microcirculatie van de vaatwand en de blootstelling aan hogere 
systeemdrukken van de voormalige pulmonaal arterie vaatwand waarschijnlijk tot een 
versneld degeneratief proces, resulterend in de beschreven afwijkingen. 
 
 In het laatste hoofdstuk van dit proefschrift (hoofdstuk 10) wordt de relatie beschreven 
tussen de pulmonale flow dynamiek en de rechter hartkamerfunctie bij 17 patiënten 
na de Ross operatie. Pulmonaalklepstenose is de belangrijkste reden van re-operatie na 
de Ross operatie, noodzakelijk bij ongeveer 10% van alle patiënten. Er is echter weinig 
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bekend over het effect van een milde vorm van stenose op de rechter hartkamerfunctie. 
Deze studie laat zien dat het grootste deel van het aantal Ross patiënten, gemiddeld 
8.3 jaar postoperatief, een milde vorm van pulmonaalklepstenose heeft, met rechter 
hartkamerhypertrofie en diastolische disfunctie tot gevolg. De systolische functie van de 
rechter hartkamer blijkt vooralsnog relatief te zijn gespaard. Aangezien het met behulp 
van MRI mogelijk is om zelfs een geringe mate van pulmonaalklepstenose en rechter 
hartkamerdisfunctie aan te tonen, wordt aanbevolen om MRI te gebruiken voor de follow-




De MRI-studies beschreven in dit proefschrift zijn bedoeld om meer inzicht te verkrijgen 
in de relatie tussen de dimensies en elasticiteit van de aorta en de aortaklep- en linker 
hartkamerfunctie bij patiënten met een bicuspide aortaklep, transpositie van de grote 
vaten, tetralogie van Fallot en patiënten na de Ross operatie. Tevens werd met behulp van 
MRI gekeken naar de interactie tussen de pulmonaal arterie en de rechter hartkamer bij de 
genoemde ziektebeelden.
 
Deze studies tonen aan dat:
1.  MRI een betrouwbare en reproduceerbare non-invasieve methode is om de 
polsgolfsnelheid in de aorta vast te stellen.
2.  aortawandafwijkingen niet alleen leiden tot dilatatie en een afgenomen elasticiteit 
van de aorta, maar ook tot aortaklep- en linker hartkamerdisfunctie. 
3.  een verstoorde pulmonale flow dynamiek, als gevolg van stenose of afgenomen 
distensibiliteit, leidt tot pulmonaalklep- en rechter hartkamerdisfunctie.
4.  MRI metingen van dimensies en elasticiteit van de aorta en aortaklep- en linker 
hartkamerfunctie van belang zijn voor de follow-up van patiënten met intrinsieke 
aortawandafwijkingen zoals bij een bicuspide aortaklep, transpositie van de grote 
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